{"text": "VIOKACE tablets, in combination with a proton pump inhibitor, is indicated in adults for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy. VIOKACE is a combination of porcine-derived lipases, proteases, and amylases. VIOKACE, in combination with a proton pump inhibitor, is indicated in adults for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy. (1)", "_input_hash": 435503004, "_task_hash": -1196171347, "_is_binary": false, "tokens": [{"text": "VIOKACE", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "tablets", "start": 8, "end": 15, "id": 1, "ws": false}, {"text": ",", "start": 15, "end": 16, "id": 2, "ws": true}, {"text": "in", "start": 17, "end": 19, "id": 3, "ws": true}, {"text": "combination", "start": 20, "end": 31, "id": 4, "ws": true}, {"text": "with", "start": 32, "end": 36, "id": 5, "ws": true}, {"text": "a", "start": 37, "end": 38, "id": 6, "ws": true}, {"text": "proton", "start": 39, "end": 45, "id": 7, "ws": true}, {"text": "pump", "start": 46, "end": 50, "id": 8, "ws": true}, {"text": "inhibitor", "start": 51, "end": 60, "id": 9, "ws": false}, {"text": ",", "start": 60, "end": 61, "id": 10, "ws": true}, {"text": "is", "start": 62, "end": 64, "id": 11, "ws": true}, {"text": "indicated", "start": 65, "end": 74, "id": 12, "ws": true}, {"text": "in", "start": 75, "end": 77, "id": 13, "ws": true}, {"text": "adults", "start": 78, "end": 84, "id": 14, "ws": true}, {"text": "for", "start": 85, "end": 88, "id": 15, "ws": true}, {"text": "the", "start": 89, "end": 92, "id": 16, "ws": true}, {"text": "treatment", "start": 93, "end": 102, "id": 17, "ws": true}, {"text": "of", "start": 103, "end": 105, "id": 18, "ws": true}, {"text": "exocrine", "start": 106, "end": 114, "id": 19, "ws": true}, {"text": "pancreatic", "start": 115, "end": 125, "id": 20, "ws": true}, {"text": "insufficiency", "start": 126, "end": 139, "id": 21, "ws": true}, {"text": "due", "start": 140, "end": 143, "id": 22, "ws": true}, {"text": "to", "start": 144, "end": 146, "id": 23, "ws": true}, {"text": "chronic", "start": 147, "end": 154, "id": 24, "ws": true}, {"text": "pancreatitis", "start": 155, "end": 167, "id": 25, "ws": true}, {"text": "or", "start": 168, "end": 170, "id": 26, "ws": true}, {"text": "pancreatectomy", "start": 171, "end": 185, "id": 27, "ws": false}, {"text": ".", "start": 185, "end": 186, "id": 28, "ws": true}, {"text": "VIOKACE", "start": 187, "end": 194, "id": 29, "ws": true}, {"text": "is", "start": 195, "end": 197, "id": 30, "ws": true}, {"text": "a", "start": 198, "end": 199, "id": 31, "ws": true}, {"text": "combination", "start": 200, "end": 211, "id": 32, "ws": true}, {"text": "of", "start": 212, "end": 214, "id": 33, "ws": true}, {"text": "porcine", "start": 215, "end": 222, "id": 34, "ws": false}, {"text": "-", "start": 222, "end": 223, "id": 35, "ws": false}, {"text": "derived", "start": 223, "end": 230, "id": 36, "ws": true}, {"text": "lipases", "start": 231, "end": 238, "id": 37, "ws": false}, {"text": ",", "start": 238, "end": 239, "id": 38, "ws": true}, {"text": "proteases", "start": 240, "end": 249, "id": 39, "ws": false}, {"text": ",", "start": 249, "end": 250, "id": 40, "ws": true}, {"text": "and", "start": 251, "end": 254, "id": 41, "ws": true}, {"text": "amylases", "start": 255, "end": 263, "id": 42, "ws": false}, {"text": ".", "start": 263, "end": 264, "id": 43, "ws": true}, {"text": "VIOKACE", "start": 265, "end": 272, "id": 44, "ws": false}, {"text": ",", "start": 272, "end": 273, "id": 45, "ws": true}, {"text": "in", "start": 274, "end": 276, "id": 46, "ws": true}, {"text": "combination", "start": 277, "end": 288, "id": 47, "ws": true}, {"text": "with", "start": 289, "end": 293, "id": 48, "ws": true}, {"text": "a", "start": 294, "end": 295, "id": 49, "ws": true}, {"text": "proton", "start": 296, "end": 302, "id": 50, "ws": true}, {"text": "pump", "start": 303, "end": 307, "id": 51, "ws": true}, {"text": "inhibitor", "start": 308, "end": 317, "id": 52, "ws": false}, {"text": ",", "start": 317, "end": 318, "id": 53, "ws": true}, {"text": "is", "start": 319, "end": 321, "id": 54, "ws": true}, {"text": "indicated", "start": 322, "end": 331, "id": 55, "ws": true}, {"text": "in", "start": 332, "end": 334, "id": 56, "ws": true}, {"text": "adults", "start": 335, "end": 341, "id": 57, "ws": true}, {"text": "for", "start": 342, "end": 345, "id": 58, "ws": true}, {"text": "the", "start": 346, "end": 349, "id": 59, "ws": true}, {"text": "treatment", "start": 350, "end": 359, "id": 60, "ws": true}, {"text": "of", "start": 360, "end": 362, "id": 61, "ws": true}, {"text": "exocrine", "start": 363, "end": 371, "id": 62, "ws": true}, {"text": "pancreatic", "start": 372, "end": 382, "id": 63, "ws": true}, {"text": "insufficiency", "start": 383, "end": 396, "id": 64, "ws": true}, {"text": "due", "start": 397, "end": 400, "id": 65, "ws": true}, {"text": "to", "start": 401, "end": 403, "id": 66, "ws": true}, {"text": "chronic", "start": 404, "end": 411, "id": 67, "ws": true}, {"text": "pancreatitis", "start": 412, "end": 424, "id": 68, "ws": true}, {"text": "or", "start": 425, "end": 427, "id": 69, "ws": true}, {"text": "pancreatectomy", "start": 428, "end": 442, "id": 70, "ws": false}, {"text": ".", "start": 442, "end": 443, "id": 71, "ws": true}, {"text": "(", "start": 444, "end": 445, "id": 72, "ws": false}, {"text": "1", "start": 445, "end": 446, "id": 73, "ws": false}, {"text": ")", "start": 446, "end": 447, "id": 74, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 8, "end": 15, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 39, "end": 60, "token_start": 7, "token_end": 9, "label": "CO_PRESCRIPTION"}, {"start": 78, "end": 84, "token_start": 14, "token_end": 14, "label": "TARGET_GROUP"}, {"start": 93, "end": 102, "token_start": 17, "token_end": 17, "label": "ACTION"}, {"start": 106, "end": 139, "token_start": 19, "token_end": 21, "label": "INDICATION"}, {"start": 140, "end": 185, "token_start": 22, "token_end": 27, "label": "CAUSED_BY"}], "answer": "accept", "_timestamp": 1694526134, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Verkazia ophthalmic emulsion is indicated for the treatment of vernal keratoconjunctivitis (VKC) in children and adults. Verkazia ophthalmic emulsion is a calcineurin inhibitor immunosuppressant indicated for the treatment of vernal keratoconjunctivitis in children and adults ( 1)", "_input_hash": 1799676102, "_task_hash": -696850929, "_is_binary": false, "tokens": [{"text": "Verkazia", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "ophthalmic", "start": 9, "end": 19, "id": 1, "ws": true}, {"text": "emulsion", "start": 20, "end": 28, "id": 2, "ws": true}, {"text": "is", "start": 29, "end": 31, "id": 3, "ws": true}, {"text": "indicated", "start": 32, "end": 41, "id": 4, "ws": true}, {"text": "for", "start": 42, "end": 45, "id": 5, "ws": true}, {"text": "the", "start": 46, "end": 49, "id": 6, "ws": true}, {"text": "treatment", "start": 50, "end": 59, "id": 7, "ws": true}, {"text": "of", "start": 60, "end": 62, "id": 8, "ws": true}, {"text": "vernal", "start": 63, "end": 69, "id": 9, "ws": true}, {"text": "keratoconjunctivitis", "start": 70, "end": 90, "id": 10, "ws": true}, {"text": "(", "start": 91, "end": 92, "id": 11, "ws": false}, {"text": "VKC", "start": 92, "end": 95, "id": 12, "ws": false}, {"text": ")", "start": 95, "end": 96, "id": 13, "ws": true}, {"text": "in", "start": 97, "end": 99, "id": 14, "ws": true}, {"text": "children", "start": 100, "end": 108, "id": 15, "ws": true}, {"text": "and", "start": 109, "end": 112, "id": 16, "ws": true}, {"text": "adults", "start": 113, "end": 119, "id": 17, "ws": false}, {"text": ".", "start": 119, "end": 120, "id": 18, "ws": true}, {"text": "Verkazia", "start": 121, "end": 129, "id": 19, "ws": true}, {"text": "ophthalmic", "start": 130, "end": 140, "id": 20, "ws": true}, {"text": "emulsion", "start": 141, "end": 149, "id": 21, "ws": true}, {"text": "is", "start": 150, "end": 152, "id": 22, "ws": true}, {"text": "a", "start": 153, "end": 154, "id": 23, "ws": true}, {"text": "calcineurin", "start": 155, "end": 166, "id": 24, "ws": true}, {"text": "inhibitor", "start": 167, "end": 176, "id": 25, "ws": true}, {"text": "immunosuppressant", "start": 177, "end": 194, "id": 26, "ws": true}, {"text": "indicated", "start": 195, "end": 204, "id": 27, "ws": true}, {"text": "for", "start": 205, "end": 208, "id": 28, "ws": true}, {"text": "the", "start": 209, "end": 212, "id": 29, "ws": true}, {"text": "treatment", "start": 213, "end": 222, "id": 30, "ws": true}, {"text": "of", "start": 223, "end": 225, "id": 31, "ws": true}, {"text": "vernal", "start": 226, "end": 232, "id": 32, "ws": true}, {"text": "keratoconjunctivitis", "start": 233, "end": 253, "id": 33, "ws": true}, {"text": "in", "start": 254, "end": 256, "id": 34, "ws": true}, {"text": "children", "start": 257, "end": 265, "id": 35, "ws": true}, {"text": "and", "start": 266, "end": 269, "id": 36, "ws": true}, {"text": "adults", "start": 270, "end": 276, "id": 37, "ws": true}, {"text": "(", "start": 277, "end": 278, "id": 38, "ws": true}, {"text": "1", "start": 279, "end": 280, "id": 39, "ws": false}, {"text": ")", "start": 280, "end": 281, "id": 40, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 19, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 20, "end": 28, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 50, "end": 59, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 63, "end": 90, "token_start": 9, "token_end": 10, "label": "INDICATION"}, {"start": 100, "end": 108, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 113, "end": 119, "token_start": 17, "token_end": 17, "label": "TARGET_GROUP"}, {"start": 121, "end": 129, "token_start": 19, "token_end": 19, "label": "DRUG"}, {"start": 130, "end": 140, "token_start": 20, "token_end": 20, "label": "ROUTE"}, {"start": 141, "end": 149, "token_start": 21, "token_end": 21, "label": "FORMULATION"}, {"start": 155, "end": 194, "token_start": 24, "token_end": 26, "label": "MECHANISM"}, {"start": 213, "end": 222, "token_start": 30, "token_end": 30, "label": "ACTION"}, {"start": 226, "end": 253, "token_start": 32, "token_end": 33, "label": "INDICATION"}, {"start": 257, "end": 265, "token_start": 35, "token_end": 35, "label": "TARGET_GROUP"}, {"start": 270, "end": 276, "token_start": 37, "token_end": 37, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694526415, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "VARUBI is indicated in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. VARUBI is a substance P/neurokinin 1 (NK1) receptor antagonist indicated in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. (1)", "_input_hash": -908696794, "_task_hash": 504257753, "_is_binary": false, "tokens": [{"text": "VARUBI", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "is", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "indicated", "start": 10, "end": 19, "id": 2, "ws": true}, {"text": "in", "start": 20, "end": 22, "id": 3, "ws": true}, {"text": "combination", "start": 23, "end": 34, "id": 4, "ws": true}, {"text": "with", "start": 35, "end": 39, "id": 5, "ws": true}, {"text": "other", "start": 40, "end": 45, "id": 6, "ws": true}, {"text": "antiemetic", "start": 46, "end": 56, "id": 7, "ws": true}, {"text": "agents", "start": 57, "end": 63, "id": 8, "ws": true}, {"text": "in", "start": 64, "end": 66, "id": 9, "ws": true}, {"text": "adults", "start": 67, "end": 73, "id": 10, "ws": true}, {"text": "for", "start": 74, "end": 77, "id": 11, "ws": true}, {"text": "the", "start": 78, "end": 81, "id": 12, "ws": true}, {"text": "prevention", "start": 82, "end": 92, "id": 13, "ws": true}, {"text": "of", "start": 93, "end": 95, "id": 14, "ws": true}, {"text": "delayed", "start": 96, "end": 103, "id": 15, "ws": true}, {"text": "nausea", "start": 104, "end": 110, "id": 16, "ws": true}, {"text": "and", "start": 111, "end": 114, "id": 17, "ws": true}, {"text": "vomiting", "start": 115, "end": 123, "id": 18, "ws": true}, {"text": "associated", "start": 124, "end": 134, "id": 19, "ws": true}, {"text": "with", "start": 135, "end": 139, "id": 20, "ws": true}, {"text": "initial", "start": 140, "end": 147, "id": 21, "ws": true}, {"text": "and", "start": 148, "end": 151, "id": 22, "ws": true}, {"text": "repeat", "start": 152, "end": 158, "id": 23, "ws": true}, {"text": "courses", "start": 159, "end": 166, "id": 24, "ws": true}, {"text": "of", "start": 167, "end": 169, "id": 25, "ws": true}, {"text": "emetogenic", "start": 170, "end": 180, "id": 26, "ws": true}, {"text": "cancer", "start": 181, "end": 187, "id": 27, "ws": true}, {"text": "chemotherapy", "start": 188, "end": 200, "id": 28, "ws": false}, {"text": ",", "start": 200, "end": 201, "id": 29, "ws": true}, {"text": "including", "start": 202, "end": 211, "id": 30, "ws": false}, {"text": ",", "start": 211, "end": 212, "id": 31, "ws": true}, {"text": "but", "start": 213, "end": 216, "id": 32, "ws": true}, {"text": "not", "start": 217, "end": 220, "id": 33, "ws": true}, {"text": "limited", "start": 221, "end": 228, "id": 34, "ws": true}, {"text": "to", "start": 229, "end": 231, "id": 35, "ws": false}, {"text": ",", "start": 231, "end": 232, "id": 36, "ws": true}, {"text": "highly", "start": 233, "end": 239, "id": 37, "ws": true}, {"text": "emetogenic", "start": 240, "end": 250, "id": 38, "ws": true}, {"text": "chemotherapy", "start": 251, "end": 263, "id": 39, "ws": false}, {"text": ".", "start": 263, "end": 264, "id": 40, "ws": true}, {"text": "VARUBI", "start": 265, "end": 271, "id": 41, "ws": true}, {"text": "is", "start": 272, "end": 274, "id": 42, "ws": true}, {"text": "a", "start": 275, "end": 276, "id": 43, "ws": true}, {"text": "substance", "start": 277, "end": 286, "id": 44, "ws": true}, {"text": "P", "start": 287, "end": 288, "id": 45, "ws": false}, {"text": "/", "start": 288, "end": 289, "id": 46, "ws": false}, {"text": "neurokinin", "start": 289, "end": 299, "id": 47, "ws": true}, {"text": "1", "start": 300, "end": 301, "id": 48, "ws": true}, {"text": "(", "start": 302, "end": 303, "id": 49, "ws": false}, {"text": "NK1", "start": 303, "end": 306, "id": 50, "ws": false}, {"text": ")", "start": 306, "end": 307, "id": 51, "ws": true}, {"text": "receptor", "start": 308, "end": 316, "id": 52, "ws": true}, {"text": "antagonist", "start": 317, "end": 327, "id": 53, "ws": true}, {"text": "indicated", "start": 328, "end": 337, "id": 54, "ws": true}, {"text": "in", "start": 338, "end": 340, "id": 55, "ws": true}, {"text": "combination", "start": 341, "end": 352, "id": 56, "ws": true}, {"text": "with", "start": 353, "end": 357, "id": 57, "ws": true}, {"text": "other", "start": 358, "end": 363, "id": 58, "ws": true}, {"text": "antiemetic", "start": 364, "end": 374, "id": 59, "ws": true}, {"text": "agents", "start": 375, "end": 381, "id": 60, "ws": true}, {"text": "in", "start": 382, "end": 384, "id": 61, "ws": true}, {"text": "adults", "start": 385, "end": 391, "id": 62, "ws": true}, {"text": "for", "start": 392, "end": 395, "id": 63, "ws": true}, {"text": "the", "start": 396, "end": 399, "id": 64, "ws": true}, {"text": "prevention", "start": 400, "end": 410, "id": 65, "ws": true}, {"text": "of", "start": 411, "end": 413, "id": 66, "ws": true}, {"text": "delayed", "start": 414, "end": 421, "id": 67, "ws": true}, {"text": "nausea", "start": 422, "end": 428, "id": 68, "ws": true}, {"text": "and", "start": 429, "end": 432, "id": 69, "ws": true}, {"text": "vomiting", "start": 433, "end": 441, "id": 70, "ws": true}, {"text": "associated", "start": 442, "end": 452, "id": 71, "ws": true}, {"text": "with", "start": 453, "end": 457, "id": 72, "ws": true}, {"text": "initial", "start": 458, "end": 465, "id": 73, "ws": true}, {"text": "and", "start": 466, "end": 469, "id": 74, "ws": true}, {"text": "repeat", "start": 470, "end": 476, "id": 75, "ws": true}, {"text": "courses", "start": 477, "end": 484, "id": 76, "ws": true}, {"text": "of", "start": 485, "end": 487, "id": 77, "ws": true}, {"text": "emetogenic", "start": 488, "end": 498, "id": 78, "ws": true}, {"text": "cancer", "start": 499, "end": 505, "id": 79, "ws": true}, {"text": "chemotherapy", "start": 506, "end": 518, "id": 80, "ws": false}, {"text": ",", "start": 518, "end": 519, "id": 81, "ws": true}, {"text": "including", "start": 520, "end": 529, "id": 82, "ws": false}, {"text": ",", "start": 529, "end": 530, "id": 83, "ws": true}, {"text": "but", "start": 531, "end": 534, "id": 84, "ws": true}, {"text": "not", "start": 535, "end": 538, "id": 85, "ws": true}, {"text": "limited", "start": 539, "end": 546, "id": 86, "ws": true}, {"text": "to", "start": 547, "end": 549, "id": 87, "ws": false}, {"text": ",", "start": 549, "end": 550, "id": 88, "ws": true}, {"text": "highly", "start": 551, "end": 557, "id": 89, "ws": true}, {"text": "emetogenic", "start": 558, "end": 568, "id": 90, "ws": true}, {"text": "chemotherapy", "start": 569, "end": 581, "id": 91, "ws": false}, {"text": ".", "start": 581, "end": 582, "id": 92, "ws": true}, {"text": "(", "start": 583, "end": 584, "id": 93, "ws": false}, {"text": "1", "start": 584, "end": 585, "id": 94, "ws": false}, {"text": ")", "start": 585, "end": 586, "id": 95, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 82, "end": 95, "token_start": 13, "token_end": 14, "label": "ACTION"}, {"start": 96, "end": 110, "token_start": 15, "token_end": 16, "label": "INDICATION"}, {"start": 115, "end": 123, "token_start": 18, "token_end": 18, "label": "INDICATION"}, {"start": 140, "end": 200, "token_start": 21, "token_end": 28, "label": "MEDICAL_CTX"}, {"start": 265, "end": 271, "token_start": 41, "token_end": 41, "label": "DRUG"}, {"start": 277, "end": 327, "token_start": 44, "token_end": 53, "label": "MECHANISM"}, {"start": 400, "end": 413, "token_start": 65, "token_end": 66, "label": "ACTION"}, {"start": 414, "end": 428, "token_start": 67, "token_end": 68, "label": "INDICATION"}, {"start": 433, "end": 441, "token_start": 70, "token_end": 70, "label": "INDICATION"}, {"start": 458, "end": 518, "token_start": 73, "token_end": 80, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694175141, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "NYMALIZE is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V). NYMALIZE is a dihydropyridine calcium channel blocker indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V). (1)", "_input_hash": -765477027, "_task_hash": -1757786262, "_is_binary": false, "tokens": [{"text": "NYMALIZE", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "improvement", "start": 30, "end": 41, "id": 5, "ws": true}, {"text": "of", "start": 42, "end": 44, "id": 6, "ws": true}, {"text": "neurological", "start": 45, "end": 57, "id": 7, "ws": true}, {"text": "outcome", "start": 58, "end": 65, "id": 8, "ws": true}, {"text": "by", "start": 66, "end": 68, "id": 9, "ws": true}, {"text": "reducing", "start": 69, "end": 77, "id": 10, "ws": true}, {"text": "the", "start": 78, "end": 81, "id": 11, "ws": true}, {"text": "incidence", "start": 82, "end": 91, "id": 12, "ws": true}, {"text": "and", "start": 92, "end": 95, "id": 13, "ws": true}, {"text": "severity", "start": 96, "end": 104, "id": 14, "ws": true}, {"text": "of", "start": 105, "end": 107, "id": 15, "ws": true}, {"text": "ischemic", "start": 108, "end": 116, "id": 16, "ws": true}, {"text": "deficits", "start": 117, "end": 125, "id": 17, "ws": true}, {"text": "in", "start": 126, "end": 128, "id": 18, "ws": true}, {"text": "adult", "start": 129, "end": 134, "id": 19, "ws": true}, {"text": "patients", "start": 135, "end": 143, "id": 20, "ws": true}, {"text": "with", "start": 144, "end": 148, "id": 21, "ws": true}, {"text": "subarachnoid", "start": 149, "end": 161, "id": 22, "ws": true}, {"text": "hemorrhage", "start": 162, "end": 172, "id": 23, "ws": true}, {"text": "(", "start": 173, "end": 174, "id": 24, "ws": false}, {"text": "SAH", "start": 174, "end": 177, "id": 25, "ws": false}, {"text": ")", "start": 177, "end": 178, "id": 26, "ws": true}, {"text": "from", "start": 179, "end": 183, "id": 27, "ws": true}, {"text": "ruptured", "start": 184, "end": 192, "id": 28, "ws": true}, {"text": "intracranial", "start": 193, "end": 205, "id": 29, "ws": true}, {"text": "berry", "start": 206, "end": 211, "id": 30, "ws": true}, {"text": "aneurysms", "start": 212, "end": 221, "id": 31, "ws": true}, {"text": "regardless", "start": 222, "end": 232, "id": 32, "ws": true}, {"text": "of", "start": 233, "end": 235, "id": 33, "ws": true}, {"text": "their", "start": 236, "end": 241, "id": 34, "ws": true}, {"text": "post", "start": 242, "end": 246, "id": 35, "ws": false}, {"text": "-", "start": 246, "end": 247, "id": 36, "ws": false}, {"text": "ictus", "start": 247, "end": 252, "id": 37, "ws": true}, {"text": "neurological", "start": 253, "end": 265, "id": 38, "ws": true}, {"text": "condition", "start": 266, "end": 275, "id": 39, "ws": true}, {"text": "(", "start": 276, "end": 277, "id": 40, "ws": false}, {"text": "i.e.", "start": 277, "end": 281, "id": 41, "ws": false}, {"text": ",", "start": 281, "end": 282, "id": 42, "ws": true}, {"text": "Hunt", "start": 283, "end": 287, "id": 43, "ws": true}, {"text": "and", "start": 288, "end": 291, "id": 44, "ws": true}, {"text": "Hess", "start": 292, "end": 296, "id": 45, "ws": true}, {"text": "Grades", "start": 297, "end": 303, "id": 46, "ws": true}, {"text": "I", "start": 304, "end": 305, "id": 47, "ws": false}, {"text": "-", "start": 305, "end": 306, "id": 48, "ws": false}, {"text": "V", "start": 306, "end": 307, "id": 49, "ws": false}, {"text": ")", "start": 307, "end": 308, "id": 50, "ws": false}, {"text": ".", "start": 308, "end": 309, "id": 51, "ws": true}, {"text": "NYMALIZE", "start": 310, "end": 318, "id": 52, "ws": true}, {"text": "is", "start": 319, "end": 321, "id": 53, "ws": true}, {"text": "a", "start": 322, "end": 323, "id": 54, "ws": true}, {"text": "dihydropyridine", "start": 324, "end": 339, "id": 55, "ws": true}, {"text": "calcium", "start": 340, "end": 347, "id": 56, "ws": true}, {"text": "channel", "start": 348, "end": 355, "id": 57, "ws": true}, {"text": "blocker", "start": 356, "end": 363, "id": 58, "ws": true}, {"text": "indicated", "start": 364, "end": 373, "id": 59, "ws": true}, {"text": "for", "start": 374, "end": 377, "id": 60, "ws": true}, {"text": "the", "start": 378, "end": 381, "id": 61, "ws": true}, {"text": "improvement", "start": 382, "end": 393, "id": 62, "ws": true}, {"text": "of", "start": 394, "end": 396, "id": 63, "ws": true}, {"text": "neurological", "start": 397, "end": 409, "id": 64, "ws": true}, {"text": "outcome", "start": 410, "end": 417, "id": 65, "ws": true}, {"text": "by", "start": 418, "end": 420, "id": 66, "ws": true}, {"text": "reducing", "start": 421, "end": 429, "id": 67, "ws": true}, {"text": "the", "start": 430, "end": 433, "id": 68, "ws": true}, {"text": "incidence", "start": 434, "end": 443, "id": 69, "ws": true}, {"text": "and", "start": 444, "end": 447, "id": 70, "ws": true}, {"text": "severity", "start": 448, "end": 456, "id": 71, "ws": true}, {"text": "of", "start": 457, "end": 459, "id": 72, "ws": true}, {"text": "ischemic", "start": 460, "end": 468, "id": 73, "ws": true}, {"text": "deficits", "start": 469, "end": 477, "id": 74, "ws": true}, {"text": "in", "start": 478, "end": 480, "id": 75, "ws": true}, {"text": "adult", "start": 481, "end": 486, "id": 76, "ws": true}, {"text": "patients", "start": 487, "end": 495, "id": 77, "ws": true}, {"text": "with", "start": 496, "end": 500, "id": 78, "ws": true}, {"text": "subarachnoid", "start": 501, "end": 513, "id": 79, "ws": true}, {"text": "hemorrhage", "start": 514, "end": 524, "id": 80, "ws": true}, {"text": "(", "start": 525, "end": 526, "id": 81, "ws": false}, {"text": "SAH", "start": 526, "end": 529, "id": 82, "ws": false}, {"text": ")", "start": 529, "end": 530, "id": 83, "ws": true}, {"text": "from", "start": 531, "end": 535, "id": 84, "ws": true}, {"text": "ruptured", "start": 536, "end": 544, "id": 85, "ws": true}, {"text": "intracranial", "start": 545, "end": 557, "id": 86, "ws": true}, {"text": "berry", "start": 558, "end": 563, "id": 87, "ws": true}, {"text": "aneurysms", "start": 564, "end": 573, "id": 88, "ws": true}, {"text": "regardless", "start": 574, "end": 584, "id": 89, "ws": true}, {"text": "of", "start": 585, "end": 587, "id": 90, "ws": true}, {"text": "their", "start": 588, "end": 593, "id": 91, "ws": true}, {"text": "post", "start": 594, "end": 598, "id": 92, "ws": false}, {"text": "-", "start": 598, "end": 599, "id": 93, "ws": false}, {"text": "ictus", "start": 599, "end": 604, "id": 94, "ws": true}, {"text": "neurological", "start": 605, "end": 617, "id": 95, "ws": true}, {"text": "condition", "start": 618, "end": 627, "id": 96, "ws": true}, {"text": "(", "start": 628, "end": 629, "id": 97, "ws": false}, {"text": "i.e.", "start": 629, "end": 633, "id": 98, "ws": false}, {"text": ",", "start": 633, "end": 634, "id": 99, "ws": true}, {"text": "Hunt", "start": 635, "end": 639, "id": 100, "ws": true}, {"text": "and", "start": 640, "end": 643, "id": 101, "ws": true}, {"text": "Hess", "start": 644, "end": 648, "id": 102, "ws": true}, {"text": "Grades", "start": 649, "end": 655, "id": 103, "ws": true}, {"text": "I", "start": 656, "end": 657, "id": 104, "ws": false}, {"text": "-", "start": 657, "end": 658, "id": 105, "ws": false}, {"text": "V", "start": 658, "end": 659, "id": 106, "ws": false}, {"text": ")", "start": 659, "end": 660, "id": 107, "ws": false}, {"text": ".", "start": 660, "end": 661, "id": 108, "ws": true}, {"text": "(", "start": 662, "end": 663, "id": 109, "ws": false}, {"text": "1", "start": 663, "end": 664, "id": 110, "ws": false}, {"text": ")", "start": 664, "end": 665, "id": 111, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 41, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 69, "end": 125, "token_start": 10, "token_end": 17, "label": "EFFECT"}, {"start": 129, "end": 143, "token_start": 19, "token_end": 20, "label": "TARGET_GROUP"}, {"start": 149, "end": 178, "token_start": 22, "token_end": 26, "label": "BASECONDITION"}, {"start": 184, "end": 221, "token_start": 28, "token_end": 31, "label": "CAUSED_BY"}], "answer": "accept", "_timestamp": 1694525602, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Renvela (sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Renvela is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis. (1)", "_input_hash": 1120133727, "_task_hash": -452201017, "_is_binary": false, "tokens": [{"text": "Renvela", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "(", "start": 8, "end": 9, "id": 1, "ws": false}, {"text": "sevelamer", "start": 9, "end": 18, "id": 2, "ws": true}, {"text": "carbonate", "start": 19, "end": 28, "id": 3, "ws": false}, {"text": ")", "start": 28, "end": 29, "id": 4, "ws": true}, {"text": "is", "start": 30, "end": 32, "id": 5, "ws": true}, {"text": "indicated", "start": 33, "end": 42, "id": 6, "ws": true}, {"text": "for", "start": 43, "end": 46, "id": 7, "ws": true}, {"text": "the", "start": 47, "end": 50, "id": 8, "ws": true}, {"text": "control", "start": 51, "end": 58, "id": 9, "ws": true}, {"text": "of", "start": 59, "end": 61, "id": 10, "ws": true}, {"text": "serum", "start": 62, "end": 67, "id": 11, "ws": true}, {"text": "phosphorus", "start": 68, "end": 78, "id": 12, "ws": true}, {"text": "in", "start": 79, "end": 81, "id": 13, "ws": true}, {"text": "adults", "start": 82, "end": 88, "id": 14, "ws": true}, {"text": "and", "start": 89, "end": 92, "id": 15, "ws": true}, {"text": "children", "start": 93, "end": 101, "id": 16, "ws": true}, {"text": "6", "start": 102, "end": 103, "id": 17, "ws": true}, {"text": "years", "start": 104, "end": 109, "id": 18, "ws": true}, {"text": "of", "start": 110, "end": 112, "id": 19, "ws": true}, {"text": "age", "start": 113, "end": 116, "id": 20, "ws": true}, {"text": "and", "start": 117, "end": 120, "id": 21, "ws": true}, {"text": "older", "start": 121, "end": 126, "id": 22, "ws": true}, {"text": "with", "start": 127, "end": 131, "id": 23, "ws": true}, {"text": "chronic", "start": 132, "end": 139, "id": 24, "ws": true}, {"text": "kidney", "start": 140, "end": 146, "id": 25, "ws": true}, {"text": "disease", "start": 147, "end": 154, "id": 26, "ws": true}, {"text": "(", "start": 155, "end": 156, "id": 27, "ws": false}, {"text": "CKD", "start": 156, "end": 159, "id": 28, "ws": false}, {"text": ")", "start": 159, "end": 160, "id": 29, "ws": true}, {"text": "on", "start": 161, "end": 163, "id": 30, "ws": true}, {"text": "dialysis", "start": 164, "end": 172, "id": 31, "ws": false}, {"text": ".", "start": 172, "end": 173, "id": 32, "ws": true}, {"text": "Renvela", "start": 174, "end": 181, "id": 33, "ws": true}, {"text": "is", "start": 182, "end": 184, "id": 34, "ws": true}, {"text": "a", "start": 185, "end": 186, "id": 35, "ws": true}, {"text": "phosphate", "start": 187, "end": 196, "id": 36, "ws": true}, {"text": "binder", "start": 197, "end": 203, "id": 37, "ws": true}, {"text": "indicated", "start": 204, "end": 213, "id": 38, "ws": true}, {"text": "for", "start": 214, "end": 217, "id": 39, "ws": true}, {"text": "the", "start": 218, "end": 221, "id": 40, "ws": true}, {"text": "control", "start": 222, "end": 229, "id": 41, "ws": true}, {"text": "of", "start": 230, "end": 232, "id": 42, "ws": true}, {"text": "serum", "start": 233, "end": 238, "id": 43, "ws": true}, {"text": "phosphorus", "start": 239, "end": 249, "id": 44, "ws": true}, {"text": "in", "start": 250, "end": 252, "id": 45, "ws": true}, {"text": "adults", "start": 253, "end": 259, "id": 46, "ws": true}, {"text": "and", "start": 260, "end": 263, "id": 47, "ws": true}, {"text": "children", "start": 264, "end": 272, "id": 48, "ws": true}, {"text": "6", "start": 273, "end": 274, "id": 49, "ws": true}, {"text": "years", "start": 275, "end": 280, "id": 50, "ws": true}, {"text": "of", "start": 281, "end": 283, "id": 51, "ws": true}, {"text": "age", "start": 284, "end": 287, "id": 52, "ws": true}, {"text": "and", "start": 288, "end": 291, "id": 53, "ws": true}, {"text": "older", "start": 292, "end": 297, "id": 54, "ws": true}, {"text": "with", "start": 298, "end": 302, "id": 55, "ws": true}, {"text": "chronic", "start": 303, "end": 310, "id": 56, "ws": true}, {"text": "kidney", "start": 311, "end": 317, "id": 57, "ws": true}, {"text": "disease", "start": 318, "end": 325, "id": 58, "ws": true}, {"text": "on", "start": 326, "end": 328, "id": 59, "ws": true}, {"text": "dialysis", "start": 329, "end": 337, "id": 60, "ws": false}, {"text": ".", "start": 337, "end": 338, "id": 61, "ws": true}, {"text": "(", "start": 339, "end": 340, "id": 62, "ws": false}, {"text": "1", "start": 340, "end": 341, "id": 63, "ws": false}, {"text": ")", "start": 341, "end": 342, "id": 64, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 18, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 19, "end": 28, "token_start": 3, "token_end": 3, "label": "SALT"}, {"start": 51, "end": 58, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 62, "end": 78, "token_start": 11, "token_end": 12, "label": "EFFECT"}, {"start": 82, "end": 88, "token_start": 14, "token_end": 14, "label": "TARGET_GROUP"}, {"start": 93, "end": 126, "token_start": 16, "token_end": 22, "label": "TARGET_GROUP"}, {"start": 132, "end": 160, "token_start": 24, "token_end": 29, "label": "BASECONDITION"}, {"start": 164, "end": 172, "token_start": 31, "token_end": 31, "label": "MEDICAL_CTX"}, {"start": 174, "end": 181, "token_start": 33, "token_end": 33, "label": "DRUG"}, {"start": 187, "end": 203, "token_start": 36, "token_end": 37, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694177179, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.", "_input_hash": -529029807, "_task_hash": -1124893915, "_is_binary": false, "tokens": [{"text": "Topical", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "corticosteroids", "start": 8, "end": 23, "id": 1, "ws": true}, {"text": "are", "start": 24, "end": 27, "id": 2, "ws": true}, {"text": "indicated", "start": 28, "end": 37, "id": 3, "ws": true}, {"text": "for", "start": 38, "end": 41, "id": 4, "ws": true}, {"text": "the", "start": 42, "end": 45, "id": 5, "ws": true}, {"text": "relief", "start": 46, "end": 52, "id": 6, "ws": true}, {"text": "of", "start": 53, "end": 55, "id": 7, "ws": true}, {"text": "the", "start": 56, "end": 59, "id": 8, "ws": true}, {"text": "inflammatory", "start": 60, "end": 72, "id": 9, "ws": true}, {"text": "and", "start": 73, "end": 76, "id": 10, "ws": true}, {"text": "pruritic", "start": 77, "end": 85, "id": 11, "ws": true}, {"text": "manifestations", "start": 86, "end": 100, "id": 12, "ws": true}, {"text": "of", "start": 101, "end": 103, "id": 13, "ws": true}, {"text": "corticosteroid", "start": 104, "end": 118, "id": 14, "ws": false}, {"text": "-", "start": 118, "end": 119, "id": 15, "ws": false}, {"text": "responsive", "start": 119, "end": 129, "id": 16, "ws": true}, {"text": "dermatoses", "start": 130, "end": 140, "id": 17, "ws": false}, {"text": ".", "start": 140, "end": 141, "id": 18, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "ROUTE"}, {"start": 8, "end": 23, "token_start": 1, "token_end": 1, "label": "DRUG"}, {"start": 46, "end": 55, "token_start": 6, "token_end": 7, "label": "ACTION"}, {"start": 60, "end": 100, "token_start": 9, "token_end": 12, "label": "INDICATION"}, {"start": 104, "end": 140, "token_start": 14, "token_end": 17, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694174996, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Triferic AVNU is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD). Limitations of Use Triferic AVNU is not intended for use in patients receiving peritoneal dialysis. Triferic AVNU has not been studied in patients receiving home hemodialysis. Triferic AVNU is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD). (1) Limitations of Use Triferic AVNU is not intended for use in patients receiving peritoneal dialysis. (1) Triferic AVNU has not been studied in patients receiving home hemodialysis (1)", "_input_hash": -877707581, "_task_hash": 1714958301, "_is_binary": false, "tokens": [{"text": "Triferic", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "AVNU", "start": 9, "end": 13, "id": 1, "ws": true}, {"text": "is", "start": 14, "end": 16, "id": 2, "ws": true}, {"text": "an", "start": 17, "end": 19, "id": 3, "ws": true}, {"text": "iron", "start": 20, "end": 24, "id": 4, "ws": true}, {"text": "replacement", "start": 25, "end": 36, "id": 5, "ws": true}, {"text": "product", "start": 37, "end": 44, "id": 6, "ws": true}, {"text": "indicated", "start": 45, "end": 54, "id": 7, "ws": true}, {"text": "for", "start": 55, "end": 58, "id": 8, "ws": true}, {"text": "the", "start": 59, "end": 62, "id": 9, "ws": true}, {"text": "replacement", "start": 63, "end": 74, "id": 10, "ws": true}, {"text": "of", "start": 75, "end": 77, "id": 11, "ws": true}, {"text": "iron", "start": 78, "end": 82, "id": 12, "ws": true}, {"text": "to", "start": 83, "end": 85, "id": 13, "ws": true}, {"text": "maintain", "start": 86, "end": 94, "id": 14, "ws": true}, {"text": "hemoglobin", "start": 95, "end": 105, "id": 15, "ws": true}, {"text": "in", "start": 106, "end": 108, "id": 16, "ws": true}, {"text": "adult", "start": 109, "end": 114, "id": 17, "ws": true}, {"text": "patients", "start": 115, "end": 123, "id": 18, "ws": true}, {"text": "with", "start": 124, "end": 128, "id": 19, "ws": true}, {"text": "hemodialysis", "start": 129, "end": 141, "id": 20, "ws": false}, {"text": "-", "start": 141, "end": 142, "id": 21, "ws": false}, {"text": "dependent", "start": 142, "end": 151, "id": 22, "ws": true}, {"text": "chronic", "start": 152, "end": 159, "id": 23, "ws": true}, {"text": "kidney", "start": 160, "end": 166, "id": 24, "ws": true}, {"text": "disease", "start": 167, "end": 174, "id": 25, "ws": true}, {"text": "(", "start": 175, "end": 176, "id": 26, "ws": false}, {"text": "HDD", "start": 176, "end": 179, "id": 27, "ws": false}, {"text": "-", "start": 179, "end": 180, "id": 28, "ws": false}, {"text": "CKD", "start": 180, "end": 183, "id": 29, "ws": false}, {"text": ")", "start": 183, "end": 184, "id": 30, "ws": false}, {"text": ".", "start": 184, "end": 185, "id": 31, "ws": true}, {"text": "Limitations", "start": 186, "end": 197, "id": 32, "ws": true}, {"text": "of", "start": 198, "end": 200, "id": 33, "ws": true}, {"text": "Use", "start": 201, "end": 204, "id": 34, "ws": true}, {"text": "Triferic", "start": 205, "end": 213, "id": 35, "ws": true}, {"text": "AVNU", "start": 214, "end": 218, "id": 36, "ws": true}, {"text": "is", "start": 219, "end": 221, "id": 37, "ws": true}, {"text": "not", "start": 222, "end": 225, "id": 38, "ws": true}, {"text": "intended", "start": 226, "end": 234, "id": 39, "ws": true}, {"text": "for", "start": 235, "end": 238, "id": 40, "ws": true}, {"text": "use", "start": 239, "end": 242, "id": 41, "ws": true}, {"text": "in", "start": 243, "end": 245, "id": 42, "ws": true}, {"text": "patients", "start": 246, "end": 254, "id": 43, "ws": true}, {"text": "receiving", "start": 255, "end": 264, "id": 44, "ws": true}, {"text": "peritoneal", "start": 265, "end": 275, "id": 45, "ws": true}, {"text": "dialysis", "start": 276, "end": 284, "id": 46, "ws": false}, {"text": ".", "start": 284, "end": 285, "id": 47, "ws": true}, {"text": "Triferic", "start": 286, "end": 294, "id": 48, "ws": true}, {"text": "AVNU", "start": 295, "end": 299, "id": 49, "ws": true}, {"text": "has", "start": 300, "end": 303, "id": 50, "ws": true}, {"text": "not", "start": 304, "end": 307, "id": 51, "ws": true}, {"text": "been", "start": 308, "end": 312, "id": 52, "ws": true}, {"text": "studied", "start": 313, "end": 320, "id": 53, "ws": true}, {"text": "in", "start": 321, "end": 323, "id": 54, "ws": true}, {"text": "patients", "start": 324, "end": 332, "id": 55, "ws": true}, {"text": "receiving", "start": 333, "end": 342, "id": 56, "ws": true}, {"text": "home", "start": 343, "end": 347, "id": 57, "ws": true}, {"text": "hemodialysis", "start": 348, "end": 360, "id": 58, "ws": false}, {"text": ".", "start": 360, "end": 361, "id": 59, "ws": true}, {"text": "Triferic", "start": 362, "end": 370, "id": 60, "ws": true}, {"text": "AVNU", "start": 371, "end": 375, "id": 61, "ws": true}, {"text": "is", "start": 376, "end": 378, "id": 62, "ws": true}, {"text": "an", "start": 379, "end": 381, "id": 63, "ws": true}, {"text": "iron", "start": 382, "end": 386, "id": 64, "ws": true}, {"text": "replacement", "start": 387, "end": 398, "id": 65, "ws": true}, {"text": "product", "start": 399, "end": 406, "id": 66, "ws": true}, {"text": "indicated", "start": 407, "end": 416, "id": 67, "ws": true}, {"text": "for", "start": 417, "end": 420, "id": 68, "ws": true}, {"text": "the", "start": 421, "end": 424, "id": 69, "ws": true}, {"text": "replacement", "start": 425, "end": 436, "id": 70, "ws": true}, {"text": "of", "start": 437, "end": 439, "id": 71, "ws": true}, {"text": "iron", "start": 440, "end": 444, "id": 72, "ws": true}, {"text": "to", "start": 445, "end": 447, "id": 73, "ws": true}, {"text": "maintain", "start": 448, "end": 456, "id": 74, "ws": true}, {"text": "hemoglobin", "start": 457, "end": 467, "id": 75, "ws": true}, {"text": "in", "start": 468, "end": 470, "id": 76, "ws": true}, {"text": "adult", "start": 471, "end": 476, "id": 77, "ws": true}, {"text": "patients", "start": 477, "end": 485, "id": 78, "ws": true}, {"text": "with", "start": 486, "end": 490, "id": 79, "ws": true}, {"text": "hemodialysis", "start": 491, "end": 503, "id": 80, "ws": false}, {"text": "-", "start": 503, "end": 504, "id": 81, "ws": false}, {"text": "dependent", "start": 504, "end": 513, "id": 82, "ws": true}, {"text": "chronic", "start": 514, "end": 521, "id": 83, "ws": true}, {"text": "kidney", "start": 522, "end": 528, "id": 84, "ws": true}, {"text": "disease", "start": 529, "end": 536, "id": 85, "ws": true}, {"text": "(", "start": 537, "end": 538, "id": 86, "ws": false}, {"text": "HDD", "start": 538, "end": 541, "id": 87, "ws": false}, {"text": "-", "start": 541, "end": 542, "id": 88, "ws": false}, {"text": "CKD", "start": 542, "end": 545, "id": 89, "ws": false}, {"text": ")", "start": 545, "end": 546, "id": 90, "ws": false}, {"text": ".", "start": 546, "end": 547, "id": 91, "ws": true}, {"text": "(", "start": 548, "end": 549, "id": 92, "ws": false}, {"text": "1", "start": 549, "end": 550, "id": 93, "ws": false}, {"text": ")", "start": 550, "end": 551, "id": 94, "ws": true}, {"text": "Limitations", "start": 552, "end": 563, "id": 95, "ws": true}, {"text": "of", "start": 564, "end": 566, "id": 96, "ws": true}, {"text": "Use", "start": 567, "end": 570, "id": 97, "ws": true}, {"text": "Triferic", "start": 571, "end": 579, "id": 98, "ws": true}, {"text": "AVNU", "start": 580, "end": 584, "id": 99, "ws": true}, {"text": "is", "start": 585, "end": 587, "id": 100, "ws": true}, {"text": "not", "start": 588, "end": 591, "id": 101, "ws": true}, {"text": "intended", "start": 592, "end": 600, "id": 102, "ws": true}, {"text": "for", "start": 601, "end": 604, "id": 103, "ws": true}, {"text": "use", "start": 605, "end": 608, "id": 104, "ws": true}, {"text": "in", "start": 609, "end": 611, "id": 105, "ws": true}, {"text": "patients", "start": 612, "end": 620, "id": 106, "ws": true}, {"text": "receiving", "start": 621, "end": 630, "id": 107, "ws": true}, {"text": "peritoneal", "start": 631, "end": 641, "id": 108, "ws": true}, {"text": "dialysis", "start": 642, "end": 650, "id": 109, "ws": false}, {"text": ".", "start": 650, "end": 651, "id": 110, "ws": true}, {"text": "(", "start": 652, "end": 653, "id": 111, "ws": false}, {"text": "1", "start": 653, "end": 654, "id": 112, "ws": false}, {"text": ")", "start": 654, "end": 655, "id": 113, "ws": true}, {"text": "Triferic", "start": 656, "end": 664, "id": 114, "ws": true}, {"text": "AVNU", "start": 665, "end": 669, "id": 115, "ws": true}, {"text": "has", "start": 670, "end": 673, "id": 116, "ws": true}, {"text": "not", "start": 674, "end": 677, "id": 117, "ws": true}, {"text": "been", "start": 678, "end": 682, "id": 118, "ws": true}, {"text": "studied", "start": 683, "end": 690, "id": 119, "ws": true}, {"text": "in", "start": 691, "end": 693, "id": 120, "ws": true}, {"text": "patients", "start": 694, "end": 702, "id": 121, "ws": true}, {"text": "receiving", "start": 703, "end": 712, "id": 122, "ws": true}, {"text": "home", "start": 713, "end": 717, "id": 123, "ws": true}, {"text": "hemodialysis", "start": 718, "end": 730, "id": 124, "ws": true}, {"text": "(", "start": 731, "end": 732, "id": 125, "ws": false}, {"text": "1", "start": 732, "end": 733, "id": 126, "ws": false}, {"text": ")", "start": 733, "end": 734, "id": 127, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 1, "label": "DRUG"}, {"start": 63, "end": 82, "token_start": 10, "token_end": 12, "label": "MECHANISM"}, {"start": 83, "end": 105, "token_start": 13, "token_end": 15, "label": "EFFECT"}, {"start": 109, "end": 123, "token_start": 17, "token_end": 18, "label": "TARGET_GROUP"}, {"start": 129, "end": 174, "token_start": 20, "token_end": 25, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694528203, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Amiodarone hydrochloride tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. Amiodarone hydrochloride tablets are an antiarrhythmic indicated for: Recurrent ventricular fibrillation. (1) Recurrent hemodynamically unstable ventricular tachycardia. (1)", "_input_hash": 1104967526, "_task_hash": 1708809828, "_is_binary": false, "tokens": [{"text": "Amiodarone", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 11, "end": 24, "id": 1, "ws": true}, {"text": "tablets", "start": 25, "end": 32, "id": 2, "ws": true}, {"text": "are", "start": 33, "end": 36, "id": 3, "ws": true}, {"text": "indicated", "start": 37, "end": 46, "id": 4, "ws": true}, {"text": "for", "start": 47, "end": 50, "id": 5, "ws": true}, {"text": "the", "start": 51, "end": 54, "id": 6, "ws": true}, {"text": "treatment", "start": 55, "end": 64, "id": 7, "ws": true}, {"text": "of", "start": 65, "end": 67, "id": 8, "ws": true}, {"text": "documented", "start": 68, "end": 78, "id": 9, "ws": false}, {"text": ",", "start": 78, "end": 79, "id": 10, "ws": true}, {"text": "life", "start": 80, "end": 84, "id": 11, "ws": false}, {"text": "-", "start": 84, "end": 85, "id": 12, "ws": false}, {"text": "threatening", "start": 85, "end": 96, "id": 13, "ws": true}, {"text": "recurrent", "start": 97, "end": 106, "id": 14, "ws": true}, {"text": "ventricular", "start": 107, "end": 118, "id": 15, "ws": true}, {"text": "fibrillation", "start": 119, "end": 131, "id": 16, "ws": true}, {"text": "and", "start": 132, "end": 135, "id": 17, "ws": true}, {"text": "life", "start": 136, "end": 140, "id": 18, "ws": false}, {"text": "-", "start": 140, "end": 141, "id": 19, "ws": false}, {"text": "threatening", "start": 141, "end": 152, "id": 20, "ws": true}, {"text": "recurrent", "start": 153, "end": 162, "id": 21, "ws": true}, {"text": "hemodynamically", "start": 163, "end": 178, "id": 22, "ws": true}, {"text": "unstable", "start": 179, "end": 187, "id": 23, "ws": true}, {"text": "tachycardia", "start": 188, "end": 199, "id": 24, "ws": true}, {"text": "in", "start": 200, "end": 202, "id": 25, "ws": true}, {"text": "adults", "start": 203, "end": 209, "id": 26, "ws": true}, {"text": "who", "start": 210, "end": 213, "id": 27, "ws": true}, {"text": "have", "start": 214, "end": 218, "id": 28, "ws": true}, {"text": "not", "start": 219, "end": 222, "id": 29, "ws": true}, {"text": "responded", "start": 223, "end": 232, "id": 30, "ws": true}, {"text": "to", "start": 233, "end": 235, "id": 31, "ws": true}, {"text": "adequate", "start": 236, "end": 244, "id": 32, "ws": true}, {"text": "doses", "start": 245, "end": 250, "id": 33, "ws": true}, {"text": "of", "start": 251, "end": 253, "id": 34, "ws": true}, {"text": "other", "start": 254, "end": 259, "id": 35, "ws": true}, {"text": "available", "start": 260, "end": 269, "id": 36, "ws": true}, {"text": "antiarrhythmics", "start": 270, "end": 285, "id": 37, "ws": true}, {"text": "or", "start": 286, "end": 288, "id": 38, "ws": true}, {"text": "when", "start": 289, "end": 293, "id": 39, "ws": true}, {"text": "alternative", "start": 294, "end": 305, "id": 40, "ws": true}, {"text": "agents", "start": 306, "end": 312, "id": 41, "ws": true}, {"text": "can", "start": 313, "end": 316, "id": 42, "ws": false}, {"text": "not", "start": 316, "end": 319, "id": 43, "ws": true}, {"text": "be", "start": 320, "end": 322, "id": 44, "ws": true}, {"text": "tolerated", "start": 323, "end": 332, "id": 45, "ws": false}, {"text": ".", "start": 332, "end": 333, "id": 46, "ws": true}, {"text": "Amiodarone", "start": 334, "end": 344, "id": 47, "ws": true}, {"text": "hydrochloride", "start": 345, "end": 358, "id": 48, "ws": true}, {"text": "tablets", "start": 359, "end": 366, "id": 49, "ws": true}, {"text": "are", "start": 367, "end": 370, "id": 50, "ws": true}, {"text": "an", "start": 371, "end": 373, "id": 51, "ws": true}, {"text": "antiarrhythmic", "start": 374, "end": 388, "id": 52, "ws": true}, {"text": "indicated", "start": 389, "end": 398, "id": 53, "ws": true}, {"text": "for", "start": 399, "end": 402, "id": 54, "ws": false}, {"text": ":", "start": 402, "end": 403, "id": 55, "ws": true}, {"text": "Recurrent", "start": 404, "end": 413, "id": 56, "ws": true}, {"text": "ventricular", "start": 414, "end": 425, "id": 57, "ws": true}, {"text": "fibrillation", "start": 426, "end": 438, "id": 58, "ws": false}, {"text": ".", "start": 438, "end": 439, "id": 59, "ws": true}, {"text": "(", "start": 440, "end": 441, "id": 60, "ws": false}, {"text": "1", "start": 441, "end": 442, "id": 61, "ws": false}, {"text": ")", "start": 442, "end": 443, "id": 62, "ws": true}, {"text": "Recurrent", "start": 444, "end": 453, "id": 63, "ws": true}, {"text": "hemodynamically", "start": 454, "end": 469, "id": 64, "ws": true}, {"text": "unstable", "start": 470, "end": 478, "id": 65, "ws": true}, {"text": "ventricular", "start": 479, "end": 490, "id": 66, "ws": true}, {"text": "tachycardia", "start": 491, "end": 502, "id": 67, "ws": false}, {"text": ".", "start": 502, "end": 503, "id": 68, "ws": true}, {"text": "(", "start": 504, "end": 505, "id": 69, "ws": false}, {"text": "1", "start": 505, "end": 506, "id": 70, "ws": false}, {"text": ")", "start": 506, "end": 507, "id": 71, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 24, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 25, "end": 32, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 55, "end": 64, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 80, "end": 96, "token_start": 11, "token_end": 13, "label": "SEVERITY"}, {"start": 97, "end": 106, "token_start": 14, "token_end": 14, "label": "SEVERITY"}, {"start": 107, "end": 131, "token_start": 15, "token_end": 16, "label": "INDICATION"}, {"start": 136, "end": 152, "token_start": 18, "token_end": 20, "label": "SEVERITY"}, {"start": 153, "end": 162, "token_start": 21, "token_end": 21, "label": "SEVERITY"}, {"start": 163, "end": 199, "token_start": 22, "token_end": 24, "label": "INDICATION"}, {"start": 203, "end": 209, "token_start": 26, "token_end": 26, "label": "TARGET_GROUP"}, {"start": 219, "end": 332, "token_start": 29, "token_end": 45, "label": "MEDICAL_CTX"}, {"start": 334, "end": 344, "token_start": 47, "token_end": 47, "label": "DRUG"}, {"start": 345, "end": 358, "token_start": 48, "token_end": 48, "label": "SALT"}, {"start": 359, "end": 366, "token_start": 49, "token_end": 49, "label": "FORMULATION"}, {"start": 374, "end": 388, "token_start": 52, "token_end": 52, "label": "MECHANISM"}, {"start": 404, "end": 438, "token_start": 56, "token_end": 58, "label": "INDICATION"}, {"start": 444, "end": 502, "token_start": 63, "token_end": 67, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694175536, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "KERYDIN (tavaborole) topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes. KERYDIN is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes. (1)", "_input_hash": -1410189287, "_task_hash": -906115994, "_is_binary": false, "tokens": [{"text": "KERYDIN", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "(", "start": 8, "end": 9, "id": 1, "ws": false}, {"text": "tavaborole", "start": 9, "end": 19, "id": 2, "ws": false}, {"text": ")", "start": 19, "end": 20, "id": 3, "ws": true}, {"text": "topical", "start": 21, "end": 28, "id": 4, "ws": true}, {"text": "solution", "start": 29, "end": 37, "id": 5, "ws": false}, {"text": ",", "start": 37, "end": 38, "id": 6, "ws": true}, {"text": "5", "start": 39, "end": 40, "id": 7, "ws": false}, {"text": "%", "start": 40, "end": 41, "id": 8, "ws": true}, {"text": "is", "start": 42, "end": 44, "id": 9, "ws": true}, {"text": "an", "start": 45, "end": 47, "id": 10, "ws": true}, {"text": "oxaborole", "start": 48, "end": 57, "id": 11, "ws": true}, {"text": "antifungal", "start": 58, "end": 68, "id": 12, "ws": true}, {"text": "indicated", "start": 69, "end": 78, "id": 13, "ws": true}, {"text": "for", "start": 79, "end": 82, "id": 14, "ws": true}, {"text": "the", "start": 83, "end": 86, "id": 15, "ws": true}, {"text": "treatment", "start": 87, "end": 96, "id": 16, "ws": true}, {"text": "of", "start": 97, "end": 99, "id": 17, "ws": true}, {"text": "onychomycosis", "start": 100, "end": 113, "id": 18, "ws": true}, {"text": "of", "start": 114, "end": 116, "id": 19, "ws": true}, {"text": "the", "start": 117, "end": 120, "id": 20, "ws": true}, {"text": "toenails", "start": 121, "end": 129, "id": 21, "ws": true}, {"text": "due", "start": 130, "end": 133, "id": 22, "ws": true}, {"text": "to", "start": 134, "end": 136, "id": 23, "ws": true}, {"text": "Trichophyton", "start": 137, "end": 149, "id": 24, "ws": true}, {"text": "rubrum", "start": 150, "end": 156, "id": 25, "ws": true}, {"text": "or", "start": 157, "end": 159, "id": 26, "ws": true}, {"text": "Trichophyton", "start": 160, "end": 172, "id": 27, "ws": true}, {"text": "mentagrophytes", "start": 173, "end": 187, "id": 28, "ws": false}, {"text": ".", "start": 187, "end": 188, "id": 29, "ws": true}, {"text": "KERYDIN", "start": 189, "end": 196, "id": 30, "ws": true}, {"text": "is", "start": 197, "end": 199, "id": 31, "ws": true}, {"text": "an", "start": 200, "end": 202, "id": 32, "ws": true}, {"text": "oxaborole", "start": 203, "end": 212, "id": 33, "ws": true}, {"text": "antifungal", "start": 213, "end": 223, "id": 34, "ws": true}, {"text": "indicated", "start": 224, "end": 233, "id": 35, "ws": true}, {"text": "for", "start": 234, "end": 237, "id": 36, "ws": true}, {"text": "the", "start": 238, "end": 241, "id": 37, "ws": true}, {"text": "topical", "start": 242, "end": 249, "id": 38, "ws": true}, {"text": "treatment", "start": 250, "end": 259, "id": 39, "ws": true}, {"text": "of", "start": 260, "end": 262, "id": 40, "ws": true}, {"text": "onychomycosis", "start": 263, "end": 276, "id": 41, "ws": true}, {"text": "of", "start": 277, "end": 279, "id": 42, "ws": true}, {"text": "the", "start": 280, "end": 283, "id": 43, "ws": true}, {"text": "toenails", "start": 284, "end": 292, "id": 44, "ws": true}, {"text": "due", "start": 293, "end": 296, "id": 45, "ws": true}, {"text": "to", "start": 297, "end": 299, "id": 46, "ws": true}, {"text": "Trichophyton", "start": 300, "end": 312, "id": 47, "ws": true}, {"text": "rubrum", "start": 313, "end": 319, "id": 48, "ws": true}, {"text": "or", "start": 320, "end": 322, "id": 49, "ws": true}, {"text": "Trichophyton", "start": 323, "end": 335, "id": 50, "ws": true}, {"text": "mentagrophytes", "start": 336, "end": 350, "id": 51, "ws": false}, {"text": ".", "start": 350, "end": 351, "id": 52, "ws": true}, {"text": "(", "start": 352, "end": 353, "id": 53, "ws": false}, {"text": "1", "start": 353, "end": 354, "id": 54, "ws": false}, {"text": ")", "start": 354, "end": 355, "id": 55, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 19, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 21, "end": 28, "token_start": 4, "token_end": 4, "label": "ROUTE"}, {"start": 29, "end": 37, "token_start": 5, "token_end": 5, "label": "FORMULATION"}, {"start": 48, "end": 68, "token_start": 11, "token_end": 12, "label": "MECHANISM"}, {"start": 87, "end": 96, "token_start": 16, "token_end": 16, "label": "ACTION"}, {"start": 100, "end": 113, "token_start": 18, "token_end": 18, "label": "INDICATION"}, {"start": 121, "end": 129, "token_start": 21, "token_end": 21, "label": "ANATOMY"}, {"start": 137, "end": 156, "token_start": 24, "token_end": 25, "label": "CAUSED_BY"}, {"start": 160, "end": 187, "token_start": 27, "token_end": 28, "label": "CAUSED_BY"}, {"start": 189, "end": 196, "token_start": 30, "token_end": 30, "label": "DRUG"}, {"start": 203, "end": 223, "token_start": 33, "token_end": 34, "label": "MECHANISM"}, {"start": 242, "end": 249, "token_start": 38, "token_end": 38, "label": "ROUTE"}, {"start": 250, "end": 259, "token_start": 39, "token_end": 39, "label": "ACTION"}, {"start": 263, "end": 276, "token_start": 41, "token_end": 41, "label": "INDICATION"}, {"start": 284, "end": 292, "token_start": 44, "token_end": 44, "label": "ANATOMY"}, {"start": 300, "end": 319, "token_start": 47, "token_end": 48, "label": "CAUSED_BY"}, {"start": 323, "end": 350, "token_start": 50, "token_end": 51, "label": "CAUSED_BY"}], "answer": "accept", "_timestamp": 1694528564, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Humalog Mix75/25, a mixture of 75% insulin lispro protamine suspension and 25% insulin lispro injection, (rDNA origin), is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia. Humalog Mix75/25 has a more rapid onset of glucoselowering activity compared with Humulin 70/30 while having a similar duration of action. This profile is achieved by combining the rapid onset of Humalog with the intermediate action of insulin lispro protamine suspension.", "_input_hash": 2027073244, "_task_hash": -1957558083, "_is_binary": false, "tokens": [{"text": "Humalog", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "Mix75/25", "start": 8, "end": 16, "id": 1, "ws": false}, {"text": ",", "start": 16, "end": 17, "id": 2, "ws": true}, {"text": "a", "start": 18, "end": 19, "id": 3, "ws": true}, {"text": "mixture", "start": 20, "end": 27, "id": 4, "ws": true}, {"text": "of", "start": 28, "end": 30, "id": 5, "ws": true}, {"text": "75", "start": 31, "end": 33, "id": 6, "ws": false}, {"text": "%", "start": 33, "end": 34, "id": 7, "ws": true}, {"text": "insulin", "start": 35, "end": 42, "id": 8, "ws": true}, {"text": "lispro", "start": 43, "end": 49, "id": 9, "ws": true}, {"text": "protamine", "start": 50, "end": 59, "id": 10, "ws": true}, {"text": "suspension", "start": 60, "end": 70, "id": 11, "ws": true}, {"text": "and", "start": 71, "end": 74, "id": 12, "ws": true}, {"text": "25", "start": 75, "end": 77, "id": 13, "ws": false}, {"text": "%", "start": 77, "end": 78, "id": 14, "ws": true}, {"text": "insulin", "start": 79, "end": 86, "id": 15, "ws": true}, {"text": "lispro", "start": 87, "end": 93, "id": 16, "ws": true}, {"text": "injection", "start": 94, "end": 103, "id": 17, "ws": false}, {"text": ",", "start": 103, "end": 104, "id": 18, "ws": true}, {"text": "(", "start": 105, "end": 106, "id": 19, "ws": false}, {"text": "rDNA", "start": 106, "end": 110, "id": 20, "ws": true}, {"text": "origin", "start": 111, "end": 117, "id": 21, "ws": false}, {"text": ")", "start": 117, "end": 118, "id": 22, "ws": false}, {"text": ",", "start": 118, "end": 119, "id": 23, "ws": true}, {"text": "is", "start": 120, "end": 122, "id": 24, "ws": true}, {"text": "indicated", "start": 123, "end": 132, "id": 25, "ws": true}, {"text": "in", "start": 133, "end": 135, "id": 26, "ws": true}, {"text": "the", "start": 136, "end": 139, "id": 27, "ws": true}, {"text": "treatment", "start": 140, "end": 149, "id": 28, "ws": true}, {"text": "of", "start": 150, "end": 152, "id": 29, "ws": true}, {"text": "patients", "start": 153, "end": 161, "id": 30, "ws": true}, {"text": "with", "start": 162, "end": 166, "id": 31, "ws": true}, {"text": "diabetes", "start": 167, "end": 175, "id": 32, "ws": true}, {"text": "mellitus", "start": 176, "end": 184, "id": 33, "ws": true}, {"text": "for", "start": 185, "end": 188, "id": 34, "ws": true}, {"text": "the", "start": 189, "end": 192, "id": 35, "ws": true}, {"text": "control", "start": 193, "end": 200, "id": 36, "ws": true}, {"text": "of", "start": 201, "end": 203, "id": 37, "ws": true}, {"text": "hyperglycemia", "start": 204, "end": 217, "id": 38, "ws": false}, {"text": ".", "start": 217, "end": 218, "id": 39, "ws": true}, {"text": "Humalog", "start": 219, "end": 226, "id": 40, "ws": true}, {"text": "Mix75/25", "start": 227, "end": 235, "id": 41, "ws": true}, {"text": "has", "start": 236, "end": 239, "id": 42, "ws": true}, {"text": "a", "start": 240, "end": 241, "id": 43, "ws": true}, {"text": "more", "start": 242, "end": 246, "id": 44, "ws": true}, {"text": "rapid", "start": 247, "end": 252, "id": 45, "ws": true}, {"text": "onset", "start": 253, "end": 258, "id": 46, "ws": true}, {"text": "of", "start": 259, "end": 261, "id": 47, "ws": true}, {"text": "glucoselowering", "start": 262, "end": 277, "id": 48, "ws": true}, {"text": "activity", "start": 278, "end": 286, "id": 49, "ws": true}, {"text": "compared", "start": 287, "end": 295, "id": 50, "ws": true}, {"text": "with", "start": 296, "end": 300, "id": 51, "ws": true}, {"text": "Humulin", "start": 301, "end": 308, "id": 52, "ws": true}, {"text": "70/30", "start": 309, "end": 314, "id": 53, "ws": true}, {"text": "while", "start": 315, "end": 320, "id": 54, "ws": true}, {"text": "having", "start": 321, "end": 327, "id": 55, "ws": true}, {"text": "a", "start": 328, "end": 329, "id": 56, "ws": true}, {"text": "similar", "start": 330, "end": 337, "id": 57, "ws": true}, {"text": "duration", "start": 338, "end": 346, "id": 58, "ws": true}, {"text": "of", "start": 347, "end": 349, "id": 59, "ws": true}, {"text": "action", "start": 350, "end": 356, "id": 60, "ws": false}, {"text": ".", "start": 356, "end": 357, "id": 61, "ws": true}, {"text": "This", "start": 358, "end": 362, "id": 62, "ws": true}, {"text": "profile", "start": 363, "end": 370, "id": 63, "ws": true}, {"text": "is", "start": 371, "end": 373, "id": 64, "ws": true}, {"text": "achieved", "start": 374, "end": 382, "id": 65, "ws": true}, {"text": "by", "start": 383, "end": 385, "id": 66, "ws": true}, {"text": "combining", "start": 386, "end": 395, "id": 67, "ws": true}, {"text": "the", "start": 396, "end": 399, "id": 68, "ws": true}, {"text": "rapid", "start": 400, "end": 405, "id": 69, "ws": true}, {"text": "onset", "start": 406, "end": 411, "id": 70, "ws": true}, {"text": "of", "start": 412, "end": 414, "id": 71, "ws": true}, {"text": "Humalog", "start": 415, "end": 422, "id": 72, "ws": true}, {"text": "with", "start": 423, "end": 427, "id": 73, "ws": true}, {"text": "the", "start": 428, "end": 431, "id": 74, "ws": true}, {"text": "intermediate", "start": 432, "end": 444, "id": 75, "ws": true}, {"text": "action", "start": 445, "end": 451, "id": 76, "ws": true}, {"text": "of", "start": 452, "end": 454, "id": 77, "ws": true}, {"text": "insulin", "start": 455, "end": 462, "id": 78, "ws": true}, {"text": "lispro", "start": 463, "end": 469, "id": 79, "ws": true}, {"text": "protamine", "start": 470, "end": 479, "id": 80, "ws": true}, {"text": "suspension", "start": 480, "end": 490, "id": 81, "ws": false}, {"text": ".", "start": 490, "end": 491, "id": 82, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 140, "end": 149, "token_start": 28, "token_end": 28, "label": "ACTION"}, {"start": 167, "end": 184, "token_start": 32, "token_end": 33, "label": "BASECONDITION"}, {"start": 193, "end": 200, "token_start": 36, "token_end": 36, "label": "ACTION"}, {"start": 204, "end": 217, "token_start": 38, "token_end": 38, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694177302, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "XADAGO is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing \"off\" episodes. XADAGO is a monoamine oxidase type B (MAO-B) inhibitor indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing \"off\" episodes ( 1)", "_input_hash": -534001247, "_task_hash": 1120799390, "_is_binary": false, "tokens": [{"text": "XADAGO", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "is", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "indicated", "start": 10, "end": 19, "id": 2, "ws": true}, {"text": "as", "start": 20, "end": 22, "id": 3, "ws": true}, {"text": "adjunctive", "start": 23, "end": 33, "id": 4, "ws": true}, {"text": "treatment", "start": 34, "end": 43, "id": 5, "ws": true}, {"text": "to", "start": 44, "end": 46, "id": 6, "ws": true}, {"text": "levodopa", "start": 47, "end": 55, "id": 7, "ws": false}, {"text": "/", "start": 55, "end": 56, "id": 8, "ws": false}, {"text": "carbidopa", "start": 56, "end": 65, "id": 9, "ws": true}, {"text": "in", "start": 66, "end": 68, "id": 10, "ws": true}, {"text": "patients", "start": 69, "end": 77, "id": 11, "ws": true}, {"text": "with", "start": 78, "end": 82, "id": 12, "ws": true}, {"text": "Parkinson", "start": 83, "end": 92, "id": 13, "ws": false}, {"text": "'s", "start": 92, "end": 94, "id": 14, "ws": true}, {"text": "disease", "start": 95, "end": 102, "id": 15, "ws": true}, {"text": "(", "start": 103, "end": 104, "id": 16, "ws": false}, {"text": "PD", "start": 104, "end": 106, "id": 17, "ws": false}, {"text": ")", "start": 106, "end": 107, "id": 18, "ws": true}, {"text": "experiencing", "start": 108, "end": 120, "id": 19, "ws": true}, {"text": "\"", "start": 121, "end": 122, "id": 20, "ws": false}, {"text": "off", "start": 122, "end": 125, "id": 21, "ws": false}, {"text": "\"", "start": 125, "end": 126, "id": 22, "ws": true}, {"text": "episodes", "start": 127, "end": 135, "id": 23, "ws": false}, {"text": ".", "start": 135, "end": 136, "id": 24, "ws": true}, {"text": "XADAGO", "start": 137, "end": 143, "id": 25, "ws": true}, {"text": "is", "start": 144, "end": 146, "id": 26, "ws": true}, {"text": "a", "start": 147, "end": 148, "id": 27, "ws": true}, {"text": "monoamine", "start": 149, "end": 158, "id": 28, "ws": true}, {"text": "oxidase", "start": 159, "end": 166, "id": 29, "ws": true}, {"text": "type", "start": 167, "end": 171, "id": 30, "ws": true}, {"text": "B", "start": 172, "end": 173, "id": 31, "ws": true}, {"text": "(", "start": 174, "end": 175, "id": 32, "ws": false}, {"text": "MAO", "start": 175, "end": 178, "id": 33, "ws": false}, {"text": "-", "start": 178, "end": 179, "id": 34, "ws": false}, {"text": "B", "start": 179, "end": 180, "id": 35, "ws": false}, {"text": ")", "start": 180, "end": 181, "id": 36, "ws": true}, {"text": "inhibitor", "start": 182, "end": 191, "id": 37, "ws": true}, {"text": "indicated", "start": 192, "end": 201, "id": 38, "ws": true}, {"text": "as", "start": 202, "end": 204, "id": 39, "ws": true}, {"text": "adjunctive", "start": 205, "end": 215, "id": 40, "ws": true}, {"text": "treatment", "start": 216, "end": 225, "id": 41, "ws": true}, {"text": "to", "start": 226, "end": 228, "id": 42, "ws": true}, {"text": "levodopa", "start": 229, "end": 237, "id": 43, "ws": false}, {"text": "/", "start": 237, "end": 238, "id": 44, "ws": false}, {"text": "carbidopa", "start": 238, "end": 247, "id": 45, "ws": true}, {"text": "in", "start": 248, "end": 250, "id": 46, "ws": true}, {"text": "patients", "start": 251, "end": 259, "id": 47, "ws": true}, {"text": "with", "start": 260, "end": 264, "id": 48, "ws": true}, {"text": "Parkinson", "start": 265, "end": 274, "id": 49, "ws": false}, {"text": "'s", "start": 274, "end": 276, "id": 50, "ws": true}, {"text": "disease", "start": 277, "end": 284, "id": 51, "ws": true}, {"text": "(", "start": 285, "end": 286, "id": 52, "ws": false}, {"text": "PD", "start": 286, "end": 288, "id": 53, "ws": false}, {"text": ")", "start": 288, "end": 289, "id": 54, "ws": true}, {"text": "experiencing", "start": 290, "end": 302, "id": 55, "ws": true}, {"text": "\"", "start": 303, "end": 304, "id": 56, "ws": false}, {"text": "off", "start": 304, "end": 307, "id": 57, "ws": false}, {"text": "\"", "start": 307, "end": 308, "id": 58, "ws": true}, {"text": "episodes", "start": 309, "end": 317, "id": 59, "ws": true}, {"text": "(", "start": 318, "end": 319, "id": 60, "ws": true}, {"text": "1", "start": 320, "end": 321, "id": 61, "ws": false}, {"text": ")", "start": 321, "end": 322, "id": 62, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 23, "end": 33, "token_start": 4, "token_end": 4, "label": "ACTION"}, {"start": 34, "end": 43, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 47, "end": 55, "token_start": 7, "token_end": 7, "label": "CO_PRESCRIPTION"}, {"start": 56, "end": 65, "token_start": 9, "token_end": 9, "label": "CO_PRESCRIPTION"}, {"start": 83, "end": 102, "token_start": 13, "token_end": 15, "label": "BASECONDITION"}, {"start": 108, "end": 135, "token_start": 19, "token_end": 23, "label": "MEDICAL_CTX"}, {"start": 137, "end": 143, "token_start": 25, "token_end": 25, "label": "DRUG"}, {"start": 149, "end": 191, "token_start": 28, "token_end": 37, "label": "MECHANISM"}, {"start": 205, "end": 215, "token_start": 40, "token_end": 40, "label": "ACTION"}, {"start": 216, "end": 225, "token_start": 41, "token_end": 41, "label": "ACTION"}, {"start": 229, "end": 237, "token_start": 43, "token_end": 43, "label": "CO_PRESCRIPTION"}, {"start": 238, "end": 247, "token_start": 45, "token_end": 45, "label": "CO_PRESCRIPTION"}, {"start": 265, "end": 289, "token_start": 49, "token_end": 54, "label": "BASECONDITION"}, {"start": 290, "end": 317, "token_start": 55, "token_end": 59, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694176249, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "NALFON is indicated for: Relief of mild to moderate pain in adults. Relief of the signs and symptoms of rheumatoid arthrites. Relief of the signs and symptoms of osteoarthritis. NALFON is a nonsteroidal anti-inflammatory drug indicated for: Relief of mild to moderate pain in adults. ( 1) Relief of the signs and symptoms of rheumatoid arthritis. ( 1) Relief of the signs and symptoms of osteoarthritis. ( 1)", "_input_hash": -182008501, "_task_hash": 169778931, "_is_binary": false, "tokens": [{"text": "NALFON", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "is", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "indicated", "start": 10, "end": 19, "id": 2, "ws": true}, {"text": "for", "start": 20, "end": 23, "id": 3, "ws": false}, {"text": ":", "start": 23, "end": 24, "id": 4, "ws": true}, {"text": "Relief", "start": 25, "end": 31, "id": 5, "ws": true}, {"text": "of", "start": 32, "end": 34, "id": 6, "ws": true}, {"text": "mild", "start": 35, "end": 39, "id": 7, "ws": true}, {"text": "to", "start": 40, "end": 42, "id": 8, "ws": true}, {"text": "moderate", "start": 43, "end": 51, "id": 9, "ws": true}, {"text": "pain", "start": 52, "end": 56, "id": 10, "ws": true}, {"text": "in", "start": 57, "end": 59, "id": 11, "ws": true}, {"text": "adults", "start": 60, "end": 66, "id": 12, "ws": false}, {"text": ".", "start": 66, "end": 67, "id": 13, "ws": true}, {"text": "Relief", "start": 68, "end": 74, "id": 14, "ws": true}, {"text": "of", "start": 75, "end": 77, "id": 15, "ws": true}, {"text": "the", "start": 78, "end": 81, "id": 16, "ws": true}, {"text": "signs", "start": 82, "end": 87, "id": 17, "ws": true}, {"text": "and", "start": 88, "end": 91, "id": 18, "ws": true}, {"text": "symptoms", "start": 92, "end": 100, "id": 19, "ws": true}, {"text": "of", "start": 101, "end": 103, "id": 20, "ws": true}, {"text": "rheumatoid", "start": 104, "end": 114, "id": 21, "ws": true}, {"text": "arthrites", "start": 115, "end": 124, "id": 22, "ws": false}, {"text": ".", "start": 124, "end": 125, "id": 23, "ws": true}, {"text": "Relief", "start": 126, "end": 132, "id": 24, "ws": true}, {"text": "of", "start": 133, "end": 135, "id": 25, "ws": true}, {"text": "the", "start": 136, "end": 139, "id": 26, "ws": true}, {"text": "signs", "start": 140, "end": 145, "id": 27, "ws": true}, {"text": "and", "start": 146, "end": 149, "id": 28, "ws": true}, {"text": "symptoms", "start": 150, "end": 158, "id": 29, "ws": true}, {"text": "of", "start": 159, "end": 161, "id": 30, "ws": true}, {"text": "osteoarthritis", "start": 162, "end": 176, "id": 31, "ws": false}, {"text": ".", "start": 176, "end": 177, "id": 32, "ws": true}, {"text": "NALFON", "start": 178, "end": 184, "id": 33, "ws": true}, {"text": "is", "start": 185, "end": 187, "id": 34, "ws": true}, {"text": "a", "start": 188, "end": 189, "id": 35, "ws": true}, {"text": "nonsteroidal", "start": 190, "end": 202, "id": 36, "ws": true}, {"text": "anti", "start": 203, "end": 207, "id": 37, "ws": false}, {"text": "-", "start": 207, "end": 208, "id": 38, "ws": false}, {"text": "inflammatory", "start": 208, "end": 220, "id": 39, "ws": true}, {"text": "drug", "start": 221, "end": 225, "id": 40, "ws": true}, {"text": "indicated", "start": 226, "end": 235, "id": 41, "ws": true}, {"text": "for", "start": 236, "end": 239, "id": 42, "ws": false}, {"text": ":", "start": 239, "end": 240, "id": 43, "ws": true}, {"text": "Relief", "start": 241, "end": 247, "id": 44, "ws": true}, {"text": "of", "start": 248, "end": 250, "id": 45, "ws": true}, {"text": "mild", "start": 251, "end": 255, "id": 46, "ws": true}, {"text": "to", "start": 256, "end": 258, "id": 47, "ws": true}, {"text": "moderate", "start": 259, "end": 267, "id": 48, "ws": true}, {"text": "pain", "start": 268, "end": 272, "id": 49, "ws": true}, {"text": "in", "start": 273, "end": 275, "id": 50, "ws": true}, {"text": "adults", "start": 276, "end": 282, "id": 51, "ws": false}, {"text": ".", "start": 282, "end": 283, "id": 52, "ws": true}, {"text": "(", "start": 284, "end": 285, "id": 53, "ws": true}, {"text": "1", "start": 286, "end": 287, "id": 54, "ws": false}, {"text": ")", "start": 287, "end": 288, "id": 55, "ws": true}, {"text": "Relief", "start": 289, "end": 295, "id": 56, "ws": true}, {"text": "of", "start": 296, "end": 298, "id": 57, "ws": true}, {"text": "the", "start": 299, "end": 302, "id": 58, "ws": true}, {"text": "signs", "start": 303, "end": 308, "id": 59, "ws": true}, {"text": "and", "start": 309, "end": 312, "id": 60, "ws": true}, {"text": "symptoms", "start": 313, "end": 321, "id": 61, "ws": true}, {"text": "of", "start": 322, "end": 324, "id": 62, "ws": true}, {"text": "rheumatoid", "start": 325, "end": 335, "id": 63, "ws": true}, {"text": "arthritis", "start": 336, "end": 345, "id": 64, "ws": false}, {"text": ".", "start": 345, "end": 346, "id": 65, "ws": true}, {"text": "(", "start": 347, "end": 348, "id": 66, "ws": true}, {"text": "1", "start": 349, "end": 350, "id": 67, "ws": false}, {"text": ")", "start": 350, "end": 351, "id": 68, "ws": true}, {"text": "Relief", "start": 352, "end": 358, "id": 69, "ws": true}, {"text": "of", "start": 359, "end": 361, "id": 70, "ws": true}, {"text": "the", "start": 362, "end": 365, "id": 71, "ws": true}, {"text": "signs", "start": 366, "end": 371, "id": 72, "ws": true}, {"text": "and", "start": 372, "end": 375, "id": 73, "ws": true}, {"text": "symptoms", "start": 376, "end": 384, "id": 74, "ws": true}, {"text": "of", "start": 385, "end": 387, "id": 75, "ws": true}, {"text": "osteoarthritis", "start": 388, "end": 402, "id": 76, "ws": false}, {"text": ".", "start": 402, "end": 403, "id": 77, "ws": true}, {"text": "(", "start": 404, "end": 405, "id": 78, "ws": true}, {"text": "1", "start": 406, "end": 407, "id": 79, "ws": false}, {"text": ")", "start": 407, "end": 408, "id": 80, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 25, "end": 31, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 35, "end": 51, "token_start": 7, "token_end": 9, "label": "SEVERITY"}, {"start": 52, "end": 56, "token_start": 10, "token_end": 10, "label": "INDICATION"}, {"start": 60, "end": 66, "token_start": 12, "token_end": 12, "label": "TARGET_GROUP"}, {"start": 68, "end": 74, "token_start": 14, "token_end": 14, "label": "ACTION"}, {"start": 82, "end": 100, "token_start": 17, "token_end": 19, "label": "INDICATION"}, {"start": 104, "end": 124, "token_start": 21, "token_end": 22, "label": "BASECONDITION"}, {"start": 126, "end": 132, "token_start": 24, "token_end": 24, "label": "ACTION"}, {"start": 140, "end": 158, "token_start": 27, "token_end": 29, "label": "INDICATION"}, {"start": 162, "end": 176, "token_start": 31, "token_end": 31, "label": "BASECONDITION"}, {"start": 178, "end": 184, "token_start": 33, "token_end": 33, "label": "DRUG"}, {"start": 190, "end": 220, "token_start": 36, "token_end": 39, "label": "MECHANISM"}, {"start": 241, "end": 247, "token_start": 44, "token_end": 44, "label": "ACTION"}, {"start": 251, "end": 267, "token_start": 46, "token_end": 48, "label": "SEVERITY"}, {"start": 268, "end": 272, "token_start": 49, "token_end": 49, "label": "INDICATION"}, {"start": 276, "end": 282, "token_start": 51, "token_end": 51, "label": "TARGET_GROUP"}, {"start": 289, "end": 295, "token_start": 56, "token_end": 56, "label": "ACTION"}, {"start": 303, "end": 321, "token_start": 59, "token_end": 61, "label": "INDICATION"}, {"start": 325, "end": 345, "token_start": 63, "token_end": 64, "label": "BASECONDITION"}, {"start": 352, "end": 358, "token_start": 69, "token_end": 69, "label": "ACTION"}, {"start": 366, "end": 384, "token_start": 72, "token_end": 74, "label": "INDICATION"}, {"start": 388, "end": 402, "token_start": 76, "token_end": 76, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694526836, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "CYCLOSET is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. CYCLOSET is an ergot derivative indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1) Limitations of Use: Should not be used to treat type 1 diabetes or diabetic ketoacidosis. (1) Limited efficacy data in combination with thiazolidinediones. (1) Efficacy has not been confirmed in combination with insulin. (1) Limitations of Use CYCLOSET should not be used to treat type 1 diabetes or diabetic ketoacidosis. Limited efficacy data in combination with thiazolidinediones. Efficacy has not been confirmed in combination with insulin.", "_input_hash": -1306233293, "_task_hash": 479534778, "_is_binary": false, "tokens": [{"text": "CYCLOSET", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "as", "start": 22, "end": 24, "id": 3, "ws": true}, {"text": "an", "start": 25, "end": 27, "id": 4, "ws": true}, {"text": "adjunct", "start": 28, "end": 35, "id": 5, "ws": true}, {"text": "to", "start": 36, "end": 38, "id": 6, "ws": true}, {"text": "diet", "start": 39, "end": 43, "id": 7, "ws": true}, {"text": "and", "start": 44, "end": 47, "id": 8, "ws": true}, {"text": "exercise", "start": 48, "end": 56, "id": 9, "ws": true}, {"text": "to", "start": 57, "end": 59, "id": 10, "ws": true}, {"text": "improve", "start": 60, "end": 67, "id": 11, "ws": true}, {"text": "glycemic", "start": 68, "end": 76, "id": 12, "ws": true}, {"text": "control", "start": 77, "end": 84, "id": 13, "ws": true}, {"text": "in", "start": 85, "end": 87, "id": 14, "ws": true}, {"text": "adults", "start": 88, "end": 94, "id": 15, "ws": true}, {"text": "with", "start": 95, "end": 99, "id": 16, "ws": true}, {"text": "type", "start": 100, "end": 104, "id": 17, "ws": true}, {"text": "2", "start": 105, "end": 106, "id": 18, "ws": true}, {"text": "diabetes", "start": 107, "end": 115, "id": 19, "ws": true}, {"text": "mellitus", "start": 116, "end": 124, "id": 20, "ws": false}, {"text": ".", "start": 124, "end": 125, "id": 21, "ws": true}, {"text": "CYCLOSET", "start": 126, "end": 134, "id": 22, "ws": true}, {"text": "is", "start": 135, "end": 137, "id": 23, "ws": true}, {"text": "an", "start": 138, "end": 140, "id": 24, "ws": true}, {"text": "ergot", "start": 141, "end": 146, "id": 25, "ws": true}, {"text": "derivative", "start": 147, "end": 157, "id": 26, "ws": true}, {"text": "indicated", "start": 158, "end": 167, "id": 27, "ws": true}, {"text": "as", "start": 168, "end": 170, "id": 28, "ws": true}, {"text": "an", "start": 171, "end": 173, "id": 29, "ws": true}, {"text": "adjunct", "start": 174, "end": 181, "id": 30, "ws": true}, {"text": "to", "start": 182, "end": 184, "id": 31, "ws": true}, {"text": "diet", "start": 185, "end": 189, "id": 32, "ws": true}, {"text": "and", "start": 190, "end": 193, "id": 33, "ws": true}, {"text": "exercise", "start": 194, "end": 202, "id": 34, "ws": true}, {"text": "to", "start": 203, "end": 205, "id": 35, "ws": true}, {"text": "improve", "start": 206, "end": 213, "id": 36, "ws": true}, {"text": "glycemic", "start": 214, "end": 222, "id": 37, "ws": true}, {"text": "control", "start": 223, "end": 230, "id": 38, "ws": true}, {"text": "in", "start": 231, "end": 233, "id": 39, "ws": true}, {"text": "adults", "start": 234, "end": 240, "id": 40, "ws": true}, {"text": "with", "start": 241, "end": 245, "id": 41, "ws": true}, {"text": "type", "start": 246, "end": 250, "id": 42, "ws": true}, {"text": "2", "start": 251, "end": 252, "id": 43, "ws": true}, {"text": "diabetes", "start": 253, "end": 261, "id": 44, "ws": true}, {"text": "mellitus", "start": 262, "end": 270, "id": 45, "ws": false}, {"text": ".", "start": 270, "end": 271, "id": 46, "ws": true}, {"text": "(", "start": 272, "end": 273, "id": 47, "ws": false}, {"text": "1", "start": 273, "end": 274, "id": 48, "ws": false}, {"text": ")", "start": 274, "end": 275, "id": 49, "ws": true}, {"text": "Limitations", "start": 276, "end": 287, "id": 50, "ws": true}, {"text": "of", "start": 288, "end": 290, "id": 51, "ws": true}, {"text": "Use", "start": 291, "end": 294, "id": 52, "ws": false}, {"text": ":", "start": 294, "end": 295, "id": 53, "ws": true}, {"text": "Should", "start": 296, "end": 302, "id": 54, "ws": true}, {"text": "not", "start": 303, "end": 306, "id": 55, "ws": true}, {"text": "be", "start": 307, "end": 309, "id": 56, "ws": true}, {"text": "used", "start": 310, "end": 314, "id": 57, "ws": true}, {"text": "to", "start": 315, "end": 317, "id": 58, "ws": true}, {"text": "treat", "start": 318, "end": 323, "id": 59, "ws": true}, {"text": "type", "start": 324, "end": 328, "id": 60, "ws": true}, {"text": "1", "start": 329, "end": 330, "id": 61, "ws": true}, {"text": "diabetes", "start": 331, "end": 339, "id": 62, "ws": true}, {"text": "or", "start": 340, "end": 342, "id": 63, "ws": true}, {"text": "diabetic", "start": 343, "end": 351, "id": 64, "ws": true}, {"text": "ketoacidosis", "start": 352, "end": 364, "id": 65, "ws": false}, {"text": ".", "start": 364, "end": 365, "id": 66, "ws": true}, {"text": "(", "start": 366, "end": 367, "id": 67, "ws": false}, {"text": "1", "start": 367, "end": 368, "id": 68, "ws": false}, {"text": ")", "start": 368, "end": 369, "id": 69, "ws": true}, {"text": "Limited", "start": 370, "end": 377, "id": 70, "ws": true}, {"text": "efficacy", "start": 378, "end": 386, "id": 71, "ws": true}, {"text": "data", "start": 387, "end": 391, "id": 72, "ws": true}, {"text": "in", "start": 392, "end": 394, "id": 73, "ws": true}, {"text": "combination", "start": 395, "end": 406, "id": 74, "ws": true}, {"text": "with", "start": 407, "end": 411, "id": 75, "ws": true}, {"text": "thiazolidinediones", "start": 412, "end": 430, "id": 76, "ws": false}, {"text": ".", "start": 430, "end": 431, "id": 77, "ws": true}, {"text": "(", "start": 432, "end": 433, "id": 78, "ws": false}, {"text": "1", "start": 433, "end": 434, "id": 79, "ws": false}, {"text": ")", "start": 434, "end": 435, "id": 80, "ws": true}, {"text": "Efficacy", "start": 436, "end": 444, "id": 81, "ws": true}, {"text": "has", "start": 445, "end": 448, "id": 82, "ws": true}, {"text": "not", "start": 449, "end": 452, "id": 83, "ws": true}, {"text": "been", "start": 453, "end": 457, "id": 84, "ws": true}, {"text": "confirmed", "start": 458, "end": 467, "id": 85, "ws": true}, {"text": "in", "start": 468, "end": 470, "id": 86, "ws": true}, {"text": "combination", "start": 471, "end": 482, "id": 87, "ws": true}, {"text": "with", "start": 483, "end": 487, "id": 88, "ws": true}, {"text": "insulin", "start": 488, "end": 495, "id": 89, "ws": false}, {"text": ".", "start": 495, "end": 496, "id": 90, "ws": true}, {"text": "(", "start": 497, "end": 498, "id": 91, "ws": false}, {"text": "1", "start": 498, "end": 499, "id": 92, "ws": false}, {"text": ")", "start": 499, "end": 500, "id": 93, "ws": true}, {"text": "Limitations", "start": 501, "end": 512, "id": 94, "ws": true}, {"text": "of", "start": 513, "end": 515, "id": 95, "ws": true}, {"text": "Use", "start": 516, "end": 519, "id": 96, "ws": true}, {"text": "CYCLOSET", "start": 520, "end": 528, "id": 97, "ws": true}, {"text": "should", "start": 529, "end": 535, "id": 98, "ws": true}, {"text": "not", "start": 536, "end": 539, "id": 99, "ws": true}, {"text": "be", "start": 540, "end": 542, "id": 100, "ws": true}, {"text": "used", "start": 543, "end": 547, "id": 101, "ws": true}, {"text": "to", "start": 548, "end": 550, "id": 102, "ws": true}, {"text": "treat", "start": 551, "end": 556, "id": 103, "ws": true}, {"text": "type", "start": 557, "end": 561, "id": 104, "ws": true}, {"text": "1", "start": 562, "end": 563, "id": 105, "ws": true}, {"text": "diabetes", "start": 564, "end": 572, "id": 106, "ws": true}, {"text": "or", "start": 573, "end": 575, "id": 107, "ws": true}, {"text": "diabetic", "start": 576, "end": 584, "id": 108, "ws": true}, {"text": "ketoacidosis", "start": 585, "end": 597, "id": 109, "ws": false}, {"text": ".", "start": 597, "end": 598, "id": 110, "ws": true}, {"text": "Limited", "start": 599, "end": 606, "id": 111, "ws": true}, {"text": "efficacy", "start": 607, "end": 615, "id": 112, "ws": true}, {"text": "data", "start": 616, "end": 620, "id": 113, "ws": true}, {"text": "in", "start": 621, "end": 623, "id": 114, "ws": true}, {"text": "combination", "start": 624, "end": 635, "id": 115, "ws": true}, {"text": "with", "start": 636, "end": 640, "id": 116, "ws": true}, {"text": "thiazolidinediones", "start": 641, "end": 659, "id": 117, "ws": false}, {"text": ".", "start": 659, "end": 660, "id": 118, "ws": true}, {"text": "Efficacy", "start": 661, "end": 669, "id": 119, "ws": true}, {"text": "has", "start": 670, "end": 673, "id": 120, "ws": true}, {"text": "not", "start": 674, "end": 677, "id": 121, "ws": true}, {"text": "been", "start": 678, "end": 682, "id": 122, "ws": true}, {"text": "confirmed", "start": 683, "end": 692, "id": 123, "ws": true}, {"text": "in", "start": 693, "end": 695, "id": 124, "ws": true}, {"text": "combination", "start": 696, "end": 707, "id": 125, "ws": true}, {"text": "with", "start": 708, "end": 712, "id": 126, "ws": true}, {"text": "insulin", "start": 713, "end": 720, "id": 127, "ws": false}, {"text": ".", "start": 720, "end": 721, "id": 128, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 28, "end": 35, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 60, "end": 84, "token_start": 11, "token_end": 13, "label": "EFFECT"}, {"start": 88, "end": 94, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 100, "end": 124, "token_start": 17, "token_end": 20, "label": "BASECONDITION"}, {"start": 126, "end": 134, "token_start": 22, "token_end": 22, "label": "DRUG"}, {"start": 141, "end": 157, "token_start": 25, "token_end": 26, "label": "MECHANISM"}, {"start": 174, "end": 181, "token_start": 30, "token_end": 30, "label": "ACTION"}, {"start": 206, "end": 230, "token_start": 36, "token_end": 38, "label": "EFFECT"}, {"start": 234, "end": 240, "token_start": 40, "token_end": 40, "label": "TARGET_GROUP"}, {"start": 246, "end": 270, "token_start": 42, "token_end": 45, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694526607, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Mesalamine extended-release capsules are indicated for the maintenance of remission of ulcerative colitis in adults. Mesalamine extended-release capsule is an aminosalicylate indicated for the maintenance of remission of ulcerative colitis in adults. (1)", "_input_hash": 985656918, "_task_hash": -1498021896, "_is_binary": false, "tokens": [{"text": "Mesalamine", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "extended", "start": 11, "end": 19, "id": 1, "ws": false}, {"text": "-", "start": 19, "end": 20, "id": 2, "ws": false}, {"text": "release", "start": 20, "end": 27, "id": 3, "ws": true}, {"text": "capsules", "start": 28, "end": 36, "id": 4, "ws": true}, {"text": "are", "start": 37, "end": 40, "id": 5, "ws": true}, {"text": "indicated", "start": 41, "end": 50, "id": 6, "ws": true}, {"text": "for", "start": 51, "end": 54, "id": 7, "ws": true}, {"text": "the", "start": 55, "end": 58, "id": 8, "ws": true}, {"text": "maintenance", "start": 59, "end": 70, "id": 9, "ws": true}, {"text": "of", "start": 71, "end": 73, "id": 10, "ws": true}, {"text": "remission", "start": 74, "end": 83, "id": 11, "ws": true}, {"text": "of", "start": 84, "end": 86, "id": 12, "ws": true}, {"text": "ulcerative", "start": 87, "end": 97, "id": 13, "ws": true}, {"text": "colitis", "start": 98, "end": 105, "id": 14, "ws": true}, {"text": "in", "start": 106, "end": 108, "id": 15, "ws": true}, {"text": "adults", "start": 109, "end": 115, "id": 16, "ws": false}, {"text": ".", "start": 115, "end": 116, "id": 17, "ws": true}, {"text": "Mesalamine", "start": 117, "end": 127, "id": 18, "ws": true}, {"text": "extended", "start": 128, "end": 136, "id": 19, "ws": false}, {"text": "-", "start": 136, "end": 137, "id": 20, "ws": false}, {"text": "release", "start": 137, "end": 144, "id": 21, "ws": true}, {"text": "capsule", "start": 145, "end": 152, "id": 22, "ws": true}, {"text": "is", "start": 153, "end": 155, "id": 23, "ws": true}, {"text": "an", "start": 156, "end": 158, "id": 24, "ws": true}, {"text": "aminosalicylate", "start": 159, "end": 174, "id": 25, "ws": true}, {"text": "indicated", "start": 175, "end": 184, "id": 26, "ws": true}, {"text": "for", "start": 185, "end": 188, "id": 27, "ws": true}, {"text": "the", "start": 189, "end": 192, "id": 28, "ws": true}, {"text": "maintenance", "start": 193, "end": 204, "id": 29, "ws": true}, {"text": "of", "start": 205, "end": 207, "id": 30, "ws": true}, {"text": "remission", "start": 208, "end": 217, "id": 31, "ws": true}, {"text": "of", "start": 218, "end": 220, "id": 32, "ws": true}, {"text": "ulcerative", "start": 221, "end": 231, "id": 33, "ws": true}, {"text": "colitis", "start": 232, "end": 239, "id": 34, "ws": true}, {"text": "in", "start": 240, "end": 242, "id": 35, "ws": true}, {"text": "adults", "start": 243, "end": 249, "id": 36, "ws": false}, {"text": ".", "start": 249, "end": 250, "id": 37, "ws": true}, {"text": "(", "start": 251, "end": 252, "id": 38, "ws": false}, {"text": "1", "start": 252, "end": 253, "id": 39, "ws": false}, {"text": ")", "start": 253, "end": 254, "id": 40, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 11, "end": 36, "token_start": 1, "token_end": 4, "label": "FORMULATION"}, {"start": 59, "end": 70, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 87, "end": 105, "token_start": 13, "token_end": 14, "label": "INDICATION"}, {"start": 109, "end": 115, "token_start": 16, "token_end": 16, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694175774, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "LUMRYZ is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. LUMRYZ is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy (1).", "_input_hash": -684758249, "_task_hash": -1003224858, "_is_binary": false, "tokens": [{"text": "LUMRYZ", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "is", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "indicated", "start": 10, "end": 19, "id": 2, "ws": true}, {"text": "for", "start": 20, "end": 23, "id": 3, "ws": true}, {"text": "the", "start": 24, "end": 27, "id": 4, "ws": true}, {"text": "treatment", "start": 28, "end": 37, "id": 5, "ws": true}, {"text": "of", "start": 38, "end": 40, "id": 6, "ws": true}, {"text": "cataplexy", "start": 41, "end": 50, "id": 7, "ws": true}, {"text": "or", "start": 51, "end": 53, "id": 8, "ws": true}, {"text": "excessive", "start": 54, "end": 63, "id": 9, "ws": true}, {"text": "daytime", "start": 64, "end": 71, "id": 10, "ws": true}, {"text": "sleepiness", "start": 72, "end": 82, "id": 11, "ws": true}, {"text": "(", "start": 83, "end": 84, "id": 12, "ws": false}, {"text": "EDS", "start": 84, "end": 87, "id": 13, "ws": false}, {"text": ")", "start": 87, "end": 88, "id": 14, "ws": true}, {"text": "in", "start": 89, "end": 91, "id": 15, "ws": true}, {"text": "adults", "start": 92, "end": 98, "id": 16, "ws": true}, {"text": "with", "start": 99, "end": 103, "id": 17, "ws": true}, {"text": "narcolepsy", "start": 104, "end": 114, "id": 18, "ws": false}, {"text": ".", "start": 114, "end": 115, "id": 19, "ws": true}, {"text": "LUMRYZ", "start": 116, "end": 122, "id": 20, "ws": true}, {"text": "is", "start": 123, "end": 125, "id": 21, "ws": true}, {"text": "a", "start": 126, "end": 127, "id": 22, "ws": true}, {"text": "central", "start": 128, "end": 135, "id": 23, "ws": true}, {"text": "nervous", "start": 136, "end": 143, "id": 24, "ws": true}, {"text": "system", "start": 144, "end": 150, "id": 25, "ws": true}, {"text": "depressant", "start": 151, "end": 161, "id": 26, "ws": true}, {"text": "indicated", "start": 162, "end": 171, "id": 27, "ws": true}, {"text": "for", "start": 172, "end": 175, "id": 28, "ws": true}, {"text": "the", "start": 176, "end": 179, "id": 29, "ws": true}, {"text": "treatment", "start": 180, "end": 189, "id": 30, "ws": true}, {"text": "of", "start": 190, "end": 192, "id": 31, "ws": true}, {"text": "cataplexy", "start": 193, "end": 202, "id": 32, "ws": true}, {"text": "or", "start": 203, "end": 205, "id": 33, "ws": true}, {"text": "excessive", "start": 206, "end": 215, "id": 34, "ws": true}, {"text": "daytime", "start": 216, "end": 223, "id": 35, "ws": true}, {"text": "sleepiness", "start": 224, "end": 234, "id": 36, "ws": true}, {"text": "(", "start": 235, "end": 236, "id": 37, "ws": false}, {"text": "EDS", "start": 236, "end": 239, "id": 38, "ws": false}, {"text": ")", "start": 239, "end": 240, "id": 39, "ws": true}, {"text": "in", "start": 241, "end": 243, "id": 40, "ws": true}, {"text": "adults", "start": 244, "end": 250, "id": 41, "ws": true}, {"text": "with", "start": 251, "end": 255, "id": 42, "ws": true}, {"text": "narcolepsy", "start": 256, "end": 266, "id": 43, "ws": true}, {"text": "(", "start": 267, "end": 268, "id": 44, "ws": false}, {"text": "1", "start": 268, "end": 269, "id": 45, "ws": false}, {"text": ")", "start": 269, "end": 270, "id": 46, "ws": false}, {"text": ".", "start": 270, "end": 271, "id": 47, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 28, "end": 37, "token_start": 5, "token_end": 5, "label": "DRUG"}, {"start": 41, "end": 50, "token_start": 7, "token_end": 7, "label": "INDICATION"}, {"start": 54, "end": 82, "token_start": 9, "token_end": 11, "label": "INDICATION"}, {"start": 92, "end": 98, "token_start": 16, "token_end": 16, "label": "TARGET_GROUP"}, {"start": 104, "end": 114, "token_start": 18, "token_end": 18, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694176102, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "THIOLA EC is indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone. THIOLA EC is a reducing and complexing thiol indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone. (1)", "_input_hash": -679316998, "_task_hash": 712807101, "_is_binary": false, "tokens": [{"text": "THIOLA", "start": 0, "end": 6, "id": 0, "ws": true}, {"text": "EC", "start": 7, "end": 9, "id": 1, "ws": true}, {"text": "is", "start": 10, "end": 12, "id": 2, "ws": true}, {"text": "indicated", "start": 13, "end": 22, "id": 3, "ws": false}, {"text": ",", "start": 22, "end": 23, "id": 4, "ws": true}, {"text": "in", "start": 24, "end": 26, "id": 5, "ws": true}, {"text": "combination", "start": 27, "end": 38, "id": 6, "ws": true}, {"text": "with", "start": 39, "end": 43, "id": 7, "ws": true}, {"text": "high", "start": 44, "end": 48, "id": 8, "ws": true}, {"text": "fluid", "start": 49, "end": 54, "id": 9, "ws": true}, {"text": "intake", "start": 55, "end": 61, "id": 10, "ws": false}, {"text": ",", "start": 61, "end": 62, "id": 11, "ws": true}, {"text": "alkali", "start": 63, "end": 69, "id": 12, "ws": false}, {"text": ",", "start": 69, "end": 70, "id": 13, "ws": true}, {"text": "and", "start": 71, "end": 74, "id": 14, "ws": true}, {"text": "diet", "start": 75, "end": 79, "id": 15, "ws": true}, {"text": "modification", "start": 80, "end": 92, "id": 16, "ws": false}, {"text": ",", "start": 92, "end": 93, "id": 17, "ws": true}, {"text": "for", "start": 94, "end": 97, "id": 18, "ws": true}, {"text": "the", "start": 98, "end": 101, "id": 19, "ws": true}, {"text": "prevention", "start": 102, "end": 112, "id": 20, "ws": true}, {"text": "of", "start": 113, "end": 115, "id": 21, "ws": true}, {"text": "cystine", "start": 116, "end": 123, "id": 22, "ws": true}, {"text": "stone", "start": 124, "end": 129, "id": 23, "ws": true}, {"text": "formation", "start": 130, "end": 139, "id": 24, "ws": true}, {"text": "in", "start": 140, "end": 142, "id": 25, "ws": true}, {"text": "adults", "start": 143, "end": 149, "id": 26, "ws": true}, {"text": "and", "start": 150, "end": 153, "id": 27, "ws": true}, {"text": "pediatric", "start": 154, "end": 163, "id": 28, "ws": true}, {"text": "patients", "start": 164, "end": 172, "id": 29, "ws": true}, {"text": "20", "start": 173, "end": 175, "id": 30, "ws": true}, {"text": "kg", "start": 176, "end": 178, "id": 31, "ws": true}, {"text": "and", "start": 179, "end": 182, "id": 32, "ws": true}, {"text": "greater", "start": 183, "end": 190, "id": 33, "ws": true}, {"text": "with", "start": 191, "end": 195, "id": 34, "ws": true}, {"text": "severe", "start": 196, "end": 202, "id": 35, "ws": true}, {"text": "homozygous", "start": 203, "end": 213, "id": 36, "ws": true}, {"text": "cystinuria", "start": 214, "end": 224, "id": 37, "ws": false}, {"text": ",", "start": 224, "end": 225, "id": 38, "ws": true}, {"text": "who", "start": 226, "end": 229, "id": 39, "ws": true}, {"text": "are", "start": 230, "end": 233, "id": 40, "ws": true}, {"text": "not", "start": 234, "end": 237, "id": 41, "ws": true}, {"text": "responsive", "start": 238, "end": 248, "id": 42, "ws": true}, {"text": "to", "start": 249, "end": 251, "id": 43, "ws": true}, {"text": "these", "start": 252, "end": 257, "id": 44, "ws": true}, {"text": "measures", "start": 258, "end": 266, "id": 45, "ws": true}, {"text": "alone", "start": 267, "end": 272, "id": 46, "ws": false}, {"text": ".", "start": 272, "end": 273, "id": 47, "ws": true}, {"text": "THIOLA", "start": 274, "end": 280, "id": 48, "ws": true}, {"text": "EC", "start": 281, "end": 283, "id": 49, "ws": true}, {"text": "is", "start": 284, "end": 286, "id": 50, "ws": true}, {"text": "a", "start": 287, "end": 288, "id": 51, "ws": true}, {"text": "reducing", "start": 289, "end": 297, "id": 52, "ws": true}, {"text": "and", "start": 298, "end": 301, "id": 53, "ws": true}, {"text": "complexing", "start": 302, "end": 312, "id": 54, "ws": true}, {"text": "thiol", "start": 313, "end": 318, "id": 55, "ws": true}, {"text": "indicated", "start": 319, "end": 328, "id": 56, "ws": false}, {"text": ",", "start": 328, "end": 329, "id": 57, "ws": true}, {"text": "in", "start": 330, "end": 332, "id": 58, "ws": true}, {"text": "combination", "start": 333, "end": 344, "id": 59, "ws": true}, {"text": "with", "start": 345, "end": 349, "id": 60, "ws": true}, {"text": "high", "start": 350, "end": 354, "id": 61, "ws": true}, {"text": "fluid", "start": 355, "end": 360, "id": 62, "ws": true}, {"text": "intake", "start": 361, "end": 367, "id": 63, "ws": false}, {"text": ",", "start": 367, "end": 368, "id": 64, "ws": true}, {"text": "alkali", "start": 369, "end": 375, "id": 65, "ws": false}, {"text": ",", "start": 375, "end": 376, "id": 66, "ws": true}, {"text": "and", "start": 377, "end": 380, "id": 67, "ws": true}, {"text": "diet", "start": 381, "end": 385, "id": 68, "ws": true}, {"text": "modification", "start": 386, "end": 398, "id": 69, "ws": false}, {"text": ",", "start": 398, "end": 399, "id": 70, "ws": true}, {"text": "for", "start": 400, "end": 403, "id": 71, "ws": true}, {"text": "the", "start": 404, "end": 407, "id": 72, "ws": true}, {"text": "prevention", "start": 408, "end": 418, "id": 73, "ws": true}, {"text": "of", "start": 419, "end": 421, "id": 74, "ws": true}, {"text": "cystine", "start": 422, "end": 429, "id": 75, "ws": true}, {"text": "stone", "start": 430, "end": 435, "id": 76, "ws": true}, {"text": "formation", "start": 436, "end": 445, "id": 77, "ws": true}, {"text": "in", "start": 446, "end": 448, "id": 78, "ws": true}, {"text": "adults", "start": 449, "end": 455, "id": 79, "ws": true}, {"text": "and", "start": 456, "end": 459, "id": 80, "ws": true}, {"text": "pediatric", "start": 460, "end": 469, "id": 81, "ws": true}, {"text": "patients", "start": 470, "end": 478, "id": 82, "ws": true}, {"text": "20", "start": 479, "end": 481, "id": 83, "ws": true}, {"text": "kg", "start": 482, "end": 484, "id": 84, "ws": true}, {"text": "and", "start": 485, "end": 488, "id": 85, "ws": true}, {"text": "greater", "start": 489, "end": 496, "id": 86, "ws": true}, {"text": "with", "start": 497, "end": 501, "id": 87, "ws": true}, {"text": "severe", "start": 502, "end": 508, "id": 88, "ws": true}, {"text": "homozygous", "start": 509, "end": 519, "id": 89, "ws": true}, {"text": "cystinuria", "start": 520, "end": 530, "id": 90, "ws": false}, {"text": ",", "start": 530, "end": 531, "id": 91, "ws": true}, {"text": "who", "start": 532, "end": 535, "id": 92, "ws": true}, {"text": "are", "start": 536, "end": 539, "id": 93, "ws": true}, {"text": "not", "start": 540, "end": 543, "id": 94, "ws": true}, {"text": "responsive", "start": 544, "end": 554, "id": 95, "ws": true}, {"text": "to", "start": 555, "end": 557, "id": 96, "ws": true}, {"text": "these", "start": 558, "end": 563, "id": 97, "ws": true}, {"text": "measures", "start": 564, "end": 572, "id": 98, "ws": true}, {"text": "alone", "start": 573, "end": 578, "id": 99, "ws": false}, {"text": ".", "start": 578, "end": 579, "id": 100, "ws": true}, {"text": "(", "start": 580, "end": 581, "id": 101, "ws": false}, {"text": "1", "start": 581, "end": 582, "id": 102, "ws": false}, {"text": ")", "start": 582, "end": 583, "id": 103, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 6, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 44, "end": 92, "token_start": 8, "token_end": 16, "label": "CO_PRESCRIPTION"}, {"start": 102, "end": 112, "token_start": 20, "token_end": 20, "label": "ACTION"}, {"start": 116, "end": 139, "token_start": 22, "token_end": 24, "label": "INDICATION"}, {"start": 143, "end": 149, "token_start": 26, "token_end": 26, "label": "TARGET_GROUP"}, {"start": 154, "end": 190, "token_start": 28, "token_end": 33, "label": "TARGET_GROUP"}, {"start": 196, "end": 224, "token_start": 35, "token_end": 37, "label": "BASECONDITION"}, {"start": 226, "end": 272, "token_start": 39, "token_end": 46, "label": "MEDICAL_CTX"}, {"start": 274, "end": 280, "token_start": 48, "token_end": 48, "label": "DRUG"}, {"start": 289, "end": 318, "token_start": 52, "token_end": 55, "label": "MECHANISM"}, {"start": 330, "end": 398, "token_start": 58, "token_end": 69, "label": "CO_PRESCRIPTION"}, {"start": 408, "end": 418, "token_start": 73, "token_end": 73, "label": "ACTION"}, {"start": 422, "end": 445, "token_start": 75, "token_end": 77, "label": "INDICATION"}, {"start": 449, "end": 455, "token_start": 79, "token_end": 79, "label": "TARGET_GROUP"}, {"start": 460, "end": 496, "token_start": 81, "token_end": 86, "label": "TARGET_GROUP"}, {"start": 502, "end": 530, "token_start": 88, "token_end": 90, "label": "BASECONDITION"}, {"start": 532, "end": 578, "token_start": 92, "token_end": 99, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694528023, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Arsenic Trioxide Injection is an arsenical indicated: For induction of remission and consolidation in patients with APL who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression. (1.2) 1.2 Relapsed or Refractory APL Arsenic Trioxide Injection is indicated for induction of remission and consolidation in patients with APL who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.", "_input_hash": -1984081664, "_task_hash": 1763151687, "_is_binary": false, "tokens": [{"text": "Arsenic", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "Trioxide", "start": 8, "end": 16, "id": 1, "ws": true}, {"text": "Injection", "start": 17, "end": 26, "id": 2, "ws": true}, {"text": "is", "start": 27, "end": 29, "id": 3, "ws": true}, {"text": "an", "start": 30, "end": 32, "id": 4, "ws": true}, {"text": "arsenical", "start": 33, "end": 42, "id": 5, "ws": true}, {"text": "indicated", "start": 43, "end": 52, "id": 6, "ws": false}, {"text": ":", "start": 52, "end": 53, "id": 7, "ws": true}, {"text": "For", "start": 54, "end": 57, "id": 8, "ws": true}, {"text": "induction", "start": 58, "end": 67, "id": 9, "ws": true}, {"text": "of", "start": 68, "end": 70, "id": 10, "ws": true}, {"text": "remission", "start": 71, "end": 80, "id": 11, "ws": true}, {"text": "and", "start": 81, "end": 84, "id": 12, "ws": true}, {"text": "consolidation", "start": 85, "end": 98, "id": 13, "ws": true}, {"text": "in", "start": 99, "end": 101, "id": 14, "ws": true}, {"text": "patients", "start": 102, "end": 110, "id": 15, "ws": true}, {"text": "with", "start": 111, "end": 115, "id": 16, "ws": true}, {"text": "APL", "start": 116, "end": 119, "id": 17, "ws": true}, {"text": "who", "start": 120, "end": 123, "id": 18, "ws": true}, {"text": "are", "start": 124, "end": 127, "id": 19, "ws": true}, {"text": "refractory", "start": 128, "end": 138, "id": 20, "ws": true}, {"text": "to", "start": 139, "end": 141, "id": 21, "ws": false}, {"text": ",", "start": 141, "end": 142, "id": 22, "ws": true}, {"text": "or", "start": 143, "end": 145, "id": 23, "ws": true}, {"text": "have", "start": 146, "end": 150, "id": 24, "ws": true}, {"text": "relapsed", "start": 151, "end": 159, "id": 25, "ws": true}, {"text": "from", "start": 160, "end": 164, "id": 26, "ws": false}, {"text": ",", "start": 164, "end": 165, "id": 27, "ws": true}, {"text": "retinoid", "start": 166, "end": 174, "id": 28, "ws": true}, {"text": "and", "start": 175, "end": 178, "id": 29, "ws": true}, {"text": "anthracycline", "start": 179, "end": 192, "id": 30, "ws": true}, {"text": "chemotherapy", "start": 193, "end": 205, "id": 31, "ws": false}, {"text": ",", "start": 205, "end": 206, "id": 32, "ws": true}, {"text": "and", "start": 207, "end": 210, "id": 33, "ws": true}, {"text": "whose", "start": 211, "end": 216, "id": 34, "ws": true}, {"text": "APL", "start": 217, "end": 220, "id": 35, "ws": true}, {"text": "is", "start": 221, "end": 223, "id": 36, "ws": true}, {"text": "characterized", "start": 224, "end": 237, "id": 37, "ws": true}, {"text": "by", "start": 238, "end": 240, "id": 38, "ws": true}, {"text": "the", "start": 241, "end": 244, "id": 39, "ws": true}, {"text": "presence", "start": 245, "end": 253, "id": 40, "ws": true}, {"text": "of", "start": 254, "end": 256, "id": 41, "ws": true}, {"text": "the", "start": 257, "end": 260, "id": 42, "ws": true}, {"text": "t(15;17", "start": 261, "end": 268, "id": 43, "ws": false}, {"text": ")", "start": 268, "end": 269, "id": 44, "ws": true}, {"text": "translocation", "start": 270, "end": 283, "id": 45, "ws": true}, {"text": "or", "start": 284, "end": 286, "id": 46, "ws": true}, {"text": "PML", "start": 287, "end": 290, "id": 47, "ws": false}, {"text": "/", "start": 290, "end": 291, "id": 48, "ws": false}, {"text": "RAR", "start": 291, "end": 294, "id": 49, "ws": false}, {"text": "-", "start": 294, "end": 295, "id": 50, "ws": false}, {"text": "alpha", "start": 295, "end": 300, "id": 51, "ws": true}, {"text": "gene", "start": 301, "end": 305, "id": 52, "ws": true}, {"text": "expression", "start": 306, "end": 316, "id": 53, "ws": false}, {"text": ".", "start": 316, "end": 317, "id": 54, "ws": true}, {"text": "(", "start": 318, "end": 319, "id": 55, "ws": false}, {"text": "1.2", "start": 319, "end": 322, "id": 56, "ws": false}, {"text": ")", "start": 322, "end": 323, "id": 57, "ws": true}, {"text": "1.2", "start": 324, "end": 327, "id": 58, "ws": true}, {"text": "Relapsed", "start": 328, "end": 336, "id": 59, "ws": true}, {"text": "or", "start": 337, "end": 339, "id": 60, "ws": true}, {"text": "Refractory", "start": 340, "end": 350, "id": 61, "ws": true}, {"text": "APL", "start": 351, "end": 354, "id": 62, "ws": true}, {"text": "Arsenic", "start": 355, "end": 362, "id": 63, "ws": true}, {"text": "Trioxide", "start": 363, "end": 371, "id": 64, "ws": true}, {"text": "Injection", "start": 372, "end": 381, "id": 65, "ws": true}, {"text": "is", "start": 382, "end": 384, "id": 66, "ws": true}, {"text": "indicated", "start": 385, "end": 394, "id": 67, "ws": true}, {"text": "for", "start": 395, "end": 398, "id": 68, "ws": true}, {"text": "induction", "start": 399, "end": 408, "id": 69, "ws": true}, {"text": "of", "start": 409, "end": 411, "id": 70, "ws": true}, {"text": "remission", "start": 412, "end": 421, "id": 71, "ws": true}, {"text": "and", "start": 422, "end": 425, "id": 72, "ws": true}, {"text": "consolidation", "start": 426, "end": 439, "id": 73, "ws": true}, {"text": "in", "start": 440, "end": 442, "id": 74, "ws": true}, {"text": "patients", "start": 443, "end": 451, "id": 75, "ws": true}, {"text": "with", "start": 452, "end": 456, "id": 76, "ws": true}, {"text": "APL", "start": 457, "end": 460, "id": 77, "ws": true}, {"text": "who", "start": 461, "end": 464, "id": 78, "ws": true}, {"text": "are", "start": 465, "end": 468, "id": 79, "ws": true}, {"text": "refractory", "start": 469, "end": 479, "id": 80, "ws": true}, {"text": "to", "start": 480, "end": 482, "id": 81, "ws": false}, {"text": ",", "start": 482, "end": 483, "id": 82, "ws": true}, {"text": "or", "start": 484, "end": 486, "id": 83, "ws": true}, {"text": "have", "start": 487, "end": 491, "id": 84, "ws": true}, {"text": "relapsed", "start": 492, "end": 500, "id": 85, "ws": true}, {"text": "from", "start": 501, "end": 505, "id": 86, "ws": false}, {"text": ",", "start": 505, "end": 506, "id": 87, "ws": true}, {"text": "retinoid", "start": 507, "end": 515, "id": 88, "ws": true}, {"text": "and", "start": 516, "end": 519, "id": 89, "ws": true}, {"text": "anthracycline", "start": 520, "end": 533, "id": 90, "ws": true}, {"text": "chemotherapy", "start": 534, "end": 546, "id": 91, "ws": false}, {"text": ",", "start": 546, "end": 547, "id": 92, "ws": true}, {"text": "and", "start": 548, "end": 551, "id": 93, "ws": true}, {"text": "whose", "start": 552, "end": 557, "id": 94, "ws": true}, {"text": "APL", "start": 558, "end": 561, "id": 95, "ws": true}, {"text": "is", "start": 562, "end": 564, "id": 96, "ws": true}, {"text": "characterized", "start": 565, "end": 578, "id": 97, "ws": true}, {"text": "by", "start": 579, "end": 581, "id": 98, "ws": true}, {"text": "the", "start": 582, "end": 585, "id": 99, "ws": true}, {"text": "presence", "start": 586, "end": 594, "id": 100, "ws": true}, {"text": "of", "start": 595, "end": 597, "id": 101, "ws": true}, {"text": "the", "start": 598, "end": 601, "id": 102, "ws": true}, {"text": "t(15;17", "start": 602, "end": 609, "id": 103, "ws": false}, {"text": ")", "start": 609, "end": 610, "id": 104, "ws": true}, {"text": "translocation", "start": 611, "end": 624, "id": 105, "ws": true}, {"text": "or", "start": 625, "end": 627, "id": 106, "ws": true}, {"text": "PML", "start": 628, "end": 631, "id": 107, "ws": false}, {"text": "/", "start": 631, "end": 632, "id": 108, "ws": false}, {"text": "RAR", "start": 632, "end": 635, "id": 109, "ws": false}, {"text": "-", "start": 635, "end": 636, "id": 110, "ws": false}, {"text": "alpha", "start": 636, "end": 641, "id": 111, "ws": true}, {"text": "gene", "start": 642, "end": 646, "id": 112, "ws": true}, {"text": "expression", "start": 647, "end": 657, "id": 113, "ws": false}, {"text": ".", "start": 657, "end": 658, "id": 114, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 16, "token_start": 0, "token_end": 1, "label": "DRUG"}, {"start": 17, "end": 26, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 33, "end": 42, "token_start": 5, "token_end": 5, "label": "MECHANISM"}, {"start": 58, "end": 98, "token_start": 9, "token_end": 13, "label": "ACTION"}, {"start": 116, "end": 119, "token_start": 17, "token_end": 17, "label": "BASECONDITION"}, {"start": 128, "end": 316, "token_start": 20, "token_end": 53, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694174954, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Aripiprazole orally disintegrating tablets are indicated for the treatment of: Schizophrenia [ see CLINICAL STUDIES ( 14.1) ] Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc.s ABILIFY  (aripiprazole) product. However, due to Otsuka America Pharmaceutical, Inc.s marketing exclusivity rights, this drug product is not labeled with that information. Aripiprazole is an atypical antipsychotic. The oral formulation is indicated for: Schizophrenia ( 14.1)", "_input_hash": -1525559938, "_task_hash": -277903102, "_is_binary": false, "tokens": [{"text": "Aripiprazole", "start": 0, "end": 12, "id": 0, "ws": true}, {"text": "orally", "start": 13, "end": 19, "id": 1, "ws": true}, {"text": "disintegrating", "start": 20, "end": 34, "id": 2, "ws": true}, {"text": "tablets", "start": 35, "end": 42, "id": 3, "ws": true}, {"text": "are", "start": 43, "end": 46, "id": 4, "ws": true}, {"text": "indicated", "start": 47, "end": 56, "id": 5, "ws": true}, {"text": "for", "start": 57, "end": 60, "id": 6, "ws": true}, {"text": "the", "start": 61, "end": 64, "id": 7, "ws": true}, {"text": "treatment", "start": 65, "end": 74, "id": 8, "ws": true}, {"text": "of", "start": 75, "end": 77, "id": 9, "ws": false}, {"text": ":", "start": 77, "end": 78, "id": 10, "ws": true}, {"text": "Schizophrenia", "start": 79, "end": 92, "id": 11, "ws": true}, {"text": "[", "start": 93, "end": 94, "id": 12, "ws": true}, {"text": "see", "start": 95, "end": 98, "id": 13, "ws": true}, {"text": "CLINICAL", "start": 99, "end": 107, "id": 14, "ws": true}, {"text": "STUDIES", "start": 108, "end": 115, "id": 15, "ws": true}, {"text": "(", "start": 116, "end": 117, "id": 16, "ws": true}, {"text": "14.1", "start": 118, "end": 122, "id": 17, "ws": false}, {"text": ")", "start": 122, "end": 123, "id": 18, "ws": true}, {"text": "]", "start": 124, "end": 125, "id": 19, "ws": true}, {"text": "Additional", "start": 126, "end": 136, "id": 20, "ws": true}, {"text": "pediatric", "start": 137, "end": 146, "id": 21, "ws": true}, {"text": "use", "start": 147, "end": 150, "id": 22, "ws": true}, {"text": "information", "start": 151, "end": 162, "id": 23, "ws": true}, {"text": "is", "start": 163, "end": 165, "id": 24, "ws": true}, {"text": "approved", "start": 166, "end": 174, "id": 25, "ws": true}, {"text": "for", "start": 175, "end": 178, "id": 26, "ws": true}, {"text": "Otsuka", "start": 179, "end": 185, "id": 27, "ws": true}, {"text": "America", "start": 186, "end": 193, "id": 28, "ws": true}, {"text": "Pharmaceutical", "start": 194, "end": 208, "id": 29, "ws": false}, {"text": ",", "start": 208, "end": 209, "id": 30, "ws": true}, {"text": "Inc.s", "start": 210, "end": 215, "id": 31, "ws": true}, {"text": "ABILIFY", "start": 216, "end": 223, "id": 32, "ws": true}, {"text": " ", "start": 224, "end": 225, "id": 33, "ws": false}, {"text": "(", "start": 225, "end": 226, "id": 34, "ws": false}, {"text": "aripiprazole", "start": 226, "end": 238, "id": 35, "ws": false}, {"text": ")", "start": 238, "end": 239, "id": 36, "ws": true}, {"text": "product", "start": 240, "end": 247, "id": 37, "ws": false}, {"text": ".", "start": 247, "end": 248, "id": 38, "ws": true}, {"text": "However", "start": 249, "end": 256, "id": 39, "ws": false}, {"text": ",", "start": 256, "end": 257, "id": 40, "ws": true}, {"text": "due", "start": 258, "end": 261, "id": 41, "ws": true}, {"text": "to", "start": 262, "end": 264, "id": 42, "ws": true}, {"text": "Otsuka", "start": 265, "end": 271, "id": 43, "ws": true}, {"text": "America", "start": 272, "end": 279, "id": 44, "ws": true}, {"text": "Pharmaceutical", "start": 280, "end": 294, "id": 45, "ws": false}, {"text": ",", "start": 294, "end": 295, "id": 46, "ws": true}, {"text": "Inc.s", "start": 296, "end": 301, "id": 47, "ws": true}, {"text": "marketing", "start": 302, "end": 311, "id": 48, "ws": true}, {"text": "exclusivity", "start": 312, "end": 323, "id": 49, "ws": true}, {"text": "rights", "start": 324, "end": 330, "id": 50, "ws": false}, {"text": ",", "start": 330, "end": 331, "id": 51, "ws": true}, {"text": "this", "start": 332, "end": 336, "id": 52, "ws": true}, {"text": "drug", "start": 337, "end": 341, "id": 53, "ws": true}, {"text": "product", "start": 342, "end": 349, "id": 54, "ws": true}, {"text": "is", "start": 350, "end": 352, "id": 55, "ws": true}, {"text": "not", "start": 353, "end": 356, "id": 56, "ws": true}, {"text": "labeled", "start": 357, "end": 364, "id": 57, "ws": true}, {"text": "with", "start": 365, "end": 369, "id": 58, "ws": true}, {"text": "that", "start": 370, "end": 374, "id": 59, "ws": true}, {"text": "information", "start": 375, "end": 386, "id": 60, "ws": false}, {"text": ".", "start": 386, "end": 387, "id": 61, "ws": true}, {"text": "Aripiprazole", "start": 388, "end": 400, "id": 62, "ws": true}, {"text": "is", "start": 401, "end": 403, "id": 63, "ws": true}, {"text": "an", "start": 404, "end": 406, "id": 64, "ws": true}, {"text": "atypical", "start": 407, "end": 415, "id": 65, "ws": true}, {"text": "antipsychotic", "start": 416, "end": 429, "id": 66, "ws": false}, {"text": ".", "start": 429, "end": 430, "id": 67, "ws": true}, {"text": "The", "start": 431, "end": 434, "id": 68, "ws": true}, {"text": "oral", "start": 435, "end": 439, "id": 69, "ws": true}, {"text": "formulation", "start": 440, "end": 451, "id": 70, "ws": true}, {"text": "is", "start": 452, "end": 454, "id": 71, "ws": true}, {"text": "indicated", "start": 455, "end": 464, "id": 72, "ws": true}, {"text": "for", "start": 465, "end": 468, "id": 73, "ws": false}, {"text": ":", "start": 468, "end": 469, "id": 74, "ws": true}, {"text": "Schizophrenia", "start": 470, "end": 483, "id": 75, "ws": true}, {"text": "(", "start": 484, "end": 485, "id": 76, "ws": true}, {"text": "14.1", "start": 486, "end": 490, "id": 77, "ws": false}, {"text": ")", "start": 490, "end": 491, "id": 78, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 12, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 13, "end": 19, "token_start": 1, "token_end": 1, "label": "ROUTE"}, {"start": 20, "end": 42, "token_start": 2, "token_end": 3, "label": "FORMULATION"}, {"start": 65, "end": 74, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 79, "end": 92, "token_start": 11, "token_end": 11, "label": "INDICATION"}, {"start": 388, "end": 400, "token_start": 62, "token_end": 62, "label": "DRUG"}, {"start": 407, "end": 429, "token_start": 65, "token_end": 66, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694526760, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Buprenorphine hydrochloride injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see WARNINGS: Addiction, Abuse, and Misuse ] reserve buprenorphine hydrochloride for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia.", "_input_hash": 731064232, "_task_hash": 674734940, "_is_binary": false, "tokens": [{"text": "Buprenorphine", "start": 0, "end": 13, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 14, "end": 27, "id": 1, "ws": true}, {"text": "injection", "start": 28, "end": 37, "id": 2, "ws": true}, {"text": "is", "start": 38, "end": 40, "id": 3, "ws": true}, {"text": "indicated", "start": 41, "end": 50, "id": 4, "ws": true}, {"text": "for", "start": 51, "end": 54, "id": 5, "ws": true}, {"text": "the", "start": 55, "end": 58, "id": 6, "ws": true}, {"text": "management", "start": 59, "end": 69, "id": 7, "ws": true}, {"text": "of", "start": 70, "end": 72, "id": 8, "ws": true}, {"text": "pain", "start": 73, "end": 77, "id": 9, "ws": true}, {"text": "severe", "start": 78, "end": 84, "id": 10, "ws": true}, {"text": "enough", "start": 85, "end": 91, "id": 11, "ws": true}, {"text": "to", "start": 92, "end": 94, "id": 12, "ws": true}, {"text": "require", "start": 95, "end": 102, "id": 13, "ws": true}, {"text": "an", "start": 103, "end": 105, "id": 14, "ws": true}, {"text": "opioid", "start": 106, "end": 112, "id": 15, "ws": true}, {"text": "analgesic", "start": 113, "end": 122, "id": 16, "ws": true}, {"text": "and", "start": 123, "end": 126, "id": 17, "ws": true}, {"text": "for", "start": 127, "end": 130, "id": 18, "ws": true}, {"text": "which", "start": 131, "end": 136, "id": 19, "ws": true}, {"text": "alternate", "start": 137, "end": 146, "id": 20, "ws": true}, {"text": "treatments", "start": 147, "end": 157, "id": 21, "ws": true}, {"text": "are", "start": 158, "end": 161, "id": 22, "ws": true}, {"text": "inadequate", "start": 162, "end": 172, "id": 23, "ws": false}, {"text": ".", "start": 172, "end": 173, "id": 24, "ws": true}, {"text": "Limitations", "start": 174, "end": 185, "id": 25, "ws": true}, {"text": "of", "start": 186, "end": 188, "id": 26, "ws": true}, {"text": "Use", "start": 189, "end": 192, "id": 27, "ws": true}, {"text": "Because", "start": 193, "end": 200, "id": 28, "ws": true}, {"text": "of", "start": 201, "end": 203, "id": 29, "ws": true}, {"text": "the", "start": 204, "end": 207, "id": 30, "ws": true}, {"text": "risks", "start": 208, "end": 213, "id": 31, "ws": true}, {"text": "of", "start": 214, "end": 216, "id": 32, "ws": true}, {"text": "addiction", "start": 217, "end": 226, "id": 33, "ws": false}, {"text": ",", "start": 226, "end": 227, "id": 34, "ws": true}, {"text": "abuse", "start": 228, "end": 233, "id": 35, "ws": false}, {"text": ",", "start": 233, "end": 234, "id": 36, "ws": true}, {"text": "and", "start": 235, "end": 238, "id": 37, "ws": true}, {"text": "misuse", "start": 239, "end": 245, "id": 38, "ws": true}, {"text": "with", "start": 246, "end": 250, "id": 39, "ws": true}, {"text": "opioids", "start": 251, "end": 258, "id": 40, "ws": false}, {"text": ",", "start": 258, "end": 259, "id": 41, "ws": true}, {"text": "even", "start": 260, "end": 264, "id": 42, "ws": true}, {"text": "at", "start": 265, "end": 267, "id": 43, "ws": true}, {"text": "recommended", "start": 268, "end": 279, "id": 44, "ws": true}, {"text": "doses", "start": 280, "end": 285, "id": 45, "ws": true}, {"text": "[", "start": 286, "end": 287, "id": 46, "ws": false}, {"text": "see", "start": 287, "end": 290, "id": 47, "ws": true}, {"text": "WARNINGS", "start": 291, "end": 299, "id": 48, "ws": false}, {"text": ":", "start": 299, "end": 300, "id": 49, "ws": true}, {"text": "Addiction", "start": 301, "end": 310, "id": 50, "ws": false}, {"text": ",", "start": 310, "end": 311, "id": 51, "ws": true}, {"text": "Abuse", "start": 312, "end": 317, "id": 52, "ws": false}, {"text": ",", "start": 317, "end": 318, "id": 53, "ws": true}, {"text": "and", "start": 319, "end": 322, "id": 54, "ws": true}, {"text": "Misuse", "start": 323, "end": 329, "id": 55, "ws": true}, {"text": "]", "start": 330, "end": 331, "id": 56, "ws": true}, {"text": "reserve", "start": 332, "end": 339, "id": 57, "ws": true}, {"text": "buprenorphine", "start": 340, "end": 353, "id": 58, "ws": true}, {"text": "hydrochloride", "start": 354, "end": 367, "id": 59, "ws": true}, {"text": "for", "start": 368, "end": 371, "id": 60, "ws": true}, {"text": "use", "start": 372, "end": 375, "id": 61, "ws": true}, {"text": "in", "start": 376, "end": 378, "id": 62, "ws": true}, {"text": "patients", "start": 379, "end": 387, "id": 63, "ws": true}, {"text": "for", "start": 388, "end": 391, "id": 64, "ws": true}, {"text": "whom", "start": 392, "end": 396, "id": 65, "ws": true}, {"text": "alternative", "start": 397, "end": 408, "id": 66, "ws": true}, {"text": "treatment", "start": 409, "end": 418, "id": 67, "ws": true}, {"text": "options", "start": 419, "end": 426, "id": 68, "ws": true}, {"text": "[", "start": 427, "end": 428, "id": 69, "ws": false}, {"text": "e.g.", "start": 428, "end": 432, "id": 70, "ws": false}, {"text": ",", "start": 432, "end": 433, "id": 71, "ws": true}, {"text": "non", "start": 434, "end": 437, "id": 72, "ws": false}, {"text": "-", "start": 437, "end": 438, "id": 73, "ws": false}, {"text": "opioid", "start": 438, "end": 444, "id": 74, "ws": true}, {"text": "analgesics", "start": 445, "end": 455, "id": 75, "ws": true}, {"text": "or", "start": 456, "end": 458, "id": 76, "ws": true}, {"text": "opioid", "start": 459, "end": 465, "id": 77, "ws": true}, {"text": "combination", "start": 466, "end": 477, "id": 78, "ws": true}, {"text": "products", "start": 478, "end": 486, "id": 79, "ws": false}, {"text": "]", "start": 486, "end": 487, "id": 80, "ws": false}, {"text": ":", "start": 487, "end": 488, "id": 81, "ws": true}, {"text": "Have", "start": 489, "end": 493, "id": 82, "ws": true}, {"text": "not", "start": 494, "end": 497, "id": 83, "ws": true}, {"text": "been", "start": 498, "end": 502, "id": 84, "ws": true}, {"text": "tolerated", "start": 503, "end": 512, "id": 85, "ws": false}, {"text": ",", "start": 512, "end": 513, "id": 86, "ws": true}, {"text": "or", "start": 514, "end": 516, "id": 87, "ws": true}, {"text": "are", "start": 517, "end": 520, "id": 88, "ws": true}, {"text": "not", "start": 521, "end": 524, "id": 89, "ws": true}, {"text": "expected", "start": 525, "end": 533, "id": 90, "ws": true}, {"text": "to", "start": 534, "end": 536, "id": 91, "ws": true}, {"text": "be", "start": 537, "end": 539, "id": 92, "ws": true}, {"text": "tolerated", "start": 540, "end": 549, "id": 93, "ws": false}, {"text": ",", "start": 549, "end": 550, "id": 94, "ws": true}, {"text": "Have", "start": 551, "end": 555, "id": 95, "ws": true}, {"text": "not", "start": 556, "end": 559, "id": 96, "ws": true}, {"text": "provided", "start": 560, "end": 568, "id": 97, "ws": true}, {"text": "adequate", "start": 569, "end": 577, "id": 98, "ws": true}, {"text": "analgesia", "start": 578, "end": 587, "id": 99, "ws": false}, {"text": ",", "start": 587, "end": 588, "id": 100, "ws": true}, {"text": "or", "start": 589, "end": 591, "id": 101, "ws": true}, {"text": "are", "start": 592, "end": 595, "id": 102, "ws": true}, {"text": "not", "start": 596, "end": 599, "id": 103, "ws": true}, {"text": "expected", "start": 600, "end": 608, "id": 104, "ws": true}, {"text": "to", "start": 609, "end": 611, "id": 105, "ws": true}, {"text": "provide", "start": 612, "end": 619, "id": 106, "ws": true}, {"text": "adequate", "start": 620, "end": 628, "id": 107, "ws": true}, {"text": "analgesia", "start": 629, "end": 638, "id": 108, "ws": false}, {"text": ".", "start": 638, "end": 639, "id": 109, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 27, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 28, "end": 37, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 59, "end": 69, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 73, "end": 77, "token_start": 9, "token_end": 9, "label": "INDICATION"}, {"start": 106, "end": 122, "token_start": 15, "token_end": 16, "label": "CO_PRESCRIPTION"}, {"start": 137, "end": 172, "token_start": 20, "token_end": 23, "label": "MEDICAL_CTX"}], "answer": "accept", "_timestamp": 1694175628, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "NOCDURNA is indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. In the NOCDURNA clinical trials nocturnal polyuria was defined as night-time urine production exceeding one-third of the 24-hour urine production. Before starting NOCDURNA: Evaluate the patient for possible causes for the nocturia, including excessive fluid intake prior to bedtime, and address other treatable causes of nocturia. Confirm the diagnosis of nocturnal polyuria with a 24-hour urine collection, if one has not been obtained previously. NOCDURNA is a vasopressin analog indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. (1)", "_input_hash": -1338929130, "_task_hash": 1402010101, "_is_binary": false, "tokens": [{"text": "NOCDURNA", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "treatment", "start": 30, "end": 39, "id": 5, "ws": true}, {"text": "of", "start": 40, "end": 42, "id": 6, "ws": true}, {"text": "nocturia", "start": 43, "end": 51, "id": 7, "ws": true}, {"text": "due", "start": 52, "end": 55, "id": 8, "ws": true}, {"text": "to", "start": 56, "end": 58, "id": 9, "ws": true}, {"text": "nocturnal", "start": 59, "end": 68, "id": 10, "ws": true}, {"text": "polyuria", "start": 69, "end": 77, "id": 11, "ws": true}, {"text": "in", "start": 78, "end": 80, "id": 12, "ws": true}, {"text": "adults", "start": 81, "end": 87, "id": 13, "ws": true}, {"text": "who", "start": 88, "end": 91, "id": 14, "ws": true}, {"text": "awaken", "start": 92, "end": 98, "id": 15, "ws": true}, {"text": "at", "start": 99, "end": 101, "id": 16, "ws": true}, {"text": "least", "start": 102, "end": 107, "id": 17, "ws": true}, {"text": "2", "start": 108, "end": 109, "id": 18, "ws": true}, {"text": "times", "start": 110, "end": 115, "id": 19, "ws": true}, {"text": "per", "start": 116, "end": 119, "id": 20, "ws": true}, {"text": "night", "start": 120, "end": 125, "id": 21, "ws": true}, {"text": "to", "start": 126, "end": 128, "id": 22, "ws": true}, {"text": "void", "start": 129, "end": 133, "id": 23, "ws": false}, {"text": ".", "start": 133, "end": 134, "id": 24, "ws": true}, {"text": "In", "start": 135, "end": 137, "id": 25, "ws": true}, {"text": "the", "start": 138, "end": 141, "id": 26, "ws": true}, {"text": "NOCDURNA", "start": 142, "end": 150, "id": 27, "ws": true}, {"text": "clinical", "start": 151, "end": 159, "id": 28, "ws": true}, {"text": "trials", "start": 160, "end": 166, "id": 29, "ws": true}, {"text": "nocturnal", "start": 167, "end": 176, "id": 30, "ws": true}, {"text": "polyuria", "start": 177, "end": 185, "id": 31, "ws": true}, {"text": "was", "start": 186, "end": 189, "id": 32, "ws": true}, {"text": "defined", "start": 190, "end": 197, "id": 33, "ws": true}, {"text": "as", "start": 198, "end": 200, "id": 34, "ws": true}, {"text": "night", "start": 201, "end": 206, "id": 35, "ws": false}, {"text": "-", "start": 206, "end": 207, "id": 36, "ws": false}, {"text": "time", "start": 207, "end": 211, "id": 37, "ws": true}, {"text": "urine", "start": 212, "end": 217, "id": 38, "ws": true}, {"text": "production", "start": 218, "end": 228, "id": 39, "ws": true}, {"text": "exceeding", "start": 229, "end": 238, "id": 40, "ws": true}, {"text": "one", "start": 239, "end": 242, "id": 41, "ws": false}, {"text": "-", "start": 242, "end": 243, "id": 42, "ws": false}, {"text": "third", "start": 243, "end": 248, "id": 43, "ws": true}, {"text": "of", "start": 249, "end": 251, "id": 44, "ws": true}, {"text": "the", "start": 252, "end": 255, "id": 45, "ws": true}, {"text": "24", "start": 256, "end": 258, "id": 46, "ws": false}, {"text": "-", "start": 258, "end": 259, "id": 47, "ws": false}, {"text": "hour", "start": 259, "end": 263, "id": 48, "ws": true}, {"text": "urine", "start": 264, "end": 269, "id": 49, "ws": true}, {"text": "production", "start": 270, "end": 280, "id": 50, "ws": false}, {"text": ".", "start": 280, "end": 281, "id": 51, "ws": true}, {"text": "Before", "start": 282, "end": 288, "id": 52, "ws": true}, {"text": "starting", "start": 289, "end": 297, "id": 53, "ws": true}, {"text": "NOCDURNA", "start": 298, "end": 306, "id": 54, "ws": false}, {"text": ":", "start": 306, "end": 307, "id": 55, "ws": true}, {"text": "Evaluate", "start": 308, "end": 316, "id": 56, "ws": true}, {"text": "the", "start": 317, "end": 320, "id": 57, "ws": true}, {"text": "patient", "start": 321, "end": 328, "id": 58, "ws": true}, {"text": "for", "start": 329, "end": 332, "id": 59, "ws": true}, {"text": "possible", "start": 333, "end": 341, "id": 60, "ws": true}, {"text": "causes", "start": 342, "end": 348, "id": 61, "ws": true}, {"text": "for", "start": 349, "end": 352, "id": 62, "ws": true}, {"text": "the", "start": 353, "end": 356, "id": 63, "ws": true}, {"text": "nocturia", "start": 357, "end": 365, "id": 64, "ws": false}, {"text": ",", "start": 365, "end": 366, "id": 65, "ws": true}, {"text": "including", "start": 367, "end": 376, "id": 66, "ws": true}, {"text": "excessive", "start": 377, "end": 386, "id": 67, "ws": true}, {"text": "fluid", "start": 387, "end": 392, "id": 68, "ws": true}, {"text": "intake", "start": 393, "end": 399, "id": 69, "ws": true}, {"text": "prior", "start": 400, "end": 405, "id": 70, "ws": true}, {"text": "to", "start": 406, "end": 408, "id": 71, "ws": true}, {"text": "bedtime", "start": 409, "end": 416, "id": 72, "ws": false}, {"text": ",", "start": 416, "end": 417, "id": 73, "ws": true}, {"text": "and", "start": 418, "end": 421, "id": 74, "ws": true}, {"text": "address", "start": 422, "end": 429, "id": 75, "ws": true}, {"text": "other", "start": 430, "end": 435, "id": 76, "ws": true}, {"text": "treatable", "start": 436, "end": 445, "id": 77, "ws": true}, {"text": "causes", "start": 446, "end": 452, "id": 78, "ws": true}, {"text": "of", "start": 453, "end": 455, "id": 79, "ws": true}, {"text": "nocturia", "start": 456, "end": 464, "id": 80, "ws": false}, {"text": ".", "start": 464, "end": 465, "id": 81, "ws": true}, {"text": "Confirm", "start": 466, "end": 473, "id": 82, "ws": true}, {"text": "the", "start": 474, "end": 477, "id": 83, "ws": true}, {"text": "diagnosis", "start": 478, "end": 487, "id": 84, "ws": true}, {"text": "of", "start": 488, "end": 490, "id": 85, "ws": true}, {"text": "nocturnal", "start": 491, "end": 500, "id": 86, "ws": true}, {"text": "polyuria", "start": 501, "end": 509, "id": 87, "ws": true}, {"text": "with", "start": 510, "end": 514, "id": 88, "ws": true}, {"text": "a", "start": 515, "end": 516, "id": 89, "ws": true}, {"text": "24", "start": 517, "end": 519, "id": 90, "ws": false}, {"text": "-", "start": 519, "end": 520, "id": 91, "ws": false}, {"text": "hour", "start": 520, "end": 524, "id": 92, "ws": true}, {"text": "urine", "start": 525, "end": 530, "id": 93, "ws": true}, {"text": "collection", "start": 531, "end": 541, "id": 94, "ws": false}, {"text": ",", "start": 541, "end": 542, "id": 95, "ws": true}, {"text": "if", "start": 543, "end": 545, "id": 96, "ws": true}, {"text": "one", "start": 546, "end": 549, "id": 97, "ws": true}, {"text": "has", "start": 550, "end": 553, "id": 98, "ws": true}, {"text": "not", "start": 554, "end": 557, "id": 99, "ws": true}, {"text": "been", "start": 558, "end": 562, "id": 100, "ws": true}, {"text": "obtained", "start": 563, "end": 571, "id": 101, "ws": true}, {"text": "previously", "start": 572, "end": 582, "id": 102, "ws": false}, {"text": ".", "start": 582, "end": 583, "id": 103, "ws": true}, {"text": "NOCDURNA", "start": 584, "end": 592, "id": 104, "ws": true}, {"text": "is", "start": 593, "end": 595, "id": 105, "ws": true}, {"text": "a", "start": 596, "end": 597, "id": 106, "ws": true}, {"text": "vasopressin", "start": 598, "end": 609, "id": 107, "ws": true}, {"text": "analog", "start": 610, "end": 616, "id": 108, "ws": true}, {"text": "indicated", "start": 617, "end": 626, "id": 109, "ws": true}, {"text": "for", "start": 627, "end": 630, "id": 110, "ws": true}, {"text": "the", "start": 631, "end": 634, "id": 111, "ws": true}, {"text": "treatment", "start": 635, "end": 644, "id": 112, "ws": true}, {"text": "of", "start": 645, "end": 647, "id": 113, "ws": true}, {"text": "nocturia", "start": 648, "end": 656, "id": 114, "ws": true}, {"text": "due", "start": 657, "end": 660, "id": 115, "ws": true}, {"text": "to", "start": 661, "end": 663, "id": 116, "ws": true}, {"text": "nocturnal", "start": 664, "end": 673, "id": 117, "ws": true}, {"text": "polyuria", "start": 674, "end": 682, "id": 118, "ws": true}, {"text": "in", "start": 683, "end": 685, "id": 119, "ws": true}, {"text": "adults", "start": 686, "end": 692, "id": 120, "ws": true}, {"text": "who", "start": 693, "end": 696, "id": 121, "ws": true}, {"text": "awaken", "start": 697, "end": 703, "id": 122, "ws": true}, {"text": "at", "start": 704, "end": 706, "id": 123, "ws": true}, {"text": "least", "start": 707, "end": 712, "id": 124, "ws": true}, {"text": "2", "start": 713, "end": 714, "id": 125, "ws": true}, {"text": "times", "start": 715, "end": 720, "id": 126, "ws": true}, {"text": "per", "start": 721, "end": 724, "id": 127, "ws": true}, {"text": "night", "start": 725, "end": 730, "id": 128, "ws": true}, {"text": "to", "start": 731, "end": 733, "id": 129, "ws": true}, {"text": "void", "start": 734, "end": 738, "id": 130, "ws": false}, {"text": ".", "start": 738, "end": 739, "id": 131, "ws": true}, {"text": "(", "start": 740, "end": 741, "id": 132, "ws": false}, {"text": "1", "start": 741, "end": 742, "id": 133, "ws": false}, {"text": ")", "start": 742, "end": 743, "id": 134, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 39, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 43, "end": 51, "token_start": 7, "token_end": 7, "label": "INDICATION"}, {"start": 59, "end": 77, "token_start": 10, "token_end": 11, "label": "BASECONDITION"}, {"start": 81, "end": 133, "token_start": 13, "token_end": 23, "label": "TARGET_GROUP"}, {"start": 598, "end": 616, "token_start": 107, "token_end": 108, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694525551, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Eszopiclone tablets are indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance. The clinical trials performed in support of efficacy were up to 6 months in duration. The final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). Eszopiclone tablets are indicated for the treatment of insomnia. Eszopiclone tablets have been shown to decrease sleep latency and improve sleep maintenance (1).", "_input_hash": -99591229, "_task_hash": -893141025, "_is_binary": false, "tokens": [{"text": "Eszopiclone", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "tablets", "start": 12, "end": 19, "id": 1, "ws": true}, {"text": "are", "start": 20, "end": 23, "id": 2, "ws": true}, {"text": "indicated", "start": 24, "end": 33, "id": 3, "ws": true}, {"text": "for", "start": 34, "end": 37, "id": 4, "ws": true}, {"text": "the", "start": 38, "end": 41, "id": 5, "ws": true}, {"text": "treatment", "start": 42, "end": 51, "id": 6, "ws": true}, {"text": "of", "start": 52, "end": 54, "id": 7, "ws": true}, {"text": "insomnia", "start": 55, "end": 63, "id": 8, "ws": false}, {"text": ".", "start": 63, "end": 64, "id": 9, "ws": true}, {"text": "In", "start": 65, "end": 67, "id": 10, "ws": true}, {"text": "controlled", "start": 68, "end": 78, "id": 11, "ws": true}, {"text": "outpatient", "start": 79, "end": 89, "id": 12, "ws": true}, {"text": "and", "start": 90, "end": 93, "id": 13, "ws": true}, {"text": "sleep", "start": 94, "end": 99, "id": 14, "ws": true}, {"text": "laboratory", "start": 100, "end": 110, "id": 15, "ws": true}, {"text": "studies", "start": 111, "end": 118, "id": 16, "ws": false}, {"text": ",", "start": 118, "end": 119, "id": 17, "ws": true}, {"text": "eszopiclone", "start": 120, "end": 131, "id": 18, "ws": true}, {"text": "tablets", "start": 132, "end": 139, "id": 19, "ws": true}, {"text": "administered", "start": 140, "end": 152, "id": 20, "ws": true}, {"text": "at", "start": 153, "end": 155, "id": 21, "ws": true}, {"text": "bedtime", "start": 156, "end": 163, "id": 22, "ws": true}, {"text": "decreased", "start": 164, "end": 173, "id": 23, "ws": true}, {"text": "sleep", "start": 174, "end": 179, "id": 24, "ws": true}, {"text": "latency", "start": 180, "end": 187, "id": 25, "ws": true}, {"text": "and", "start": 188, "end": 191, "id": 26, "ws": true}, {"text": "improved", "start": 192, "end": 200, "id": 27, "ws": true}, {"text": "sleep", "start": 201, "end": 206, "id": 28, "ws": true}, {"text": "maintenance", "start": 207, "end": 218, "id": 29, "ws": false}, {"text": ".", "start": 218, "end": 219, "id": 30, "ws": true}, {"text": "The", "start": 220, "end": 223, "id": 31, "ws": true}, {"text": "clinical", "start": 224, "end": 232, "id": 32, "ws": true}, {"text": "trials", "start": 233, "end": 239, "id": 33, "ws": true}, {"text": "performed", "start": 240, "end": 249, "id": 34, "ws": true}, {"text": "in", "start": 250, "end": 252, "id": 35, "ws": true}, {"text": "support", "start": 253, "end": 260, "id": 36, "ws": true}, {"text": "of", "start": 261, "end": 263, "id": 37, "ws": true}, {"text": "efficacy", "start": 264, "end": 272, "id": 38, "ws": true}, {"text": "were", "start": 273, "end": 277, "id": 39, "ws": true}, {"text": "up", "start": 278, "end": 280, "id": 40, "ws": true}, {"text": "to", "start": 281, "end": 283, "id": 41, "ws": true}, {"text": "6", "start": 284, "end": 285, "id": 42, "ws": true}, {"text": "months", "start": 286, "end": 292, "id": 43, "ws": true}, {"text": "in", "start": 293, "end": 295, "id": 44, "ws": true}, {"text": "duration", "start": 296, "end": 304, "id": 45, "ws": false}, {"text": ".", "start": 304, "end": 305, "id": 46, "ws": true}, {"text": "The", "start": 306, "end": 309, "id": 47, "ws": true}, {"text": "final", "start": 310, "end": 315, "id": 48, "ws": true}, {"text": "formal", "start": 316, "end": 322, "id": 49, "ws": true}, {"text": "assessments", "start": 323, "end": 334, "id": 50, "ws": true}, {"text": "of", "start": 335, "end": 337, "id": 51, "ws": true}, {"text": "sleep", "start": 338, "end": 343, "id": 52, "ws": true}, {"text": "latency", "start": 344, "end": 351, "id": 53, "ws": true}, {"text": "and", "start": 352, "end": 355, "id": 54, "ws": true}, {"text": "maintenance", "start": 356, "end": 367, "id": 55, "ws": true}, {"text": "were", "start": 368, "end": 372, "id": 56, "ws": true}, {"text": "performed", "start": 373, "end": 382, "id": 57, "ws": true}, {"text": "at", "start": 383, "end": 385, "id": 58, "ws": true}, {"text": "4", "start": 386, "end": 387, "id": 59, "ws": true}, {"text": "weeks", "start": 388, "end": 393, "id": 60, "ws": true}, {"text": "in", "start": 394, "end": 396, "id": 61, "ws": true}, {"text": "the", "start": 397, "end": 400, "id": 62, "ws": true}, {"text": "6", "start": 401, "end": 402, "id": 63, "ws": false}, {"text": "-", "start": 402, "end": 403, "id": 64, "ws": false}, {"text": "week", "start": 403, "end": 407, "id": 65, "ws": true}, {"text": "study", "start": 408, "end": 413, "id": 66, "ws": true}, {"text": "(", "start": 414, "end": 415, "id": 67, "ws": false}, {"text": "adults", "start": 415, "end": 421, "id": 68, "ws": true}, {"text": "only", "start": 422, "end": 426, "id": 69, "ws": false}, {"text": ")", "start": 426, "end": 427, "id": 70, "ws": false}, {"text": ",", "start": 427, "end": 428, "id": 71, "ws": true}, {"text": "at", "start": 429, "end": 431, "id": 72, "ws": true}, {"text": "the", "start": 432, "end": 435, "id": 73, "ws": true}, {"text": "end", "start": 436, "end": 439, "id": 74, "ws": true}, {"text": "of", "start": 440, "end": 442, "id": 75, "ws": true}, {"text": "both", "start": 443, "end": 447, "id": 76, "ws": true}, {"text": "2", "start": 448, "end": 449, "id": 77, "ws": false}, {"text": "-", "start": 449, "end": 450, "id": 78, "ws": false}, {"text": "week", "start": 450, "end": 454, "id": 79, "ws": true}, {"text": "studies", "start": 455, "end": 462, "id": 80, "ws": true}, {"text": "(", "start": 463, "end": 464, "id": 81, "ws": false}, {"text": "elderly", "start": 464, "end": 471, "id": 82, "ws": true}, {"text": "only", "start": 472, "end": 476, "id": 83, "ws": false}, {"text": ")", "start": 476, "end": 477, "id": 84, "ws": true}, {"text": "and", "start": 478, "end": 481, "id": 85, "ws": true}, {"text": "at", "start": 482, "end": 484, "id": 86, "ws": true}, {"text": "the", "start": 485, "end": 488, "id": 87, "ws": true}, {"text": "end", "start": 489, "end": 492, "id": 88, "ws": true}, {"text": "of", "start": 493, "end": 495, "id": 89, "ws": true}, {"text": "the", "start": 496, "end": 499, "id": 90, "ws": true}, {"text": "6", "start": 500, "end": 501, "id": 91, "ws": false}, {"text": "-", "start": 501, "end": 502, "id": 92, "ws": false}, {"text": "month", "start": 502, "end": 507, "id": 93, "ws": true}, {"text": "study", "start": 508, "end": 513, "id": 94, "ws": true}, {"text": "(", "start": 514, "end": 515, "id": 95, "ws": false}, {"text": "adults", "start": 515, "end": 521, "id": 96, "ws": true}, {"text": "only", "start": 522, "end": 526, "id": 97, "ws": false}, {"text": ")", "start": 526, "end": 527, "id": 98, "ws": false}, {"text": ".", "start": 527, "end": 528, "id": 99, "ws": true}, {"text": "Eszopiclone", "start": 529, "end": 540, "id": 100, "ws": true}, {"text": "tablets", "start": 541, "end": 548, "id": 101, "ws": true}, {"text": "are", "start": 549, "end": 552, "id": 102, "ws": true}, {"text": "indicated", "start": 553, "end": 562, "id": 103, "ws": true}, {"text": "for", "start": 563, "end": 566, "id": 104, "ws": true}, {"text": "the", "start": 567, "end": 570, "id": 105, "ws": true}, {"text": "treatment", "start": 571, "end": 580, "id": 106, "ws": true}, {"text": "of", "start": 581, "end": 583, "id": 107, "ws": true}, {"text": "insomnia", "start": 584, "end": 592, "id": 108, "ws": false}, {"text": ".", "start": 592, "end": 593, "id": 109, "ws": true}, {"text": "Eszopiclone", "start": 594, "end": 605, "id": 110, "ws": true}, {"text": "tablets", "start": 606, "end": 613, "id": 111, "ws": true}, {"text": "have", "start": 614, "end": 618, "id": 112, "ws": true}, {"text": "been", "start": 619, "end": 623, "id": 113, "ws": true}, {"text": "shown", "start": 624, "end": 629, "id": 114, "ws": true}, {"text": "to", "start": 630, "end": 632, "id": 115, "ws": true}, {"text": "decrease", "start": 633, "end": 641, "id": 116, "ws": true}, {"text": "sleep", "start": 642, "end": 647, "id": 117, "ws": true}, {"text": "latency", "start": 648, "end": 655, "id": 118, "ws": true}, {"text": "and", "start": 656, "end": 659, "id": 119, "ws": true}, {"text": "improve", "start": 660, "end": 667, "id": 120, "ws": true}, {"text": "sleep", "start": 668, "end": 673, "id": 121, "ws": true}, {"text": "maintenance", "start": 674, "end": 685, "id": 122, "ws": true}, {"text": "(", "start": 686, "end": 687, "id": 123, "ws": false}, {"text": "1", "start": 687, "end": 688, "id": 124, "ws": false}, {"text": ")", "start": 688, "end": 689, "id": 125, "ws": false}, {"text": ".", "start": 689, "end": 690, "id": 126, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 19, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 42, "end": 51, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 55, "end": 63, "token_start": 8, "token_end": 8, "label": "INDICATION"}, {"start": 529, "end": 540, "token_start": 100, "token_end": 100, "label": "DRUG"}, {"start": 541, "end": 548, "token_start": 101, "token_end": 101, "label": "FORMULATION"}, {"start": 571, "end": 580, "token_start": 106, "token_end": 106, "label": "ACTION"}, {"start": 584, "end": 592, "token_start": 108, "token_end": 108, "label": "INDICATION"}, {"start": 594, "end": 605, "token_start": 110, "token_end": 110, "label": "DRUG"}, {"start": 606, "end": 613, "token_start": 111, "token_end": 111, "label": "FORMULATION"}, {"start": 633, "end": 655, "token_start": 116, "token_end": 118, "label": "EFFECT"}, {"start": 660, "end": 685, "token_start": 120, "token_end": 122, "label": "EFFECT"}], "answer": "accept", "_timestamp": 1694527878, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Altavera is indicated for use by females of reproductive potential to prevent pregnancy.", "_input_hash": -919398397, "_task_hash": -1325266740, "_is_binary": false, "tokens": [{"text": "Altavera", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "use", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "by", "start": 30, "end": 32, "id": 5, "ws": true}, {"text": "females", "start": 33, "end": 40, "id": 6, "ws": true}, {"text": "of", "start": 41, "end": 43, "id": 7, "ws": true}, {"text": "reproductive", "start": 44, "end": 56, "id": 8, "ws": true}, {"text": "potential", "start": 57, "end": 66, "id": 9, "ws": true}, {"text": "to", "start": 67, "end": 69, "id": 10, "ws": true}, {"text": "prevent", "start": 70, "end": 77, "id": 11, "ws": true}, {"text": "pregnancy", "start": 78, "end": 87, "id": 12, "ws": false}, {"text": ".", "start": 87, "end": 88, "id": 13, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 33, "end": 66, "token_start": 6, "token_end": 9, "label": "TARGET_GROUP"}, {"start": 70, "end": 77, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 78, "end": 87, "token_start": 12, "token_end": 12, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694527583, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "TYRVAYA (varenicline solution) nasal spray is indicated for the treatment of the signs and symptoms of dry eye disease. TYRVAYA (varenicline solution) nasal spray is a cholinergic agonist indicated for the treatment of the signs and symptoms of dry eye disease. (1)", "_input_hash": 190836455, "_task_hash": 1103000841, "_is_binary": false, "tokens": [{"text": "TYRVAYA", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "(", "start": 8, "end": 9, "id": 1, "ws": false}, {"text": "varenicline", "start": 9, "end": 20, "id": 2, "ws": true}, {"text": "solution", "start": 21, "end": 29, "id": 3, "ws": false}, {"text": ")", "start": 29, "end": 30, "id": 4, "ws": true}, {"text": "nasal", "start": 31, "end": 36, "id": 5, "ws": true}, {"text": "spray", "start": 37, "end": 42, "id": 6, "ws": true}, {"text": "is", "start": 43, "end": 45, "id": 7, "ws": true}, {"text": "indicated", "start": 46, "end": 55, "id": 8, "ws": true}, {"text": "for", "start": 56, "end": 59, "id": 9, "ws": true}, {"text": "the", "start": 60, "end": 63, "id": 10, "ws": true}, {"text": "treatment", "start": 64, "end": 73, "id": 11, "ws": true}, {"text": "of", "start": 74, "end": 76, "id": 12, "ws": true}, {"text": "the", "start": 77, "end": 80, "id": 13, "ws": true}, {"text": "signs", "start": 81, "end": 86, "id": 14, "ws": true}, {"text": "and", "start": 87, "end": 90, "id": 15, "ws": true}, {"text": "symptoms", "start": 91, "end": 99, "id": 16, "ws": true}, {"text": "of", "start": 100, "end": 102, "id": 17, "ws": true}, {"text": "dry", "start": 103, "end": 106, "id": 18, "ws": true}, {"text": "eye", "start": 107, "end": 110, "id": 19, "ws": true}, {"text": "disease", "start": 111, "end": 118, "id": 20, "ws": false}, {"text": ".", "start": 118, "end": 119, "id": 21, "ws": true}, {"text": "TYRVAYA", "start": 120, "end": 127, "id": 22, "ws": true}, {"text": "(", "start": 128, "end": 129, "id": 23, "ws": false}, {"text": "varenicline", "start": 129, "end": 140, "id": 24, "ws": true}, {"text": "solution", "start": 141, "end": 149, "id": 25, "ws": false}, {"text": ")", "start": 149, "end": 150, "id": 26, "ws": true}, {"text": "nasal", "start": 151, "end": 156, "id": 27, "ws": true}, {"text": "spray", "start": 157, "end": 162, "id": 28, "ws": true}, {"text": "is", "start": 163, "end": 165, "id": 29, "ws": true}, {"text": "a", "start": 166, "end": 167, "id": 30, "ws": true}, {"text": "cholinergic", "start": 168, "end": 179, "id": 31, "ws": true}, {"text": "agonist", "start": 180, "end": 187, "id": 32, "ws": true}, {"text": "indicated", "start": 188, "end": 197, "id": 33, "ws": true}, {"text": "for", "start": 198, "end": 201, "id": 34, "ws": true}, {"text": "the", "start": 202, "end": 205, "id": 35, "ws": true}, {"text": "treatment", "start": 206, "end": 215, "id": 36, "ws": true}, {"text": "of", "start": 216, "end": 218, "id": 37, "ws": true}, {"text": "the", "start": 219, "end": 222, "id": 38, "ws": true}, {"text": "signs", "start": 223, "end": 228, "id": 39, "ws": true}, {"text": "and", "start": 229, "end": 232, "id": 40, "ws": true}, {"text": "symptoms", "start": 233, "end": 241, "id": 41, "ws": true}, {"text": "of", "start": 242, "end": 244, "id": 42, "ws": true}, {"text": "dry", "start": 245, "end": 248, "id": 43, "ws": true}, {"text": "eye", "start": 249, "end": 252, "id": 44, "ws": true}, {"text": "disease", "start": 253, "end": 260, "id": 45, "ws": false}, {"text": ".", "start": 260, "end": 261, "id": 46, "ws": true}, {"text": "(", "start": 262, "end": 263, "id": 47, "ws": false}, {"text": "1", "start": 263, "end": 264, "id": 48, "ws": false}, {"text": ")", "start": 264, "end": 265, "id": 49, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 20, "token_start": 2, "token_end": 2, "label": "DRUG"}, {"start": 21, "end": 29, "token_start": 3, "token_end": 3, "label": "FORMULATION"}, {"start": 31, "end": 36, "token_start": 5, "token_end": 5, "label": "ROUTE"}, {"start": 64, "end": 73, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 81, "end": 99, "token_start": 14, "token_end": 16, "label": "INDICATION"}, {"start": 103, "end": 118, "token_start": 18, "token_end": 20, "label": "BASECONDITION"}, {"start": 168, "end": 187, "token_start": 31, "token_end": 32, "label": "MECHANISM"}], "answer": "accept", "_timestamp": 1694177237, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "CIMERLI is indicated for the treatment of patients with: CIMERLI, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the treatment of patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1.1) Macular Edema Following Retinal Vein Occlusion (RVO) ( 1.2) Diabetic Macular Edema (DME) ( 1.3) Diabetic Retinopathy (DR) ( 1.4) Myopic Choroidal Neovascularization (mCNV) ( 1.5) 1.1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) 1.2 Macular Edema Following Retinal Vein Occlusion (RVO) 1.3 Diabetic Macular Edema (DME) 1.4 Diabetic Retinopathy (DR) 1.5 Myopic Choroidal Neovascularization (mCNV)", "_input_hash": 98676098, "_task_hash": 1674934495, "_is_binary": false, "tokens": [{"text": "CIMERLI", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "treatment", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "of", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "patients", "start": 42, "end": 50, "id": 7, "ws": true}, {"text": "with", "start": 51, "end": 55, "id": 8, "ws": false}, {"text": ":", "start": 55, "end": 56, "id": 9, "ws": true}, {"text": "CIMERLI", "start": 57, "end": 64, "id": 10, "ws": false}, {"text": ",", "start": 64, "end": 65, "id": 11, "ws": true}, {"text": "a", "start": 66, "end": 67, "id": 12, "ws": true}, {"text": "vascular", "start": 68, "end": 76, "id": 13, "ws": true}, {"text": "endothelial", "start": 77, "end": 88, "id": 14, "ws": true}, {"text": "growth", "start": 89, "end": 95, "id": 15, "ws": true}, {"text": "factor", "start": 96, "end": 102, "id": 16, "ws": true}, {"text": "(", "start": 103, "end": 104, "id": 17, "ws": false}, {"text": "VEGF", "start": 104, "end": 108, "id": 18, "ws": false}, {"text": ")", "start": 108, "end": 109, "id": 19, "ws": true}, {"text": "inhibitor", "start": 110, "end": 119, "id": 20, "ws": false}, {"text": ",", "start": 119, "end": 120, "id": 21, "ws": true}, {"text": "is", "start": 121, "end": 123, "id": 22, "ws": true}, {"text": "indicated", "start": 124, "end": 133, "id": 23, "ws": true}, {"text": "for", "start": 134, "end": 137, "id": 24, "ws": true}, {"text": "the", "start": 138, "end": 141, "id": 25, "ws": true}, {"text": "treatment", "start": 142, "end": 151, "id": 26, "ws": true}, {"text": "of", "start": 152, "end": 154, "id": 27, "ws": true}, {"text": "patients", "start": 155, "end": 163, "id": 28, "ws": true}, {"text": "with", "start": 164, "end": 168, "id": 29, "ws": false}, {"text": ":", "start": 168, "end": 169, "id": 30, "ws": true}, {"text": "Neovascular", "start": 170, "end": 181, "id": 31, "ws": true}, {"text": "(", "start": 182, "end": 183, "id": 32, "ws": false}, {"text": "Wet", "start": 183, "end": 186, "id": 33, "ws": false}, {"text": ")", "start": 186, "end": 187, "id": 34, "ws": true}, {"text": "Age", "start": 188, "end": 191, "id": 35, "ws": false}, {"text": "-", "start": 191, "end": 192, "id": 36, "ws": false}, {"text": "Related", "start": 192, "end": 199, "id": 37, "ws": true}, {"text": "Macular", "start": 200, "end": 207, "id": 38, "ws": true}, {"text": "Degeneration", "start": 208, "end": 220, "id": 39, "ws": true}, {"text": "(", "start": 221, "end": 222, "id": 40, "ws": false}, {"text": "AMD", "start": 222, "end": 225, "id": 41, "ws": false}, {"text": ")", "start": 225, "end": 226, "id": 42, "ws": true}, {"text": "(", "start": 227, "end": 228, "id": 43, "ws": true}, {"text": "1.1", "start": 229, "end": 232, "id": 44, "ws": false}, {"text": ")", "start": 232, "end": 233, "id": 45, "ws": true}, {"text": "Macular", "start": 234, "end": 241, "id": 46, "ws": true}, {"text": "Edema", "start": 242, "end": 247, "id": 47, "ws": true}, {"text": "Following", "start": 248, "end": 257, "id": 48, "ws": true}, {"text": "Retinal", "start": 258, "end": 265, "id": 49, "ws": true}, {"text": "Vein", "start": 266, "end": 270, "id": 50, "ws": true}, {"text": "Occlusion", "start": 271, "end": 280, "id": 51, "ws": true}, {"text": "(", "start": 281, "end": 282, "id": 52, "ws": false}, {"text": "RVO", "start": 282, "end": 285, "id": 53, "ws": false}, {"text": ")", "start": 285, "end": 286, "id": 54, "ws": true}, {"text": "(", "start": 287, "end": 288, "id": 55, "ws": true}, {"text": "1.2", "start": 289, "end": 292, "id": 56, "ws": false}, {"text": ")", "start": 292, "end": 293, "id": 57, "ws": true}, {"text": "Diabetic", "start": 294, "end": 302, "id": 58, "ws": true}, {"text": "Macular", "start": 303, "end": 310, "id": 59, "ws": true}, {"text": "Edema", "start": 311, "end": 316, "id": 60, "ws": true}, {"text": "(", "start": 317, "end": 318, "id": 61, "ws": false}, {"text": "DME", "start": 318, "end": 321, "id": 62, "ws": false}, {"text": ")", "start": 321, "end": 322, "id": 63, "ws": true}, {"text": "(", "start": 323, "end": 324, "id": 64, "ws": true}, {"text": "1.3", "start": 325, "end": 328, "id": 65, "ws": false}, {"text": ")", "start": 328, "end": 329, "id": 66, "ws": true}, {"text": "Diabetic", "start": 330, "end": 338, "id": 67, "ws": true}, {"text": "Retinopathy", "start": 339, "end": 350, "id": 68, "ws": true}, {"text": "(", "start": 351, "end": 352, "id": 69, "ws": false}, {"text": "DR", "start": 352, "end": 354, "id": 70, "ws": false}, {"text": ")", "start": 354, "end": 355, "id": 71, "ws": true}, {"text": "(", "start": 356, "end": 357, "id": 72, "ws": true}, {"text": "1.4", "start": 358, "end": 361, "id": 73, "ws": false}, {"text": ")", "start": 361, "end": 362, "id": 74, "ws": true}, {"text": "Myopic", "start": 363, "end": 369, "id": 75, "ws": true}, {"text": "Choroidal", "start": 370, "end": 379, "id": 76, "ws": true}, {"text": "Neovascularization", "start": 380, "end": 398, "id": 77, "ws": true}, {"text": "(", "start": 399, "end": 400, "id": 78, "ws": false}, {"text": "mCNV", "start": 400, "end": 404, "id": 79, "ws": false}, {"text": ")", "start": 404, "end": 405, "id": 80, "ws": true}, {"text": "(", "start": 406, "end": 407, "id": 81, "ws": true}, {"text": "1.5", "start": 408, "end": 411, "id": 82, "ws": false}, {"text": ")", "start": 411, "end": 412, "id": 83, "ws": true}, {"text": "1.1", "start": 413, "end": 416, "id": 84, "ws": true}, {"text": "Neovascular", "start": 417, "end": 428, "id": 85, "ws": true}, {"text": "(", "start": 429, "end": 430, "id": 86, "ws": false}, {"text": "Wet", "start": 430, "end": 433, "id": 87, "ws": false}, {"text": ")", "start": 433, "end": 434, "id": 88, "ws": true}, {"text": "Age", "start": 435, "end": 438, "id": 89, "ws": false}, {"text": "-", "start": 438, "end": 439, "id": 90, "ws": false}, {"text": "Related", "start": 439, "end": 446, "id": 91, "ws": true}, {"text": "Macular", "start": 447, "end": 454, "id": 92, "ws": true}, {"text": "Degeneration", "start": 455, "end": 467, "id": 93, "ws": true}, {"text": "(", "start": 468, "end": 469, "id": 94, "ws": false}, {"text": "AMD", "start": 469, "end": 472, "id": 95, "ws": false}, {"text": ")", "start": 472, "end": 473, "id": 96, "ws": true}, {"text": "1.2", "start": 474, "end": 477, "id": 97, "ws": true}, {"text": "Macular", "start": 478, "end": 485, "id": 98, "ws": true}, {"text": "Edema", "start": 486, "end": 491, "id": 99, "ws": true}, {"text": "Following", "start": 492, "end": 501, "id": 100, "ws": true}, {"text": "Retinal", "start": 502, "end": 509, "id": 101, "ws": true}, {"text": "Vein", "start": 510, "end": 514, "id": 102, "ws": true}, {"text": "Occlusion", "start": 515, "end": 524, "id": 103, "ws": true}, {"text": "(", "start": 525, "end": 526, "id": 104, "ws": false}, {"text": "RVO", "start": 526, "end": 529, "id": 105, "ws": false}, {"text": ")", "start": 529, "end": 530, "id": 106, "ws": true}, {"text": "1.3", "start": 531, "end": 534, "id": 107, "ws": true}, {"text": "Diabetic", "start": 535, "end": 543, "id": 108, "ws": true}, {"text": "Macular", "start": 544, "end": 551, "id": 109, "ws": true}, {"text": "Edema", "start": 552, "end": 557, "id": 110, "ws": true}, {"text": "(", "start": 558, "end": 559, "id": 111, "ws": false}, {"text": "DME", "start": 559, "end": 562, "id": 112, "ws": false}, {"text": ")", "start": 562, "end": 563, "id": 113, "ws": true}, {"text": "1.4", "start": 564, "end": 567, "id": 114, "ws": true}, {"text": "Diabetic", "start": 568, "end": 576, "id": 115, "ws": true}, {"text": "Retinopathy", "start": 577, "end": 588, "id": 116, "ws": true}, {"text": "(", "start": 589, "end": 590, "id": 117, "ws": false}, {"text": "DR", "start": 590, "end": 592, "id": 118, "ws": false}, {"text": ")", "start": 592, "end": 593, "id": 119, "ws": true}, {"text": "1.5", "start": 594, "end": 597, "id": 120, "ws": true}, {"text": "Myopic", "start": 598, "end": 604, "id": 121, "ws": true}, {"text": "Choroidal", "start": 605, "end": 614, "id": 122, "ws": true}, {"text": "Neovascularization", "start": 615, "end": 633, "id": 123, "ws": true}, {"text": "(", "start": 634, "end": 635, "id": 124, "ws": false}, {"text": "mCNV", "start": 635, "end": 639, "id": 125, "ws": false}, {"text": ")", "start": 639, "end": 640, "id": 126, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 38, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 68, "end": 119, "token_start": 13, "token_end": 20, "label": "MECHANISM"}, {"start": 170, "end": 220, "token_start": 31, "token_end": 39, "label": "INDICATION"}, {"start": 234, "end": 280, "token_start": 46, "token_end": 51, "label": "INDICATION"}, {"start": 294, "end": 316, "token_start": 58, "token_end": 60, "label": "INDICATION"}, {"start": 330, "end": 350, "token_start": 67, "token_end": 68, "label": "INDICATION"}, {"start": 363, "end": 398, "token_start": 75, "token_end": 77, "label": "INDICATION"}, {"start": 417, "end": 467, "token_start": 85, "token_end": 93, "label": "INDICATION"}, {"start": 478, "end": 524, "token_start": 98, "token_end": 103, "label": "INDICATION"}, {"start": 535, "end": 557, "token_start": 108, "token_end": 110, "label": "INDICATION"}, {"start": 568, "end": 588, "token_start": 115, "token_end": 116, "label": "INDICATION"}, {"start": 598, "end": 633, "token_start": 121, "token_end": 123, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526382, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "BOSULIF is indicated for the treatment of adult patients with: Newly-diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). Chronic phase, accelerated phase (AP), or blast phase (BP) Ph+ CML with resistance or intolerance to prior therapy. BOSULIF is a kinase inhibitor indicated for the treatment of adult patients with Newly-diagnosed chronic phase Ph+ chronic myelogenous leukemia (CML). (1) Chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy. (1)", "_input_hash": 1526078341, "_task_hash": 1838600253, "_is_binary": false, "tokens": [{"text": "BOSULIF", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "treatment", "start": 29, "end": 38, "id": 5, "ws": true}, {"text": "of", "start": 39, "end": 41, "id": 6, "ws": true}, {"text": "adult", "start": 42, "end": 47, "id": 7, "ws": true}, {"text": "patients", "start": 48, "end": 56, "id": 8, "ws": true}, {"text": "with", "start": 57, "end": 61, "id": 9, "ws": false}, {"text": ":", "start": 61, "end": 62, "id": 10, "ws": true}, {"text": "Newly", "start": 63, "end": 68, "id": 11, "ws": false}, {"text": "-", "start": 68, "end": 69, "id": 12, "ws": false}, {"text": "diagnosed", "start": 69, "end": 78, "id": 13, "ws": true}, {"text": "chronic", "start": 79, "end": 86, "id": 14, "ws": true}, {"text": "phase", "start": 87, "end": 92, "id": 15, "ws": true}, {"text": "(", "start": 93, "end": 94, "id": 16, "ws": false}, {"text": "CP", "start": 94, "end": 96, "id": 17, "ws": false}, {"text": ")", "start": 96, "end": 97, "id": 18, "ws": true}, {"text": "Philadelphia", "start": 98, "end": 110, "id": 19, "ws": true}, {"text": "chromosome", "start": 111, "end": 121, "id": 20, "ws": false}, {"text": "-", "start": 121, "end": 122, "id": 21, "ws": false}, {"text": "positive", "start": 122, "end": 130, "id": 22, "ws": true}, {"text": "chronic", "start": 131, "end": 138, "id": 23, "ws": true}, {"text": "myelogenous", "start": 139, "end": 150, "id": 24, "ws": true}, {"text": "leukemia", "start": 151, "end": 159, "id": 25, "ws": true}, {"text": "(", "start": 160, "end": 161, "id": 26, "ws": false}, {"text": "Ph+", "start": 161, "end": 164, "id": 27, "ws": true}, {"text": "CML", "start": 165, "end": 168, "id": 28, "ws": false}, {"text": ")", "start": 168, "end": 169, "id": 29, "ws": false}, {"text": ".", "start": 169, "end": 170, "id": 30, "ws": true}, {"text": "Chronic", "start": 171, "end": 178, "id": 31, "ws": true}, {"text": "phase", "start": 179, "end": 184, "id": 32, "ws": false}, {"text": ",", "start": 184, "end": 185, "id": 33, "ws": true}, {"text": "accelerated", "start": 186, "end": 197, "id": 34, "ws": true}, {"text": "phase", "start": 198, "end": 203, "id": 35, "ws": true}, {"text": "(", "start": 204, "end": 205, "id": 36, "ws": false}, {"text": "AP", "start": 205, "end": 207, "id": 37, "ws": false}, {"text": ")", "start": 207, "end": 208, "id": 38, "ws": false}, {"text": ",", "start": 208, "end": 209, "id": 39, "ws": true}, {"text": "or", "start": 210, "end": 212, "id": 40, "ws": true}, {"text": "blast", "start": 213, "end": 218, "id": 41, "ws": true}, {"text": "phase", "start": 219, "end": 224, "id": 42, "ws": true}, {"text": "(", "start": 225, "end": 226, "id": 43, "ws": false}, {"text": "BP", "start": 226, "end": 228, "id": 44, "ws": false}, {"text": ")", "start": 228, "end": 229, "id": 45, "ws": true}, {"text": "Ph+", "start": 230, "end": 233, "id": 46, "ws": true}, {"text": "CML", "start": 234, "end": 237, "id": 47, "ws": true}, {"text": "with", "start": 238, "end": 242, "id": 48, "ws": true}, {"text": "resistance", "start": 243, "end": 253, "id": 49, "ws": true}, {"text": "or", "start": 254, "end": 256, "id": 50, "ws": true}, {"text": "intolerance", "start": 257, "end": 268, "id": 51, "ws": true}, {"text": "to", "start": 269, "end": 271, "id": 52, "ws": true}, {"text": "prior", "start": 272, "end": 277, "id": 53, "ws": true}, {"text": "therapy", "start": 278, "end": 285, "id": 54, "ws": false}, {"text": ".", "start": 285, "end": 286, "id": 55, "ws": true}, {"text": "BOSULIF", "start": 287, "end": 294, "id": 56, "ws": true}, {"text": "is", "start": 295, "end": 297, "id": 57, "ws": true}, {"text": "a", "start": 298, "end": 299, "id": 58, "ws": true}, {"text": "kinase", "start": 300, "end": 306, "id": 59, "ws": true}, {"text": "inhibitor", "start": 307, "end": 316, "id": 60, "ws": true}, {"text": "indicated", "start": 317, "end": 326, "id": 61, "ws": true}, {"text": "for", "start": 327, "end": 330, "id": 62, "ws": true}, {"text": "the", "start": 331, "end": 334, "id": 63, "ws": true}, {"text": "treatment", "start": 335, "end": 344, "id": 64, "ws": true}, {"text": "of", "start": 345, "end": 347, "id": 65, "ws": true}, {"text": "adult", "start": 348, "end": 353, "id": 66, "ws": true}, {"text": "patients", "start": 354, "end": 362, "id": 67, "ws": true}, {"text": "with", "start": 363, "end": 367, "id": 68, "ws": true}, {"text": "Newly", "start": 368, "end": 373, "id": 69, "ws": false}, {"text": "-", "start": 373, "end": 374, "id": 70, "ws": false}, {"text": "diagnosed", "start": 374, "end": 383, "id": 71, "ws": true}, {"text": "chronic", "start": 384, "end": 391, "id": 72, "ws": true}, {"text": "phase", "start": 392, "end": 397, "id": 73, "ws": true}, {"text": "Ph+", "start": 398, "end": 401, "id": 74, "ws": true}, {"text": "chronic", "start": 402, "end": 409, "id": 75, "ws": true}, {"text": "myelogenous", "start": 410, "end": 421, "id": 76, "ws": true}, {"text": "leukemia", "start": 422, "end": 430, "id": 77, "ws": true}, {"text": "(", "start": 431, "end": 432, "id": 78, "ws": false}, {"text": "CML", "start": 432, "end": 435, "id": 79, "ws": false}, {"text": ")", "start": 435, "end": 436, "id": 80, "ws": false}, {"text": ".", "start": 436, "end": 437, "id": 81, "ws": true}, {"text": "(", "start": 438, "end": 439, "id": 82, "ws": false}, {"text": "1", "start": 439, "end": 440, "id": 83, "ws": false}, {"text": ")", "start": 440, "end": 441, "id": 84, "ws": true}, {"text": "Chronic", "start": 442, "end": 449, "id": 85, "ws": false}, {"text": ",", "start": 449, "end": 450, "id": 86, "ws": true}, {"text": "accelerated", "start": 451, "end": 462, "id": 87, "ws": false}, {"text": ",", "start": 462, "end": 463, "id": 88, "ws": true}, {"text": "or", "start": 464, "end": 466, "id": 89, "ws": true}, {"text": "blast", "start": 467, "end": 472, "id": 90, "ws": true}, {"text": "phase", "start": 473, "end": 478, "id": 91, "ws": true}, {"text": "Ph+", "start": 479, "end": 482, "id": 92, "ws": true}, {"text": "CML", "start": 483, "end": 486, "id": 93, "ws": true}, {"text": "with", "start": 487, "end": 491, "id": 94, "ws": true}, {"text": "resistance", "start": 492, "end": 502, "id": 95, "ws": true}, {"text": "or", "start": 503, "end": 505, "id": 96, "ws": true}, {"text": "intolerance", "start": 506, "end": 517, "id": 97, "ws": true}, {"text": "to", "start": 518, "end": 520, "id": 98, "ws": true}, {"text": "prior", "start": 521, "end": 526, "id": 99, "ws": true}, {"text": "therapy", "start": 527, "end": 534, "id": 100, "ws": false}, {"text": ".", "start": 534, "end": 535, "id": 101, "ws": true}, {"text": "(", "start": 536, "end": 537, "id": 102, "ws": false}, {"text": "1", "start": 537, "end": 538, "id": 103, "ws": false}, {"text": ")", "start": 538, "end": 539, "id": 104, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 38, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 42, "end": 47, "token_start": 7, "token_end": 7, "label": "TARGET_GROUP"}, {"start": 63, "end": 92, "token_start": 11, "token_end": 15, "label": "INDICATION"}, {"start": 98, "end": 159, "token_start": 19, "token_end": 25, "label": "INDICATION"}, {"start": 171, "end": 237, "token_start": 31, "token_end": 47, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694176513, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Topical corticosteroids are indicated for relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.", "_input_hash": -922416790, "_task_hash": 1953679986, "_is_binary": false, "tokens": [{"text": "Topical", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "corticosteroids", "start": 8, "end": 23, "id": 1, "ws": true}, {"text": "are", "start": 24, "end": 27, "id": 2, "ws": true}, {"text": "indicated", "start": 28, "end": 37, "id": 3, "ws": true}, {"text": "for", "start": 38, "end": 41, "id": 4, "ws": true}, {"text": "relief", "start": 42, "end": 48, "id": 5, "ws": true}, {"text": "of", "start": 49, "end": 51, "id": 6, "ws": true}, {"text": "the", "start": 52, "end": 55, "id": 7, "ws": true}, {"text": "inflammatory", "start": 56, "end": 68, "id": 8, "ws": true}, {"text": "and", "start": 69, "end": 72, "id": 9, "ws": true}, {"text": "pruritic", "start": 73, "end": 81, "id": 10, "ws": true}, {"text": "manifestations", "start": 82, "end": 96, "id": 11, "ws": true}, {"text": "of", "start": 97, "end": 99, "id": 12, "ws": true}, {"text": "corticosteroid", "start": 100, "end": 114, "id": 13, "ws": true}, {"text": "responsive", "start": 115, "end": 125, "id": 14, "ws": true}, {"text": "dermatoses", "start": 126, "end": 136, "id": 15, "ws": false}, {"text": ".", "start": 136, "end": 137, "id": 16, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "ROUTE"}, {"start": 8, "end": 23, "token_start": 1, "token_end": 1, "label": "DRUG"}, {"start": 42, "end": 48, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 56, "end": 96, "token_start": 8, "token_end": 11, "label": "INDICATION"}, {"start": 100, "end": 136, "token_start": 13, "token_end": 15, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694525726, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Relapsed or Refractory Acute Myeloid Leukemia REZLIDHIA is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test [see Dosage and Administration (2.1), Clinical Pharmacology (12.1), and Clinical Studies (14.1)]. REZLIDHIA is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test. (1)", "_input_hash": -1590212606, "_task_hash": 603126530, "_is_binary": false, "tokens": [{"text": "Relapsed", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "or", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "Refractory", "start": 12, "end": 22, "id": 2, "ws": true}, {"text": "Acute", "start": 23, "end": 28, "id": 3, "ws": true}, {"text": "Myeloid", "start": 29, "end": 36, "id": 4, "ws": true}, {"text": "Leukemia", "start": 37, "end": 45, "id": 5, "ws": true}, {"text": "REZLIDHIA", "start": 46, "end": 55, "id": 6, "ws": true}, {"text": "is", "start": 56, "end": 58, "id": 7, "ws": true}, {"text": "indicated", "start": 59, "end": 68, "id": 8, "ws": true}, {"text": "for", "start": 69, "end": 72, "id": 9, "ws": true}, {"text": "the", "start": 73, "end": 76, "id": 10, "ws": true}, {"text": "treatment", "start": 77, "end": 86, "id": 11, "ws": true}, {"text": "of", "start": 87, "end": 89, "id": 12, "ws": true}, {"text": "adult", "start": 90, "end": 95, "id": 13, "ws": true}, {"text": "patients", "start": 96, "end": 104, "id": 14, "ws": true}, {"text": "with", "start": 105, "end": 109, "id": 15, "ws": true}, {"text": "relapsed", "start": 110, "end": 118, "id": 16, "ws": true}, {"text": "or", "start": 119, "end": 121, "id": 17, "ws": true}, {"text": "refractory", "start": 122, "end": 132, "id": 18, "ws": true}, {"text": "acute", "start": 133, "end": 138, "id": 19, "ws": true}, {"text": "myeloid", "start": 139, "end": 146, "id": 20, "ws": true}, {"text": "leukemia", "start": 147, "end": 155, "id": 21, "ws": true}, {"text": "(", "start": 156, "end": 157, "id": 22, "ws": false}, {"text": "AML", "start": 157, "end": 160, "id": 23, "ws": false}, {"text": ")", "start": 160, "end": 161, "id": 24, "ws": true}, {"text": "with", "start": 162, "end": 166, "id": 25, "ws": true}, {"text": "a", "start": 167, "end": 168, "id": 26, "ws": true}, {"text": "susceptible", "start": 169, "end": 180, "id": 27, "ws": true}, {"text": "isocitrate", "start": 181, "end": 191, "id": 28, "ws": true}, {"text": "dehydrogenase-1", "start": 192, "end": 207, "id": 29, "ws": true}, {"text": "(", "start": 208, "end": 209, "id": 30, "ws": false}, {"text": "IDH1", "start": 209, "end": 213, "id": 31, "ws": false}, {"text": ")", "start": 213, "end": 214, "id": 32, "ws": true}, {"text": "mutation", "start": 215, "end": 223, "id": 33, "ws": true}, {"text": "as", "start": 224, "end": 226, "id": 34, "ws": true}, {"text": "detected", "start": 227, "end": 235, "id": 35, "ws": true}, {"text": "by", "start": 236, "end": 238, "id": 36, "ws": true}, {"text": "an", "start": 239, "end": 241, "id": 37, "ws": true}, {"text": "FDA", "start": 242, "end": 245, "id": 38, "ws": false}, {"text": "-", "start": 245, "end": 246, "id": 39, "ws": false}, {"text": "approved", "start": 246, "end": 254, "id": 40, "ws": true}, {"text": "test", "start": 255, "end": 259, "id": 41, "ws": true}, {"text": "[", "start": 260, "end": 261, "id": 42, "ws": false}, {"text": "see", "start": 261, "end": 264, "id": 43, "ws": true}, {"text": "Dosage", "start": 265, "end": 271, "id": 44, "ws": true}, {"text": "and", "start": 272, "end": 275, "id": 45, "ws": true}, {"text": "Administration", "start": 276, "end": 290, "id": 46, "ws": true}, {"text": "(", "start": 291, "end": 292, "id": 47, "ws": false}, {"text": "2.1", "start": 292, "end": 295, "id": 48, "ws": false}, {"text": ")", "start": 295, "end": 296, "id": 49, "ws": false}, {"text": ",", "start": 296, "end": 297, "id": 50, "ws": true}, {"text": "Clinical", "start": 298, "end": 306, "id": 51, "ws": true}, {"text": "Pharmacology", "start": 307, "end": 319, "id": 52, "ws": true}, {"text": "(", "start": 320, "end": 321, "id": 53, "ws": false}, {"text": "12.1", "start": 321, "end": 325, "id": 54, "ws": false}, {"text": ")", "start": 325, "end": 326, "id": 55, "ws": false}, {"text": ",", "start": 326, "end": 327, "id": 56, "ws": true}, {"text": "and", "start": 328, "end": 331, "id": 57, "ws": true}, {"text": "Clinical", "start": 332, "end": 340, "id": 58, "ws": true}, {"text": "Studies", "start": 341, "end": 348, "id": 59, "ws": true}, {"text": "(", "start": 349, "end": 350, "id": 60, "ws": false}, {"text": "14.1", "start": 350, "end": 354, "id": 61, "ws": false}, {"text": ")", "start": 354, "end": 355, "id": 62, "ws": false}, {"text": "]", "start": 355, "end": 356, "id": 63, "ws": false}, {"text": ".", "start": 356, "end": 357, "id": 64, "ws": true}, {"text": "REZLIDHIA", "start": 358, "end": 367, "id": 65, "ws": true}, {"text": "is", "start": 368, "end": 370, "id": 66, "ws": true}, {"text": "an", "start": 371, "end": 373, "id": 67, "ws": true}, {"text": "isocitrate", "start": 374, "end": 384, "id": 68, "ws": true}, {"text": "dehydrogenase-1", "start": 385, "end": 400, "id": 69, "ws": true}, {"text": "(", "start": 401, "end": 402, "id": 70, "ws": false}, {"text": "IDH1", "start": 402, "end": 406, "id": 71, "ws": false}, {"text": ")", "start": 406, "end": 407, "id": 72, "ws": true}, {"text": "inhibitor", "start": 408, "end": 417, "id": 73, "ws": true}, {"text": "indicated", "start": 418, "end": 427, "id": 74, "ws": true}, {"text": "for", "start": 428, "end": 431, "id": 75, "ws": true}, {"text": "the", "start": 432, "end": 435, "id": 76, "ws": true}, {"text": "treatment", "start": 436, "end": 445, "id": 77, "ws": true}, {"text": "of", "start": 446, "end": 448, "id": 78, "ws": true}, {"text": "adult", "start": 449, "end": 454, "id": 79, "ws": true}, {"text": "patients", "start": 455, "end": 463, "id": 80, "ws": true}, {"text": "with", "start": 464, "end": 468, "id": 81, "ws": true}, {"text": "relapsed", "start": 469, "end": 477, "id": 82, "ws": true}, {"text": "or", "start": 478, "end": 480, "id": 83, "ws": true}, {"text": "refractory", "start": 481, "end": 491, "id": 84, "ws": true}, {"text": "acute", "start": 492, "end": 497, "id": 85, "ws": true}, {"text": "myeloid", "start": 498, "end": 505, "id": 86, "ws": true}, {"text": "leukemia", "start": 506, "end": 514, "id": 87, "ws": true}, {"text": "(", "start": 515, "end": 516, "id": 88, "ws": false}, {"text": "AML", "start": 516, "end": 519, "id": 89, "ws": false}, {"text": ")", "start": 519, "end": 520, "id": 90, "ws": true}, {"text": "with", "start": 521, "end": 525, "id": 91, "ws": true}, {"text": "a", "start": 526, "end": 527, "id": 92, "ws": true}, {"text": "susceptible", "start": 528, "end": 539, "id": 93, "ws": true}, {"text": "IDH1", "start": 540, "end": 544, "id": 94, "ws": true}, {"text": "mutation", "start": 545, "end": 553, "id": 95, "ws": true}, {"text": "as", "start": 554, "end": 556, "id": 96, "ws": true}, {"text": "detected", "start": 557, "end": 565, "id": 97, "ws": true}, {"text": "by", "start": 566, "end": 568, "id": 98, "ws": true}, {"text": "an", "start": 569, "end": 571, "id": 99, "ws": true}, {"text": "FDA", "start": 572, "end": 575, "id": 100, "ws": false}, {"text": "-", "start": 575, "end": 576, "id": 101, "ws": false}, {"text": "approved", "start": 576, "end": 584, "id": 102, "ws": true}, {"text": "test", "start": 585, "end": 589, "id": 103, "ws": false}, {"text": ".", "start": 589, "end": 590, "id": 104, "ws": true}, {"text": "(", "start": 591, "end": 592, "id": 105, "ws": false}, {"text": "1", "start": 592, "end": 593, "id": 106, "ws": false}, {"text": ")", "start": 593, "end": 594, "id": 107, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 46, "end": 55, "token_start": 6, "token_end": 6, "label": "DRUG"}, {"start": 77, "end": 86, "token_start": 11, "token_end": 11, "label": "ACTION"}, {"start": 90, "end": 95, "token_start": 13, "token_end": 13, "label": "TARGET_GROUP"}, {"start": 133, "end": 155, "token_start": 19, "token_end": 21, "label": "BASECONDITION"}, {"start": 169, "end": 223, "token_start": 27, "token_end": 33, "label": "CO_MORBIDITY"}], "answer": "accept", "_timestamp": 1694525400, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Fluphenazine hydrochloride tablets are indicated in the management of manifestations of psychotic disorders. Fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation.", "_input_hash": 1304103663, "_task_hash": 2044102741, "_is_binary": false, "tokens": [{"text": "Fluphenazine", "start": 0, "end": 12, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 13, "end": 26, "id": 1, "ws": true}, {"text": "tablets", "start": 27, "end": 34, "id": 2, "ws": true}, {"text": "are", "start": 35, "end": 38, "id": 3, "ws": true}, {"text": "indicated", "start": 39, "end": 48, "id": 4, "ws": true}, {"text": "in", "start": 49, "end": 51, "id": 5, "ws": true}, {"text": "the", "start": 52, "end": 55, "id": 6, "ws": true}, {"text": "management", "start": 56, "end": 66, "id": 7, "ws": true}, {"text": "of", "start": 67, "end": 69, "id": 8, "ws": true}, {"text": "manifestations", "start": 70, "end": 84, "id": 9, "ws": true}, {"text": "of", "start": 85, "end": 87, "id": 10, "ws": true}, {"text": "psychotic", "start": 88, "end": 97, "id": 11, "ws": true}, {"text": "disorders", "start": 98, "end": 107, "id": 12, "ws": false}, {"text": ".", "start": 107, "end": 108, "id": 13, "ws": true}, {"text": "Fluphenazine", "start": 109, "end": 121, "id": 14, "ws": true}, {"text": "hydrochloride", "start": 122, "end": 135, "id": 15, "ws": true}, {"text": "has", "start": 136, "end": 139, "id": 16, "ws": true}, {"text": "not", "start": 140, "end": 143, "id": 17, "ws": true}, {"text": "been", "start": 144, "end": 148, "id": 18, "ws": true}, {"text": "shown", "start": 149, "end": 154, "id": 19, "ws": true}, {"text": "effective", "start": 155, "end": 164, "id": 20, "ws": true}, {"text": "in", "start": 165, "end": 167, "id": 21, "ws": true}, {"text": "the", "start": 168, "end": 171, "id": 22, "ws": true}, {"text": "management", "start": 172, "end": 182, "id": 23, "ws": true}, {"text": "of", "start": 183, "end": 185, "id": 24, "ws": true}, {"text": "behavioral", "start": 186, "end": 196, "id": 25, "ws": true}, {"text": "complications", "start": 197, "end": 210, "id": 26, "ws": true}, {"text": "in", "start": 211, "end": 213, "id": 27, "ws": true}, {"text": "patients", "start": 214, "end": 222, "id": 28, "ws": true}, {"text": "with", "start": 223, "end": 227, "id": 29, "ws": true}, {"text": "mental", "start": 228, "end": 234, "id": 30, "ws": true}, {"text": "retardation", "start": 235, "end": 246, "id": 31, "ws": false}, {"text": ".", "start": 246, "end": 247, "id": 32, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 12, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 13, "end": 26, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 27, "end": 34, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 56, "end": 66, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 70, "end": 84, "token_start": 9, "token_end": 9, "label": "INDICATION"}, {"start": 88, "end": 107, "token_start": 11, "token_end": 12, "label": "BASECONDITION"}, {"start": 109, "end": 246, "token_start": 14, "token_end": 31, "label": "INEFFECTIVE"}], "answer": "accept", "_timestamp": 1694176482, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older. FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older. (1)", "_input_hash": -38141343, "_task_hash": -1669419516, "_is_binary": false, "tokens": [{"text": "FINTEPLA", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "treatment", "start": 30, "end": 39, "id": 5, "ws": true}, {"text": "of", "start": 40, "end": 42, "id": 6, "ws": true}, {"text": "seizures", "start": 43, "end": 51, "id": 7, "ws": true}, {"text": "associated", "start": 52, "end": 62, "id": 8, "ws": true}, {"text": "with", "start": 63, "end": 67, "id": 9, "ws": true}, {"text": "Dravet", "start": 68, "end": 74, "id": 10, "ws": true}, {"text": "syndrome", "start": 75, "end": 83, "id": 11, "ws": true}, {"text": "(", "start": 84, "end": 85, "id": 12, "ws": false}, {"text": "DS", "start": 85, "end": 87, "id": 13, "ws": false}, {"text": ")", "start": 87, "end": 88, "id": 14, "ws": true}, {"text": "and", "start": 89, "end": 92, "id": 15, "ws": true}, {"text": "Lennox", "start": 93, "end": 99, "id": 16, "ws": false}, {"text": "-", "start": 99, "end": 100, "id": 17, "ws": false}, {"text": "Gastaut", "start": 100, "end": 107, "id": 18, "ws": true}, {"text": "syndrome", "start": 108, "end": 116, "id": 19, "ws": true}, {"text": "(", "start": 117, "end": 118, "id": 20, "ws": false}, {"text": "LGS", "start": 118, "end": 121, "id": 21, "ws": false}, {"text": ")", "start": 121, "end": 122, "id": 22, "ws": true}, {"text": "in", "start": 123, "end": 125, "id": 23, "ws": true}, {"text": "patients", "start": 126, "end": 134, "id": 24, "ws": true}, {"text": "2", "start": 135, "end": 136, "id": 25, "ws": true}, {"text": "years", "start": 137, "end": 142, "id": 26, "ws": true}, {"text": "of", "start": 143, "end": 145, "id": 27, "ws": true}, {"text": "age", "start": 146, "end": 149, "id": 28, "ws": true}, {"text": "and", "start": 150, "end": 153, "id": 29, "ws": true}, {"text": "older", "start": 154, "end": 159, "id": 30, "ws": false}, {"text": ".", "start": 159, "end": 160, "id": 31, "ws": true}, {"text": "FINTEPLA", "start": 161, "end": 169, "id": 32, "ws": true}, {"text": "is", "start": 170, "end": 172, "id": 33, "ws": true}, {"text": "indicated", "start": 173, "end": 182, "id": 34, "ws": true}, {"text": "for", "start": 183, "end": 186, "id": 35, "ws": true}, {"text": "the", "start": 187, "end": 190, "id": 36, "ws": true}, {"text": "treatment", "start": 191, "end": 200, "id": 37, "ws": true}, {"text": "of", "start": 201, "end": 203, "id": 38, "ws": true}, {"text": "seizures", "start": 204, "end": 212, "id": 39, "ws": true}, {"text": "associated", "start": 213, "end": 223, "id": 40, "ws": true}, {"text": "with", "start": 224, "end": 228, "id": 41, "ws": true}, {"text": "Dravet", "start": 229, "end": 235, "id": 42, "ws": true}, {"text": "syndrome", "start": 236, "end": 244, "id": 43, "ws": true}, {"text": "and", "start": 245, "end": 248, "id": 44, "ws": true}, {"text": "Lennox", "start": 249, "end": 255, "id": 45, "ws": false}, {"text": "-", "start": 255, "end": 256, "id": 46, "ws": false}, {"text": "Gastaut", "start": 256, "end": 263, "id": 47, "ws": true}, {"text": "syndrome", "start": 264, "end": 272, "id": 48, "ws": true}, {"text": "in", "start": 273, "end": 275, "id": 49, "ws": true}, {"text": "patients", "start": 276, "end": 284, "id": 50, "ws": true}, {"text": "2", "start": 285, "end": 286, "id": 51, "ws": true}, {"text": "years", "start": 287, "end": 292, "id": 52, "ws": true}, {"text": "of", "start": 293, "end": 295, "id": 53, "ws": true}, {"text": "age", "start": 296, "end": 299, "id": 54, "ws": true}, {"text": "and", "start": 300, "end": 303, "id": 55, "ws": true}, {"text": "older", "start": 304, "end": 309, "id": 56, "ws": false}, {"text": ".", "start": 309, "end": 310, "id": 57, "ws": true}, {"text": "(", "start": 311, "end": 312, "id": 58, "ws": false}, {"text": "1", "start": 312, "end": 313, "id": 59, "ws": false}, {"text": ")", "start": 313, "end": 314, "id": 60, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 42, "token_start": 5, "token_end": 6, "label": "ACTION"}, {"start": 43, "end": 51, "token_start": 7, "token_end": 7, "label": "INDICATION"}, {"start": 68, "end": 83, "token_start": 10, "token_end": 11, "label": "BASECONDITION"}, {"start": 93, "end": 116, "token_start": 16, "token_end": 19, "label": "BASECONDITION"}, {"start": 126, "end": 159, "token_start": 24, "token_end": 30, "label": "TARGET_GROUP"}, {"start": 161, "end": 169, "token_start": 32, "token_end": 32, "label": "DRUG"}, {"start": 191, "end": 203, "token_start": 37, "token_end": 38, "label": "ACTION"}, {"start": 204, "end": 212, "token_start": 39, "token_end": 39, "label": "INDICATION"}, {"start": 229, "end": 244, "token_start": 42, "token_end": 43, "label": "BASECONDITION"}, {"start": 249, "end": 272, "token_start": 45, "token_end": 48, "label": "BASECONDITION"}, {"start": 276, "end": 309, "token_start": 50, "token_end": 56, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694174479, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Nortriptyline hydrochloride, USP is indicated for the relief of symptoms of depression. Endogenous depressions are more likely to be alleviated than are other depressive states.", "_input_hash": -976139337, "_task_hash": -1148281695, "_is_binary": false, "tokens": [{"text": "Nortriptyline", "start": 0, "end": 13, "id": 0, "ws": true}, {"text": "hydrochloride", "start": 14, "end": 27, "id": 1, "ws": false}, {"text": ",", "start": 27, "end": 28, "id": 2, "ws": true}, {"text": "USP", "start": 29, "end": 32, "id": 3, "ws": true}, {"text": "is", "start": 33, "end": 35, "id": 4, "ws": true}, {"text": "indicated", "start": 36, "end": 45, "id": 5, "ws": true}, {"text": "for", "start": 46, "end": 49, "id": 6, "ws": true}, {"text": "the", "start": 50, "end": 53, "id": 7, "ws": true}, {"text": "relief", "start": 54, "end": 60, "id": 8, "ws": true}, {"text": "of", "start": 61, "end": 63, "id": 9, "ws": true}, {"text": "symptoms", "start": 64, "end": 72, "id": 10, "ws": true}, {"text": "of", "start": 73, "end": 75, "id": 11, "ws": true}, {"text": "depression", "start": 76, "end": 86, "id": 12, "ws": false}, {"text": ".", "start": 86, "end": 87, "id": 13, "ws": true}, {"text": "Endogenous", "start": 88, "end": 98, "id": 14, "ws": true}, {"text": "depressions", "start": 99, "end": 110, "id": 15, "ws": true}, {"text": "are", "start": 111, "end": 114, "id": 16, "ws": true}, {"text": "more", "start": 115, "end": 119, "id": 17, "ws": true}, {"text": "likely", "start": 120, "end": 126, "id": 18, "ws": true}, {"text": "to", "start": 127, "end": 129, "id": 19, "ws": true}, {"text": "be", "start": 130, "end": 132, "id": 20, "ws": true}, {"text": "alleviated", "start": 133, "end": 143, "id": 21, "ws": true}, {"text": "than", "start": 144, "end": 148, "id": 22, "ws": true}, {"text": "are", "start": 149, "end": 152, "id": 23, "ws": true}, {"text": "other", "start": 153, "end": 158, "id": 24, "ws": true}, {"text": "depressive", "start": 159, "end": 169, "id": 25, "ws": true}, {"text": "states", "start": 170, "end": 176, "id": 26, "ws": false}, {"text": ".", "start": 176, "end": 177, "id": 27, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 27, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 54, "end": 63, "token_start": 8, "token_end": 9, "label": "ACTION"}, {"start": 64, "end": 72, "token_start": 10, "token_end": 10, "label": "INDICATION"}, {"start": 76, "end": 86, "token_start": 12, "token_end": 12, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694175389, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Nymyo is an estrogen/progestin COC, indicated for use by women to prevent pregnancy. (1.1) 1.1 Oral Contraceptive Nymyo Tablets are indicated for use by females of reproductive potential to prevent pregnancy [see Clinical Studies ( 14 )].", "_input_hash": 279601720, "_task_hash": -1406786359, "_is_binary": false, "tokens": [{"text": "Nymyo", "start": 0, "end": 5, "id": 0, "ws": true}, {"text": "is", "start": 6, "end": 8, "id": 1, "ws": true}, {"text": "an", "start": 9, "end": 11, "id": 2, "ws": true}, {"text": "estrogen", "start": 12, "end": 20, "id": 3, "ws": false}, {"text": "/", "start": 20, "end": 21, "id": 4, "ws": false}, {"text": "progestin", "start": 21, "end": 30, "id": 5, "ws": true}, {"text": "COC", "start": 31, "end": 34, "id": 6, "ws": false}, {"text": ",", "start": 34, "end": 35, "id": 7, "ws": true}, {"text": "indicated", "start": 36, "end": 45, "id": 8, "ws": true}, {"text": "for", "start": 46, "end": 49, "id": 9, "ws": true}, {"text": "use", "start": 50, "end": 53, "id": 10, "ws": true}, {"text": "by", "start": 54, "end": 56, "id": 11, "ws": true}, {"text": "women", "start": 57, "end": 62, "id": 12, "ws": true}, {"text": "to", "start": 63, "end": 65, "id": 13, "ws": true}, {"text": "prevent", "start": 66, "end": 73, "id": 14, "ws": true}, {"text": "pregnancy", "start": 74, "end": 83, "id": 15, "ws": false}, {"text": ".", "start": 83, "end": 84, "id": 16, "ws": true}, {"text": "(", "start": 85, "end": 86, "id": 17, "ws": false}, {"text": "1.1", "start": 86, "end": 89, "id": 18, "ws": false}, {"text": ")", "start": 89, "end": 90, "id": 19, "ws": true}, {"text": "1.1", "start": 91, "end": 94, "id": 20, "ws": true}, {"text": "Oral", "start": 95, "end": 99, "id": 21, "ws": true}, {"text": "Contraceptive", "start": 100, "end": 113, "id": 22, "ws": true}, {"text": "Nymyo", "start": 114, "end": 119, "id": 23, "ws": true}, {"text": "Tablets", "start": 120, "end": 127, "id": 24, "ws": true}, {"text": "are", "start": 128, "end": 131, "id": 25, "ws": true}, {"text": "indicated", "start": 132, "end": 141, "id": 26, "ws": true}, {"text": "for", "start": 142, "end": 145, "id": 27, "ws": true}, {"text": "use", "start": 146, "end": 149, "id": 28, "ws": true}, {"text": "by", "start": 150, "end": 152, "id": 29, "ws": true}, {"text": "females", "start": 153, "end": 160, "id": 30, "ws": true}, {"text": "of", "start": 161, "end": 163, "id": 31, "ws": true}, {"text": "reproductive", "start": 164, "end": 176, "id": 32, "ws": true}, {"text": "potential", "start": 177, "end": 186, "id": 33, "ws": true}, {"text": "to", "start": 187, "end": 189, "id": 34, "ws": true}, {"text": "prevent", "start": 190, "end": 197, "id": 35, "ws": true}, {"text": "pregnancy", "start": 198, "end": 207, "id": 36, "ws": true}, {"text": "[", "start": 208, "end": 209, "id": 37, "ws": false}, {"text": "see", "start": 209, "end": 212, "id": 38, "ws": true}, {"text": "Clinical", "start": 213, "end": 221, "id": 39, "ws": true}, {"text": "Studies", "start": 222, "end": 229, "id": 40, "ws": true}, {"text": "(", "start": 230, "end": 231, "id": 41, "ws": true}, {"text": "14", "start": 232, "end": 234, "id": 42, "ws": true}, {"text": ")", "start": 235, "end": 236, "id": 43, "ws": false}, {"text": "]", "start": 236, "end": 237, "id": 44, "ws": false}, {"text": ".", "start": 237, "end": 238, "id": 45, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 5, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 34, "token_start": 3, "token_end": 6, "label": "MECHANISM"}, {"start": 57, "end": 62, "token_start": 12, "token_end": 12, "label": "TARGET_GROUP"}, {"start": 66, "end": 73, "token_start": 14, "token_end": 14, "label": "ACTION"}, {"start": 74, "end": 83, "token_start": 15, "token_end": 15, "label": "INDICATION"}, {"start": 114, "end": 119, "token_start": 23, "token_end": 23, "label": "DRUG"}, {"start": 120, "end": 127, "token_start": 24, "token_end": 24, "label": "FORMULATION"}, {"start": 153, "end": 186, "token_start": 30, "token_end": 33, "label": "TARGET_GROUP"}, {"start": 190, "end": 197, "token_start": 35, "token_end": 35, "label": "ACTION"}, {"start": 198, "end": 207, "token_start": 36, "token_end": 36, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694176912, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Edema Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide tablets are particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone.", "_input_hash": -583275566, "_task_hash": 32251736, "_is_binary": false, "tokens": [{"text": "Edema", "start": 0, "end": 5, "id": 0, "ws": true}, {"text": "Furosemide", "start": 6, "end": 16, "id": 1, "ws": true}, {"text": "tablets", "start": 17, "end": 24, "id": 2, "ws": true}, {"text": "are", "start": 25, "end": 28, "id": 3, "ws": true}, {"text": "indicated", "start": 29, "end": 38, "id": 4, "ws": true}, {"text": "in", "start": 39, "end": 41, "id": 5, "ws": true}, {"text": "adults", "start": 42, "end": 48, "id": 6, "ws": true}, {"text": "and", "start": 49, "end": 52, "id": 7, "ws": true}, {"text": "pediatric", "start": 53, "end": 62, "id": 8, "ws": true}, {"text": "patients", "start": 63, "end": 71, "id": 9, "ws": true}, {"text": "for", "start": 72, "end": 75, "id": 10, "ws": true}, {"text": "the", "start": 76, "end": 79, "id": 11, "ws": true}, {"text": "treatment", "start": 80, "end": 89, "id": 12, "ws": true}, {"text": "of", "start": 90, "end": 92, "id": 13, "ws": true}, {"text": "edema", "start": 93, "end": 98, "id": 14, "ws": true}, {"text": "associated", "start": 99, "end": 109, "id": 15, "ws": true}, {"text": "with", "start": 110, "end": 114, "id": 16, "ws": true}, {"text": "congestive", "start": 115, "end": 125, "id": 17, "ws": true}, {"text": "heart", "start": 126, "end": 131, "id": 18, "ws": true}, {"text": "failure", "start": 132, "end": 139, "id": 19, "ws": false}, {"text": ",", "start": 139, "end": 140, "id": 20, "ws": true}, {"text": "cirrhosis", "start": 141, "end": 150, "id": 21, "ws": true}, {"text": "of", "start": 151, "end": 153, "id": 22, "ws": true}, {"text": "the", "start": 154, "end": 157, "id": 23, "ws": true}, {"text": "liver", "start": 158, "end": 163, "id": 24, "ws": false}, {"text": ",", "start": 163, "end": 164, "id": 25, "ws": true}, {"text": "and", "start": 165, "end": 168, "id": 26, "ws": true}, {"text": "renal", "start": 169, "end": 174, "id": 27, "ws": true}, {"text": "disease", "start": 175, "end": 182, "id": 28, "ws": false}, {"text": ",", "start": 182, "end": 183, "id": 29, "ws": true}, {"text": "including", "start": 184, "end": 193, "id": 30, "ws": true}, {"text": "the", "start": 194, "end": 197, "id": 31, "ws": true}, {"text": "nephrotic", "start": 198, "end": 207, "id": 32, "ws": true}, {"text": "syndrome", "start": 208, "end": 216, "id": 33, "ws": false}, {"text": ".", "start": 216, "end": 217, "id": 34, "ws": true}, {"text": "Furosemide", "start": 218, "end": 228, "id": 35, "ws": true}, {"text": "tablets", "start": 229, "end": 236, "id": 36, "ws": true}, {"text": "are", "start": 237, "end": 240, "id": 37, "ws": true}, {"text": "particularly", "start": 241, "end": 253, "id": 38, "ws": true}, {"text": "useful", "start": 254, "end": 260, "id": 39, "ws": true}, {"text": "when", "start": 261, "end": 265, "id": 40, "ws": true}, {"text": "an", "start": 266, "end": 268, "id": 41, "ws": true}, {"text": "agent", "start": 269, "end": 274, "id": 42, "ws": true}, {"text": "with", "start": 275, "end": 279, "id": 43, "ws": true}, {"text": "greater", "start": 280, "end": 287, "id": 44, "ws": true}, {"text": "diuretic", "start": 288, "end": 296, "id": 45, "ws": true}, {"text": "potential", "start": 297, "end": 306, "id": 46, "ws": true}, {"text": "is", "start": 307, "end": 309, "id": 47, "ws": true}, {"text": "desired", "start": 310, "end": 317, "id": 48, "ws": false}, {"text": ".", "start": 317, "end": 318, "id": 49, "ws": true}, {"text": "Hypertension", "start": 319, "end": 331, "id": 50, "ws": true}, {"text": "Oral", "start": 332, "end": 336, "id": 51, "ws": true}, {"text": "furosemide", "start": 337, "end": 347, "id": 52, "ws": true}, {"text": "may", "start": 348, "end": 351, "id": 53, "ws": true}, {"text": "be", "start": 352, "end": 354, "id": 54, "ws": true}, {"text": "used", "start": 355, "end": 359, "id": 55, "ws": true}, {"text": "in", "start": 360, "end": 362, "id": 56, "ws": true}, {"text": "adults", "start": 363, "end": 369, "id": 57, "ws": true}, {"text": "for", "start": 370, "end": 373, "id": 58, "ws": true}, {"text": "the", "start": 374, "end": 377, "id": 59, "ws": true}, {"text": "treatment", "start": 378, "end": 387, "id": 60, "ws": true}, {"text": "of", "start": 388, "end": 390, "id": 61, "ws": true}, {"text": "hypertension", "start": 391, "end": 403, "id": 62, "ws": true}, {"text": "alone", "start": 404, "end": 409, "id": 63, "ws": true}, {"text": "or", "start": 410, "end": 412, "id": 64, "ws": true}, {"text": "in", "start": 413, "end": 415, "id": 65, "ws": true}, {"text": "combination", "start": 416, "end": 427, "id": 66, "ws": true}, {"text": "with", "start": 428, "end": 432, "id": 67, "ws": true}, {"text": "other", "start": 433, "end": 438, "id": 68, "ws": true}, {"text": "antihypertensive", "start": 439, "end": 455, "id": 69, "ws": true}, {"text": "agents", "start": 456, "end": 462, "id": 70, "ws": false}, {"text": ".", "start": 462, "end": 463, "id": 71, "ws": true}, {"text": "Hypertensive", "start": 464, "end": 476, "id": 72, "ws": true}, {"text": "patients", "start": 477, "end": 485, "id": 73, "ws": true}, {"text": "who", "start": 486, "end": 489, "id": 74, "ws": true}, {"text": "can", "start": 490, "end": 493, "id": 75, "ws": false}, {"text": "not", "start": 493, "end": 496, "id": 76, "ws": true}, {"text": "be", "start": 497, "end": 499, "id": 77, "ws": true}, {"text": "adequately", "start": 500, "end": 510, "id": 78, "ws": true}, {"text": "controlled", "start": 511, "end": 521, "id": 79, "ws": true}, {"text": "with", "start": 522, "end": 526, "id": 80, "ws": true}, {"text": "thiazides", "start": 527, "end": 536, "id": 81, "ws": true}, {"text": "will", "start": 537, "end": 541, "id": 82, "ws": true}, {"text": "probably", "start": 542, "end": 550, "id": 83, "ws": true}, {"text": "also", "start": 551, "end": 555, "id": 84, "ws": true}, {"text": "not", "start": 556, "end": 559, "id": 85, "ws": true}, {"text": "be", "start": 560, "end": 562, "id": 86, "ws": true}, {"text": "adequately", "start": 563, "end": 573, "id": 87, "ws": true}, {"text": "controlled", "start": 574, "end": 584, "id": 88, "ws": true}, {"text": "with", "start": 585, "end": 589, "id": 89, "ws": true}, {"text": "furosemide", "start": 590, "end": 600, "id": 90, "ws": true}, {"text": "alone", "start": 601, "end": 606, "id": 91, "ws": false}, {"text": ".", "start": 606, "end": 607, "id": 92, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 5, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 6, "end": 16, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 17, "end": 24, "token_start": 2, "token_end": 2, "label": "FORMULATION"}, {"start": 42, "end": 48, "token_start": 6, "token_end": 6, "label": "TARGET_GROUP"}, {"start": 53, "end": 62, "token_start": 8, "token_end": 8, "label": "TARGET_GROUP"}, {"start": 80, "end": 89, "token_start": 12, "token_end": 12, "label": "ACTION"}, {"start": 93, "end": 98, "token_start": 14, "token_end": 14, "label": "INDICATION"}, {"start": 115, "end": 139, "token_start": 17, "token_end": 19, "label": "BASECONDITION"}, {"start": 141, "end": 163, "token_start": 21, "token_end": 24, "label": "BASECONDITION"}, {"start": 169, "end": 182, "token_start": 27, "token_end": 28, "label": "BASECONDITION"}, {"start": 198, "end": 216, "token_start": 32, "token_end": 33, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694527717, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Naphazoline Hydrochloride Ophthalmic Solution is indicated for use as a topical ocular vasoconstrictor.", "_input_hash": -280102924, "_task_hash": 1338430075, "_is_binary": false, "tokens": [{"text": "Naphazoline", "start": 0, "end": 11, "id": 0, "ws": true}, {"text": "Hydrochloride", "start": 12, "end": 25, "id": 1, "ws": true}, {"text": "Ophthalmic", "start": 26, "end": 36, "id": 2, "ws": true}, {"text": "Solution", "start": 37, "end": 45, "id": 3, "ws": true}, {"text": "is", "start": 46, "end": 48, "id": 4, "ws": true}, {"text": "indicated", "start": 49, "end": 58, "id": 5, "ws": true}, {"text": "for", "start": 59, "end": 62, "id": 6, "ws": true}, {"text": "use", "start": 63, "end": 66, "id": 7, "ws": true}, {"text": "as", "start": 67, "end": 69, "id": 8, "ws": true}, {"text": "a", "start": 70, "end": 71, "id": 9, "ws": true}, {"text": "topical", "start": 72, "end": 79, "id": 10, "ws": true}, {"text": "ocular", "start": 80, "end": 86, "id": 11, "ws": true}, {"text": "vasoconstrictor", "start": 87, "end": 102, "id": 12, "ws": false}, {"text": ".", "start": 102, "end": 103, "id": 13, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 11, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 12, "end": 25, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 26, "end": 36, "token_start": 2, "token_end": 2, "label": "ROUTE"}, {"start": 37, "end": 45, "token_start": 3, "token_end": 3, "label": "FORMULATION"}, {"start": 63, "end": 66, "token_start": 7, "token_end": 7, "label": "ACTION"}, {"start": 72, "end": 79, "token_start": 10, "token_end": 10, "label": "ROUTE"}, {"start": 80, "end": 102, "token_start": 11, "token_end": 12, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694526658, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "ELIGARD is indicated for the palliative treatment of advanced prostate cancer. ELIGARD is a gonadotropin releasing hormone (GnRH) agonist indicated for the palliative treatment of advanced prostate cancer (1)", "_input_hash": 156725108, "_task_hash": 486951493, "_is_binary": false, "tokens": [{"text": "ELIGARD", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "for", "start": 21, "end": 24, "id": 3, "ws": true}, {"text": "the", "start": 25, "end": 28, "id": 4, "ws": true}, {"text": "palliative", "start": 29, "end": 39, "id": 5, "ws": true}, {"text": "treatment", "start": 40, "end": 49, "id": 6, "ws": true}, {"text": "of", "start": 50, "end": 52, "id": 7, "ws": true}, {"text": "advanced", "start": 53, "end": 61, "id": 8, "ws": true}, {"text": "prostate", "start": 62, "end": 70, "id": 9, "ws": true}, {"text": "cancer", "start": 71, "end": 77, "id": 10, "ws": false}, {"text": ".", "start": 77, "end": 78, "id": 11, "ws": true}, {"text": "ELIGARD", "start": 79, "end": 86, "id": 12, "ws": true}, {"text": "is", "start": 87, "end": 89, "id": 13, "ws": true}, {"text": "a", "start": 90, "end": 91, "id": 14, "ws": true}, {"text": "gonadotropin", "start": 92, "end": 104, "id": 15, "ws": true}, {"text": "releasing", "start": 105, "end": 114, "id": 16, "ws": true}, {"text": "hormone", "start": 115, "end": 122, "id": 17, "ws": true}, {"text": "(", "start": 123, "end": 124, "id": 18, "ws": false}, {"text": "GnRH", "start": 124, "end": 128, "id": 19, "ws": false}, {"text": ")", "start": 128, "end": 129, "id": 20, "ws": true}, {"text": "agonist", "start": 130, "end": 137, "id": 21, "ws": true}, {"text": "indicated", "start": 138, "end": 147, "id": 22, "ws": true}, {"text": "for", "start": 148, "end": 151, "id": 23, "ws": true}, {"text": "the", "start": 152, "end": 155, "id": 24, "ws": true}, {"text": "palliative", "start": 156, "end": 166, "id": 25, "ws": true}, {"text": "treatment", "start": 167, "end": 176, "id": 26, "ws": true}, {"text": "of", "start": 177, "end": 179, "id": 27, "ws": true}, {"text": "advanced", "start": 180, "end": 188, "id": 28, "ws": true}, {"text": "prostate", "start": 189, "end": 197, "id": 29, "ws": true}, {"text": "cancer", "start": 198, "end": 204, "id": 30, "ws": true}, {"text": "(", "start": 205, "end": 206, "id": 31, "ws": false}, {"text": "1", "start": 206, "end": 207, "id": 32, "ws": false}, {"text": ")", "start": 207, "end": 208, "id": 33, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 29, "end": 49, "token_start": 5, "token_end": 6, "label": "ACTION"}, {"start": 53, "end": 61, "token_start": 8, "token_end": 8, "label": "SEVERITY"}, {"start": 62, "end": 77, "token_start": 9, "token_end": 10, "label": "BASECONDITION"}, {"start": 79, "end": 86, "token_start": 12, "token_end": 12, "label": "DRUG"}, {"start": 92, "end": 137, "token_start": 15, "token_end": 21, "label": "MECHANISM"}, {"start": 156, "end": 176, "token_start": 25, "token_end": 26, "label": "ACTION"}, {"start": 180, "end": 188, "token_start": 28, "token_end": 28, "label": "SEVERITY"}, {"start": 189, "end": 204, "token_start": 29, "token_end": 30, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694528609, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "PURINETHOL is a nucleoside metabolic inhibitor indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. ( 1.1) 1.1 Acute Lymphoblastic Leukemia PURINETHOL is indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.", "_input_hash": 1887263240, "_task_hash": -57918627, "_is_binary": false, "tokens": [{"text": "PURINETHOL", "start": 0, "end": 10, "id": 0, "ws": true}, {"text": "is", "start": 11, "end": 13, "id": 1, "ws": true}, {"text": "a", "start": 14, "end": 15, "id": 2, "ws": true}, {"text": "nucleoside", "start": 16, "end": 26, "id": 3, "ws": true}, {"text": "metabolic", "start": 27, "end": 36, "id": 4, "ws": true}, {"text": "inhibitor", "start": 37, "end": 46, "id": 5, "ws": true}, {"text": "indicated", "start": 47, "end": 56, "id": 6, "ws": true}, {"text": "for", "start": 57, "end": 60, "id": 7, "ws": true}, {"text": "treatment", "start": 61, "end": 70, "id": 8, "ws": true}, {"text": "of", "start": 71, "end": 73, "id": 9, "ws": true}, {"text": "adult", "start": 74, "end": 79, "id": 10, "ws": true}, {"text": "and", "start": 80, "end": 83, "id": 11, "ws": true}, {"text": "pediatric", "start": 84, "end": 93, "id": 12, "ws": true}, {"text": "patients", "start": 94, "end": 102, "id": 13, "ws": true}, {"text": "with", "start": 103, "end": 107, "id": 14, "ws": true}, {"text": "acute", "start": 108, "end": 113, "id": 15, "ws": true}, {"text": "lymphoblastic", "start": 114, "end": 127, "id": 16, "ws": true}, {"text": "leukemia", "start": 128, "end": 136, "id": 17, "ws": true}, {"text": "(", "start": 137, "end": 138, "id": 18, "ws": false}, {"text": "ALL", "start": 138, "end": 141, "id": 19, "ws": false}, {"text": ")", "start": 141, "end": 142, "id": 20, "ws": true}, {"text": "as", "start": 143, "end": 145, "id": 21, "ws": true}, {"text": "part", "start": 146, "end": 150, "id": 22, "ws": true}, {"text": "of", "start": 151, "end": 153, "id": 23, "ws": true}, {"text": "a", "start": 154, "end": 155, "id": 24, "ws": true}, {"text": "combination", "start": 156, "end": 167, "id": 25, "ws": true}, {"text": "chemotherapy", "start": 168, "end": 180, "id": 26, "ws": true}, {"text": "maintenance", "start": 181, "end": 192, "id": 27, "ws": true}, {"text": "regimen", "start": 193, "end": 200, "id": 28, "ws": false}, {"text": ".", "start": 200, "end": 201, "id": 29, "ws": true}, {"text": "(", "start": 202, "end": 203, "id": 30, "ws": true}, {"text": "1.1", "start": 204, "end": 207, "id": 31, "ws": false}, {"text": ")", "start": 207, "end": 208, "id": 32, "ws": true}, {"text": "1.1", "start": 209, "end": 212, "id": 33, "ws": true}, {"text": "Acute", "start": 213, "end": 218, "id": 34, "ws": true}, {"text": "Lymphoblastic", "start": 219, "end": 232, "id": 35, "ws": true}, {"text": "Leukemia", "start": 233, "end": 241, "id": 36, "ws": true}, {"text": "PURINETHOL", "start": 242, "end": 252, "id": 37, "ws": true}, {"text": "is", "start": 253, "end": 255, "id": 38, "ws": true}, {"text": "indicated", "start": 256, "end": 265, "id": 39, "ws": true}, {"text": "for", "start": 266, "end": 269, "id": 40, "ws": true}, {"text": "treatment", "start": 270, "end": 279, "id": 41, "ws": true}, {"text": "of", "start": 280, "end": 282, "id": 42, "ws": true}, {"text": "adult", "start": 283, "end": 288, "id": 43, "ws": true}, {"text": "and", "start": 289, "end": 292, "id": 44, "ws": true}, {"text": "pediatric", "start": 293, "end": 302, "id": 45, "ws": true}, {"text": "patients", "start": 303, "end": 311, "id": 46, "ws": true}, {"text": "with", "start": 312, "end": 316, "id": 47, "ws": true}, {"text": "acute", "start": 317, "end": 322, "id": 48, "ws": true}, {"text": "lymphoblastic", "start": 323, "end": 336, "id": 49, "ws": true}, {"text": "leukemia", "start": 337, "end": 345, "id": 50, "ws": true}, {"text": "(", "start": 346, "end": 347, "id": 51, "ws": false}, {"text": "ALL", "start": 347, "end": 350, "id": 52, "ws": false}, {"text": ")", "start": 350, "end": 351, "id": 53, "ws": true}, {"text": "as", "start": 352, "end": 354, "id": 54, "ws": true}, {"text": "part", "start": 355, "end": 359, "id": 55, "ws": true}, {"text": "of", "start": 360, "end": 362, "id": 56, "ws": true}, {"text": "a", "start": 363, "end": 364, "id": 57, "ws": true}, {"text": "combination", "start": 365, "end": 376, "id": 58, "ws": true}, {"text": "chemotherapy", "start": 377, "end": 389, "id": 59, "ws": true}, {"text": "maintenance", "start": 390, "end": 401, "id": 60, "ws": true}, {"text": "regimen", "start": 402, "end": 409, "id": 61, "ws": false}, {"text": ".", "start": 409, "end": 410, "id": 62, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 10, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 16, "end": 46, "token_start": 3, "token_end": 5, "label": "MECHANISM"}, {"start": 61, "end": 70, "token_start": 8, "token_end": 8, "label": "ACTION"}, {"start": 74, "end": 79, "token_start": 10, "token_end": 10, "label": "TARGET_GROUP"}, {"start": 84, "end": 102, "token_start": 12, "token_end": 13, "label": "TARGET_GROUP"}, {"start": 108, "end": 136, "token_start": 15, "token_end": 17, "label": "INDICATION"}, {"start": 143, "end": 200, "token_start": 21, "token_end": 28, "label": "CO_PRESCRIPTION"}, {"start": 242, "end": 252, "token_start": 37, "token_end": 37, "label": "DRUG"}, {"start": 270, "end": 279, "token_start": 41, "token_end": 41, "label": "ACTION"}, {"start": 283, "end": 288, "token_start": 43, "token_end": 43, "label": "TARGET_GROUP"}, {"start": 293, "end": 311, "token_start": 45, "token_end": 46, "label": "TARGET_GROUP"}, {"start": 317, "end": 345, "token_start": 48, "token_end": 50, "label": "INDICATION"}, {"start": 352, "end": 409, "token_start": 54, "token_end": 61, "label": "CO_PRESCRIPTION"}], "answer": "accept", "_timestamp": 1694528138, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "PRECOSE is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.", "_input_hash": 89873652, "_task_hash": -787218444, "_is_binary": false, "tokens": [{"text": "PRECOSE", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "is", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "indicated", "start": 11, "end": 20, "id": 2, "ws": true}, {"text": "as", "start": 21, "end": 23, "id": 3, "ws": true}, {"text": "an", "start": 24, "end": 26, "id": 4, "ws": true}, {"text": "adjunct", "start": 27, "end": 34, "id": 5, "ws": true}, {"text": "to", "start": 35, "end": 37, "id": 6, "ws": true}, {"text": "diet", "start": 38, "end": 42, "id": 7, "ws": true}, {"text": "and", "start": 43, "end": 46, "id": 8, "ws": true}, {"text": "exercise", "start": 47, "end": 55, "id": 9, "ws": true}, {"text": "to", "start": 56, "end": 58, "id": 10, "ws": true}, {"text": "improve", "start": 59, "end": 66, "id": 11, "ws": true}, {"text": "glycemic", "start": 67, "end": 75, "id": 12, "ws": true}, {"text": "control", "start": 76, "end": 83, "id": 13, "ws": true}, {"text": "in", "start": 84, "end": 86, "id": 14, "ws": true}, {"text": "adults", "start": 87, "end": 93, "id": 15, "ws": true}, {"text": "with", "start": 94, "end": 98, "id": 16, "ws": true}, {"text": "type", "start": 99, "end": 103, "id": 17, "ws": true}, {"text": "2", "start": 104, "end": 105, "id": 18, "ws": true}, {"text": "diabetes", "start": 106, "end": 114, "id": 19, "ws": true}, {"text": "mellitus", "start": 115, "end": 123, "id": 20, "ws": false}, {"text": ".", "start": 123, "end": 124, "id": 21, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 27, "end": 34, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 59, "end": 83, "token_start": 11, "token_end": 13, "label": "EFFECT"}, {"start": 87, "end": 93, "token_start": 15, "token_end": 15, "label": "TARGET_GROUP"}, {"start": 99, "end": 123, "token_start": 17, "token_end": 20, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694175966, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Zaleplon capsules are indicated for the short-term treatment of insomnia. Zaleplon capsules have been shown to decrease the time to sleep onset for up to 30 days in controlled clinical studies (see Clinical Trials under CLINICAL PHARMACOLOGY). It has not been shown to increase total sleep time or decrease the number of awakenings. The clinical trials performed in support of efficacy ranged from a single night to 5 weeks in duration. The final formal assessments of sleep latency were performed at the end of treatment.", "_input_hash": 726721508, "_task_hash": -309777310, "_is_binary": false, "tokens": [{"text": "Zaleplon", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "capsules", "start": 9, "end": 17, "id": 1, "ws": true}, {"text": "are", "start": 18, "end": 21, "id": 2, "ws": true}, {"text": "indicated", "start": 22, "end": 31, "id": 3, "ws": true}, {"text": "for", "start": 32, "end": 35, "id": 4, "ws": true}, {"text": "the", "start": 36, "end": 39, "id": 5, "ws": true}, {"text": "short", "start": 40, "end": 45, "id": 6, "ws": false}, {"text": "-", "start": 45, "end": 46, "id": 7, "ws": false}, {"text": "term", "start": 46, "end": 50, "id": 8, "ws": true}, {"text": "treatment", "start": 51, "end": 60, "id": 9, "ws": true}, {"text": "of", "start": 61, "end": 63, "id": 10, "ws": true}, {"text": "insomnia", "start": 64, "end": 72, "id": 11, "ws": false}, {"text": ".", "start": 72, "end": 73, "id": 12, "ws": true}, {"text": "Zaleplon", "start": 74, "end": 82, "id": 13, "ws": true}, {"text": "capsules", "start": 83, "end": 91, "id": 14, "ws": true}, {"text": "have", "start": 92, "end": 96, "id": 15, "ws": true}, {"text": "been", "start": 97, "end": 101, "id": 16, "ws": true}, {"text": "shown", "start": 102, "end": 107, "id": 17, "ws": true}, {"text": "to", "start": 108, "end": 110, "id": 18, "ws": true}, {"text": "decrease", "start": 111, "end": 119, "id": 19, "ws": true}, {"text": "the", "start": 120, "end": 123, "id": 20, "ws": true}, {"text": "time", "start": 124, "end": 128, "id": 21, "ws": true}, {"text": "to", "start": 129, "end": 131, "id": 22, "ws": true}, {"text": "sleep", "start": 132, "end": 137, "id": 23, "ws": true}, {"text": "onset", "start": 138, "end": 143, "id": 24, "ws": true}, {"text": "for", "start": 144, "end": 147, "id": 25, "ws": true}, {"text": "up", "start": 148, "end": 150, "id": 26, "ws": true}, {"text": "to", "start": 151, "end": 153, "id": 27, "ws": true}, {"text": "30", "start": 154, "end": 156, "id": 28, "ws": true}, {"text": "days", "start": 157, "end": 161, "id": 29, "ws": true}, {"text": "in", "start": 162, "end": 164, "id": 30, "ws": true}, {"text": "controlled", "start": 165, "end": 175, "id": 31, "ws": true}, {"text": "clinical", "start": 176, "end": 184, "id": 32, "ws": true}, {"text": "studies", "start": 185, "end": 192, "id": 33, "ws": true}, {"text": "(", "start": 193, "end": 194, "id": 34, "ws": false}, {"text": "see", "start": 194, "end": 197, "id": 35, "ws": true}, {"text": "Clinical", "start": 198, "end": 206, "id": 36, "ws": true}, {"text": "Trials", "start": 207, "end": 213, "id": 37, "ws": true}, {"text": "under", "start": 214, "end": 219, "id": 38, "ws": true}, {"text": "CLINICAL", "start": 220, "end": 228, "id": 39, "ws": true}, {"text": "PHARMACOLOGY", "start": 229, "end": 241, "id": 40, "ws": false}, {"text": ")", "start": 241, "end": 242, "id": 41, "ws": false}, {"text": ".", "start": 242, "end": 243, "id": 42, "ws": true}, {"text": "It", "start": 244, "end": 246, "id": 43, "ws": true}, {"text": "has", "start": 247, "end": 250, "id": 44, "ws": true}, {"text": "not", "start": 251, "end": 254, "id": 45, "ws": true}, {"text": "been", "start": 255, "end": 259, "id": 46, "ws": true}, {"text": "shown", "start": 260, "end": 265, "id": 47, "ws": true}, {"text": "to", "start": 266, "end": 268, "id": 48, "ws": true}, {"text": "increase", "start": 269, "end": 277, "id": 49, "ws": true}, {"text": "total", "start": 278, "end": 283, "id": 50, "ws": true}, {"text": "sleep", "start": 284, "end": 289, "id": 51, "ws": true}, {"text": "time", "start": 290, "end": 294, "id": 52, "ws": true}, {"text": "or", "start": 295, "end": 297, "id": 53, "ws": true}, {"text": "decrease", "start": 298, "end": 306, "id": 54, "ws": true}, {"text": "the", "start": 307, "end": 310, "id": 55, "ws": true}, {"text": "number", "start": 311, "end": 317, "id": 56, "ws": true}, {"text": "of", "start": 318, "end": 320, "id": 57, "ws": true}, {"text": "awakenings", "start": 321, "end": 331, "id": 58, "ws": false}, {"text": ".", "start": 331, "end": 332, "id": 59, "ws": true}, {"text": "The", "start": 333, "end": 336, "id": 60, "ws": true}, {"text": "clinical", "start": 337, "end": 345, "id": 61, "ws": true}, {"text": "trials", "start": 346, "end": 352, "id": 62, "ws": true}, {"text": "performed", "start": 353, "end": 362, "id": 63, "ws": true}, {"text": "in", "start": 363, "end": 365, "id": 64, "ws": true}, {"text": "support", "start": 366, "end": 373, "id": 65, "ws": true}, {"text": "of", "start": 374, "end": 376, "id": 66, "ws": true}, {"text": "efficacy", "start": 377, "end": 385, "id": 67, "ws": true}, {"text": "ranged", "start": 386, "end": 392, "id": 68, "ws": true}, {"text": "from", "start": 393, "end": 397, "id": 69, "ws": true}, {"text": "a", "start": 398, "end": 399, "id": 70, "ws": true}, {"text": "single", "start": 400, "end": 406, "id": 71, "ws": true}, {"text": "night", "start": 407, "end": 412, "id": 72, "ws": true}, {"text": "to", "start": 413, "end": 415, "id": 73, "ws": true}, {"text": "5", "start": 416, "end": 417, "id": 74, "ws": true}, {"text": "weeks", "start": 418, "end": 423, "id": 75, "ws": true}, {"text": "in", "start": 424, "end": 426, "id": 76, "ws": true}, {"text": "duration", "start": 427, "end": 435, "id": 77, "ws": false}, {"text": ".", "start": 435, "end": 436, "id": 78, "ws": true}, {"text": "The", "start": 437, "end": 440, "id": 79, "ws": true}, {"text": "final", "start": 441, "end": 446, "id": 80, "ws": true}, {"text": "formal", "start": 447, "end": 453, "id": 81, "ws": true}, {"text": "assessments", "start": 454, "end": 465, "id": 82, "ws": true}, {"text": "of", "start": 466, "end": 468, "id": 83, "ws": true}, {"text": "sleep", "start": 469, "end": 474, "id": 84, "ws": true}, {"text": "latency", "start": 475, "end": 482, "id": 85, "ws": true}, {"text": "were", "start": 483, "end": 487, "id": 86, "ws": true}, {"text": "performed", "start": 488, "end": 497, "id": 87, "ws": true}, {"text": "at", "start": 498, "end": 500, "id": 88, "ws": true}, {"text": "the", "start": 501, "end": 504, "id": 89, "ws": true}, {"text": "end", "start": 505, "end": 508, "id": 90, "ws": true}, {"text": "of", "start": 509, "end": 511, "id": 91, "ws": true}, {"text": "treatment", "start": 512, "end": 521, "id": 92, "ws": false}, {"text": ".", "start": 521, "end": 522, "id": 93, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 9, "end": 17, "token_start": 1, "token_end": 1, "label": "FORMULATION"}, {"start": 51, "end": 60, "token_start": 9, "token_end": 9, "label": "ACTION"}, {"start": 64, "end": 72, "token_start": 11, "token_end": 11, "label": "INDICATION"}], "answer": "accept", "_timestamp": 1694177007, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "Diphenoxylate HCl and atropine sulfate tablets are indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older.", "_input_hash": 742772466, "_task_hash": 738576860, "_is_binary": false, "tokens": [{"text": "Diphenoxylate", "start": 0, "end": 13, "id": 0, "ws": true}, {"text": "HCl", "start": 14, "end": 17, "id": 1, "ws": true}, {"text": "and", "start": 18, "end": 21, "id": 2, "ws": true}, {"text": "atropine", "start": 22, "end": 30, "id": 3, "ws": true}, {"text": "sulfate", "start": 31, "end": 38, "id": 4, "ws": true}, {"text": "tablets", "start": 39, "end": 46, "id": 5, "ws": true}, {"text": "are", "start": 47, "end": 50, "id": 6, "ws": true}, {"text": "indicated", "start": 51, "end": 60, "id": 7, "ws": true}, {"text": "as", "start": 61, "end": 63, "id": 8, "ws": true}, {"text": "adjunctive", "start": 64, "end": 74, "id": 9, "ws": true}, {"text": "therapy", "start": 75, "end": 82, "id": 10, "ws": true}, {"text": "in", "start": 83, "end": 85, "id": 11, "ws": true}, {"text": "the", "start": 86, "end": 89, "id": 12, "ws": true}, {"text": "management", "start": 90, "end": 100, "id": 13, "ws": true}, {"text": "of", "start": 101, "end": 103, "id": 14, "ws": true}, {"text": "diarrhea", "start": 104, "end": 112, "id": 15, "ws": true}, {"text": "in", "start": 113, "end": 115, "id": 16, "ws": true}, {"text": "patients", "start": 116, "end": 124, "id": 17, "ws": true}, {"text": "13", "start": 125, "end": 127, "id": 18, "ws": true}, {"text": "years", "start": 128, "end": 133, "id": 19, "ws": true}, {"text": "of", "start": 134, "end": 136, "id": 20, "ws": true}, {"text": "age", "start": 137, "end": 140, "id": 21, "ws": true}, {"text": "and", "start": 141, "end": 144, "id": 22, "ws": true}, {"text": "older", "start": 145, "end": 150, "id": 23, "ws": false}, {"text": ".", "start": 150, "end": 151, "id": 24, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 14, "end": 17, "token_start": 1, "token_end": 1, "label": "SALT"}, {"start": 22, "end": 30, "token_start": 3, "token_end": 3, "label": "DRUG"}, {"start": 31, "end": 38, "token_start": 4, "token_end": 4, "label": "SALT"}, {"start": 39, "end": 46, "token_start": 5, "token_end": 5, "label": "FORMULATION"}, {"start": 64, "end": 82, "token_start": 9, "token_end": 10, "label": "ACTION"}, {"start": 90, "end": 100, "token_start": 13, "token_end": 13, "label": "ACTION"}, {"start": 104, "end": 112, "token_start": 15, "token_end": 15, "label": "INDICATION"}, {"start": 116, "end": 150, "token_start": 17, "token_end": 23, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694525200, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "AUVELITY is indicated for the treatment of major depressive disorder (MDD) in adults. AUVELITY is a combination of dextromethorphan, an uncompetitive N-methyl D-aspartate (NMDA) receptor antagonist and sigma-1 receptor agonist, and bupropion, an aminoketone and CYP450 2D6 inhibitor, indicated for the treatment of major depressive disorder (MDD) in adults. (1)", "_input_hash": -1528780822, "_task_hash": -821949142, "_is_binary": false, "tokens": [{"text": "AUVELITY", "start": 0, "end": 8, "id": 0, "ws": true}, {"text": "is", "start": 9, "end": 11, "id": 1, "ws": true}, {"text": "indicated", "start": 12, "end": 21, "id": 2, "ws": true}, {"text": "for", "start": 22, "end": 25, "id": 3, "ws": true}, {"text": "the", "start": 26, "end": 29, "id": 4, "ws": true}, {"text": "treatment", "start": 30, "end": 39, "id": 5, "ws": true}, {"text": "of", "start": 40, "end": 42, "id": 6, "ws": true}, {"text": "major", "start": 43, "end": 48, "id": 7, "ws": true}, {"text": "depressive", "start": 49, "end": 59, "id": 8, "ws": true}, {"text": "disorder", "start": 60, "end": 68, "id": 9, "ws": true}, {"text": "(", "start": 69, "end": 70, "id": 10, "ws": false}, {"text": "MDD", "start": 70, "end": 73, "id": 11, "ws": false}, {"text": ")", "start": 73, "end": 74, "id": 12, "ws": true}, {"text": "in", "start": 75, "end": 77, "id": 13, "ws": true}, {"text": "adults", "start": 78, "end": 84, "id": 14, "ws": false}, {"text": ".", "start": 84, "end": 85, "id": 15, "ws": true}, {"text": "AUVELITY", "start": 86, "end": 94, "id": 16, "ws": true}, {"text": "is", "start": 95, "end": 97, "id": 17, "ws": true}, {"text": "a", "start": 98, "end": 99, "id": 18, "ws": true}, {"text": "combination", "start": 100, "end": 111, "id": 19, "ws": true}, {"text": "of", "start": 112, "end": 114, "id": 20, "ws": true}, {"text": "dextromethorphan", "start": 115, "end": 131, "id": 21, "ws": false}, {"text": ",", "start": 131, "end": 132, "id": 22, "ws": true}, {"text": "an", "start": 133, "end": 135, "id": 23, "ws": true}, {"text": "uncompetitive", "start": 136, "end": 149, "id": 24, "ws": true}, {"text": "N", "start": 150, "end": 151, "id": 25, "ws": false}, {"text": "-", "start": 151, "end": 152, "id": 26, "ws": false}, {"text": "methyl", "start": 152, "end": 158, "id": 27, "ws": true}, {"text": "D", "start": 159, "end": 160, "id": 28, "ws": false}, {"text": "-", "start": 160, "end": 161, "id": 29, "ws": false}, {"text": "aspartate", "start": 161, "end": 170, "id": 30, "ws": true}, {"text": "(", "start": 171, "end": 172, "id": 31, "ws": false}, {"text": "NMDA", "start": 172, "end": 176, "id": 32, "ws": false}, {"text": ")", "start": 176, "end": 177, "id": 33, "ws": true}, {"text": "receptor", "start": 178, "end": 186, "id": 34, "ws": true}, {"text": "antagonist", "start": 187, "end": 197, "id": 35, "ws": true}, {"text": "and", "start": 198, "end": 201, "id": 36, "ws": true}, {"text": "sigma-1", "start": 202, "end": 209, "id": 37, "ws": true}, {"text": "receptor", "start": 210, "end": 218, "id": 38, "ws": true}, {"text": "agonist", "start": 219, "end": 226, "id": 39, "ws": false}, {"text": ",", "start": 226, "end": 227, "id": 40, "ws": true}, {"text": "and", "start": 228, "end": 231, "id": 41, "ws": true}, {"text": "bupropion", "start": 232, "end": 241, "id": 42, "ws": false}, {"text": ",", "start": 241, "end": 242, "id": 43, "ws": true}, {"text": "an", "start": 243, "end": 245, "id": 44, "ws": true}, {"text": "aminoketone", "start": 246, "end": 257, "id": 45, "ws": true}, {"text": "and", "start": 258, "end": 261, "id": 46, "ws": true}, {"text": "CYP450", "start": 262, "end": 268, "id": 47, "ws": true}, {"text": "2D6", "start": 269, "end": 272, "id": 48, "ws": true}, {"text": "inhibitor", "start": 273, "end": 282, "id": 49, "ws": false}, {"text": ",", "start": 282, "end": 283, "id": 50, "ws": true}, {"text": "indicated", "start": 284, "end": 293, "id": 51, "ws": true}, {"text": "for", "start": 294, "end": 297, "id": 52, "ws": true}, {"text": "the", "start": 298, "end": 301, "id": 53, "ws": true}, {"text": "treatment", "start": 302, "end": 311, "id": 54, "ws": true}, {"text": "of", "start": 312, "end": 314, "id": 55, "ws": true}, {"text": "major", "start": 315, "end": 320, "id": 56, "ws": true}, {"text": "depressive", "start": 321, "end": 331, "id": 57, "ws": true}, {"text": "disorder", "start": 332, "end": 340, "id": 58, "ws": true}, {"text": "(", "start": 341, "end": 342, "id": 59, "ws": false}, {"text": "MDD", "start": 342, "end": 345, "id": 60, "ws": false}, {"text": ")", "start": 345, "end": 346, "id": 61, "ws": true}, {"text": "in", "start": 347, "end": 349, "id": 62, "ws": true}, {"text": "adults", "start": 350, "end": 356, "id": 63, "ws": false}, {"text": ".", "start": 356, "end": 357, "id": 64, "ws": true}, {"text": "(", "start": 358, "end": 359, "id": 65, "ws": false}, {"text": "1", "start": 359, "end": 360, "id": 66, "ws": false}, {"text": ")", "start": 360, "end": 361, "id": 67, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 8, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 30, "end": 39, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 43, "end": 68, "token_start": 7, "token_end": 9, "label": "INDICATION"}, {"start": 78, "end": 84, "token_start": 14, "token_end": 14, "label": "TARGET_GROUP"}, {"start": 86, "end": 94, "token_start": 16, "token_end": 16, "label": "DRUG"}, {"start": 115, "end": 131, "token_start": 21, "token_end": 21, "label": "DRUG"}, {"start": 136, "end": 197, "token_start": 24, "token_end": 35, "label": "MECHANISM"}, {"start": 202, "end": 226, "token_start": 37, "token_end": 39, "label": "MECHANISM"}, {"start": 232, "end": 241, "token_start": 42, "token_end": 42, "label": "DRUG"}, {"start": 246, "end": 282, "token_start": 45, "token_end": 49, "label": "MECHANISM"}, {"start": 302, "end": 311, "token_start": 54, "token_end": 54, "label": "ACTION"}, {"start": 315, "end": 346, "token_start": 56, "token_end": 61, "label": "INDICATION"}, {"start": 350, "end": 356, "token_start": 63, "token_end": 63, "label": "TARGET_GROUP"}], "answer": "accept", "_timestamp": 1694177107, "_annotator_id": "dm_michel-michel", "_session_id": "dm_michel-michel"}
{"text": "VILEVEV MB is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections and antispasmodic. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.", "_input_hash": 1777583561, "_task_hash": 560917676, "_is_binary": false, "tokens": [{"text": "VILEVEV", "start": 0, "end": 7, "id": 0, "ws": true}, {"text": "MB", "start": 8, "end": 10, "id": 1, "ws": true}, {"text": "is", "start": 11, "end": 13, "id": 2, "ws": true}, {"text": "indicated", "start": 14, "end": 23, "id": 3, "ws": true}, {"text": "for", "start": 24, "end": 27, "id": 4, "ws": true}, {"text": "the", "start": 28, "end": 31, "id": 5, "ws": true}, {"text": "treatment", "start": 32, "end": 41, "id": 6, "ws": true}, {"text": "of", "start": 42, "end": 44, "id": 7, "ws": true}, {"text": "symptoms", "start": 45, "end": 53, "id": 8, "ws": true}, {"text": "of", "start": 54, "end": 56, "id": 9, "ws": true}, {"text": "irritative", "start": 57, "end": 67, "id": 10, "ws": true}, {"text": "voiding", "start": 68, "end": 75, "id": 11, "ws": false}, {"text": ".", "start": 75, "end": 76, "id": 12, "ws": true}, {"text": "Indicated", "start": 77, "end": 86, "id": 13, "ws": true}, {"text": "for", "start": 87, "end": 90, "id": 14, "ws": true}, {"text": "the", "start": 91, "end": 94, "id": 15, "ws": true}, {"text": "relief", "start": 95, "end": 101, "id": 16, "ws": true}, {"text": "of", "start": 102, "end": 104, "id": 17, "ws": true}, {"text": "local", "start": 105, "end": 110, "id": 18, "ws": true}, {"text": "symptoms", "start": 111, "end": 119, "id": 19, "ws": false}, {"text": ",", "start": 119, "end": 120, "id": 20, "ws": true}, {"text": "such", "start": 121, "end": 125, "id": 21, "ws": true}, {"text": "as", "start": 126, "end": 128, "id": 22, "ws": true}, {"text": "inflammation", "start": 129, "end": 141, "id": 23, "ws": false}, {"text": ",", "start": 141, "end": 142, "id": 24, "ws": true}, {"text": "hypermotility", "start": 143, "end": 156, "id": 25, "ws": false}, {"text": ",", "start": 156, "end": 157, "id": 26, "ws": true}, {"text": "and", "start": 158, "end": 161, "id": 27, "ws": true}, {"text": "pain", "start": 162, "end": 166, "id": 28, "ws": false}, {"text": ",", "start": 166, "end": 167, "id": 29, "ws": true}, {"text": "which", "start": 168, "end": 173, "id": 30, "ws": true}, {"text": "accompany", "start": 174, "end": 183, "id": 31, "ws": true}, {"text": "lower", "start": 184, "end": 189, "id": 32, "ws": true}, {"text": "urinary", "start": 190, "end": 197, "id": 33, "ws": true}, {"text": "tract", "start": 198, "end": 203, "id": 34, "ws": true}, {"text": "infections", "start": 204, "end": 214, "id": 35, "ws": true}, {"text": "and", "start": 215, "end": 218, "id": 36, "ws": true}, {"text": "antispasmodic", "start": 219, "end": 232, "id": 37, "ws": false}, {"text": ".", "start": 232, "end": 233, "id": 38, "ws": true}, {"text": "Indicated", "start": 234, "end": 243, "id": 39, "ws": true}, {"text": "for", "start": 244, "end": 247, "id": 40, "ws": true}, {"text": "the", "start": 248, "end": 251, "id": 41, "ws": true}, {"text": "relief", "start": 252, "end": 258, "id": 42, "ws": true}, {"text": "of", "start": 259, "end": 261, "id": 43, "ws": true}, {"text": "urinary", "start": 262, "end": 269, "id": 44, "ws": true}, {"text": "tract", "start": 270, "end": 275, "id": 45, "ws": true}, {"text": "symptoms", "start": 276, "end": 284, "id": 46, "ws": true}, {"text": "caused", "start": 285, "end": 291, "id": 47, "ws": true}, {"text": "by", "start": 292, "end": 294, "id": 48, "ws": true}, {"text": "diagnostic", "start": 295, "end": 305, "id": 49, "ws": true}, {"text": "procedures", "start": 306, "end": 316, "id": 50, "ws": false}, {"text": ".", "start": 316, "end": 317, "id": 51, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 7, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 32, "end": 41, "token_start": 6, "token_end": 6, "label": "ACTION"}, {"start": 45, "end": 53, "token_start": 8, "token_end": 8, "label": "INDICATION"}, {"start": 57, "end": 75, "token_start": 10, "token_end": 11, "label": "BASECONDITION"}, {"start": 129, "end": 141, "token_start": 23, "token_end": 23, "label": "INDICATION"}, {"start": 143, "end": 156, "token_start": 25, "token_end": 25, "label": "INDICATION"}, {"start": 162, "end": 166, "token_start": 28, "token_end": 28, "label": "INDICATION"}, {"start": 190, "end": 214, "token_start": 33, "token_end": 35, "label": "CAUSED_BY"}, {"start": 252, "end": 258, "token_start": 42, "token_end": 42, "label": "ACTION"}, {"start": 262, "end": 284, "token_start": 44, "token_end": 46, "label": "INDICATION"}, {"start": 295, "end": 316, "token_start": 49, "token_end": 50, "label": "CAUSED_BY"}], "answer": "accept", "_timestamp": 1694525707, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
{"text": "Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man.", "_input_hash": -1085078170, "_task_hash": -188396551, "_is_binary": false, "tokens": [{"text": "Chlorzoxazone", "start": 0, "end": 13, "id": 0, "ws": true}, {"text": "is", "start": 14, "end": 16, "id": 1, "ws": true}, {"text": "indicated", "start": 17, "end": 26, "id": 2, "ws": true}, {"text": "as", "start": 27, "end": 29, "id": 3, "ws": true}, {"text": "an", "start": 30, "end": 32, "id": 4, "ws": true}, {"text": "adjunct", "start": 33, "end": 40, "id": 5, "ws": true}, {"text": "to", "start": 41, "end": 43, "id": 6, "ws": true}, {"text": "rest", "start": 44, "end": 48, "id": 7, "ws": false}, {"text": ",", "start": 48, "end": 49, "id": 8, "ws": true}, {"text": "physical", "start": 50, "end": 58, "id": 9, "ws": true}, {"text": "therapy", "start": 59, "end": 66, "id": 10, "ws": false}, {"text": ",", "start": 66, "end": 67, "id": 11, "ws": true}, {"text": "and", "start": 68, "end": 71, "id": 12, "ws": true}, {"text": "other", "start": 72, "end": 77, "id": 13, "ws": true}, {"text": "measures", "start": 78, "end": 86, "id": 14, "ws": true}, {"text": "for", "start": 87, "end": 90, "id": 15, "ws": true}, {"text": "the", "start": 91, "end": 94, "id": 16, "ws": true}, {"text": "relief", "start": 95, "end": 101, "id": 17, "ws": true}, {"text": "of", "start": 102, "end": 104, "id": 18, "ws": true}, {"text": "discomfort", "start": 105, "end": 115, "id": 19, "ws": true}, {"text": "associated", "start": 116, "end": 126, "id": 20, "ws": true}, {"text": "with", "start": 127, "end": 131, "id": 21, "ws": true}, {"text": "acute", "start": 132, "end": 137, "id": 22, "ws": false}, {"text": ",", "start": 137, "end": 138, "id": 23, "ws": true}, {"text": "painful", "start": 139, "end": 146, "id": 24, "ws": true}, {"text": "musculoskeletal", "start": 147, "end": 162, "id": 25, "ws": true}, {"text": "conditions", "start": 163, "end": 173, "id": 26, "ws": false}, {"text": ".", "start": 173, "end": 174, "id": 27, "ws": true}, {"text": "The", "start": 175, "end": 178, "id": 28, "ws": true}, {"text": "mode", "start": 179, "end": 183, "id": 29, "ws": true}, {"text": "of", "start": 184, "end": 186, "id": 30, "ws": true}, {"text": "action", "start": 187, "end": 193, "id": 31, "ws": true}, {"text": "of", "start": 194, "end": 196, "id": 32, "ws": true}, {"text": "this", "start": 197, "end": 201, "id": 33, "ws": true}, {"text": "drug", "start": 202, "end": 206, "id": 34, "ws": true}, {"text": "has", "start": 207, "end": 210, "id": 35, "ws": true}, {"text": "not", "start": 211, "end": 214, "id": 36, "ws": true}, {"text": "been", "start": 215, "end": 219, "id": 37, "ws": true}, {"text": "clearly", "start": 220, "end": 227, "id": 38, "ws": true}, {"text": "identified", "start": 228, "end": 238, "id": 39, "ws": false}, {"text": ",", "start": 238, "end": 239, "id": 40, "ws": true}, {"text": "but", "start": 240, "end": 243, "id": 41, "ws": true}, {"text": "may", "start": 244, "end": 247, "id": 42, "ws": true}, {"text": "be", "start": 248, "end": 250, "id": 43, "ws": true}, {"text": "related", "start": 251, "end": 258, "id": 44, "ws": true}, {"text": "to", "start": 259, "end": 261, "id": 45, "ws": true}, {"text": "its", "start": 262, "end": 265, "id": 46, "ws": true}, {"text": "sedative", "start": 266, "end": 274, "id": 47, "ws": true}, {"text": "properties", "start": 275, "end": 285, "id": 48, "ws": false}, {"text": ".", "start": 285, "end": 286, "id": 49, "ws": true}, {"text": "Chlorzoxazone", "start": 287, "end": 300, "id": 50, "ws": true}, {"text": "does", "start": 301, "end": 305, "id": 51, "ws": true}, {"text": "not", "start": 306, "end": 309, "id": 52, "ws": true}, {"text": "directly", "start": 310, "end": 318, "id": 53, "ws": true}, {"text": "relax", "start": 319, "end": 324, "id": 54, "ws": true}, {"text": "tense", "start": 325, "end": 330, "id": 55, "ws": true}, {"text": "skeletal", "start": 331, "end": 339, "id": 56, "ws": true}, {"text": "muscles", "start": 340, "end": 347, "id": 57, "ws": true}, {"text": "in", "start": 348, "end": 350, "id": 58, "ws": true}, {"text": "man", "start": 351, "end": 354, "id": 59, "ws": false}, {"text": ".", "start": 354, "end": 355, "id": 60, "ws": false}], "_view_id": "ner_manual", "spans": [{"start": 0, "end": 13, "token_start": 0, "token_end": 0, "label": "DRUG"}, {"start": 33, "end": 40, "token_start": 5, "token_end": 5, "label": "ACTION"}, {"start": 95, "end": 101, "token_start": 17, "token_end": 17, "label": "ACTION"}, {"start": 105, "end": 115, "token_start": 19, "token_end": 19, "label": "INDICATION"}, {"start": 132, "end": 173, "token_start": 22, "token_end": 26, "label": "BASECONDITION"}], "answer": "accept", "_timestamp": 1694526537, "_annotator_id": "curation_md-michel", "_session_id": "curation_md-michel"}
